syndrome	score	normalized_score
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-HAND ANOMALIES SYNDROME	2.16857176	100.0
TRISOMY 8P	1.9141801899999997	88.26916523159002
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	1.583333	73.01270952638433
PSEUDOAMINOPTERIN SYNDROME	1.377592824	63.525351081764526
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	1.28305719	59.166001036553205
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	1.265608214	58.36137117270217
CZEIZEL-LOSONCI SYNDROME	1.1936639199999999	55.043782364850124
NON-DISTAL MONOSOMY 20Q	1.1126284499999999	51.306969431345905
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	1.10856877	51.11976418986477
TUBEROUS SCLEROSIS COMPLEX	1.1032388999999998	50.87398629593884
POLYDACTYLY, PREAXIAL IV; PPD4	1.1	50.72462992877856
CRANIOSYNOSTOSIS 4; CRS4	1.0666667	49.18752146804679
OTOSCLEROSIS 7	1.05030887	48.4332079469669
MARFAN SYNDROME	1.05	48.4189649320159
DEAFNESS, AUTOSOMAL DOMINANT 1	1.04695826	48.278700263070846
DEAFNESS, AUTOSOMAL DOMINANT 6	1.0232558	47.1857016158875
RING CHROMOSOME 12 SYNDROME	1.0139136139999998	46.75490259081857
EMANUEL SYNDROME	1.0136084939999999	46.74083250074233
SYNDACTYLY, TYPE IV; SDTY4	1.0131579	46.720054124471304
MIDDLE EAR NEUROENDOCRINE TUMOR	1.00150376	46.18264327116388
DISTAL 16P11.2 MICRODELETION SYNDROME	1.000545554	46.13845723048611
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	1.000545554	46.13845723048611
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	1.0	46.113299935253245
LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	1.0	46.113299935253245
HYDROLETHALUS SYNDROME 1	1.0	46.113299935253245
HEMIDYSTONIA-HEMIATROPHY SYNDROME	1.0	46.113299935253245
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 4; HHT4	1.0	46.113299935253245
RADIAL HEMIMELIA	1.0	46.113299935253245
ATRESIA OF SMALL INTESTINE	1.0	46.113299935253245
SYNDACTYLY-POLYDACTYLY-EARLOBE SYNDROME	1.0	46.113299935253245
DEAFNESS, AMINOGLYCOSIDE-INDUCED	1.0	46.113299935253245
TOWNES-BROCKS SYNDROME 1; TBS1	0.942130314	43.44473774757632
CRANIOSYNOSTOSIS 2	0.833333	38.42773457494439
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.708941244	32.69162022104356
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.667211554	30.767326509868415
CORTICAL DEFECTS, WORMIAN BONES, AND DENTINOGENESIS IMPERFECTA	0.666666	30.742169214635535
ANEURYSM-OSTEOARTHRITIS SYNDROME	0.65873	30.376214066349373
DUPLICATION/INVERSION 15Q11	0.6269936999999999	28.912748545614186
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.6166568139999999	28.43608062109967
COLE-CARPENTER SYNDROME 1; CLCRP1	0.58861342	27.142907182375193
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.546778674	25.213768992362052
BRANCHIOOTORENAL SYNDROME 1	0.5357143	24.703554195504235
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.531795554	24.52284788583616
DEAFNESS-HYPOGONADISM SYNDROME	0.5232558	24.129051648260884
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.514831254	23.740568031744544
227210 EYEBROWS, DUPLICATION OF, WITH STRETCHABLE SKIN AND SYNDACTYLY	0.5131579	23.663404156844685
OCULODENTODIGITAL DYSPLASIA; ODDD	0.51040993	23.536686192021612
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.5093157640000001	23.486230587084663
SYNDACTYLY TYPE 4	0.50735294	23.39571829525254
CRANIOSYNOSTOSIS-DANDY-WALKER MALFORMATION-HYDROCEPHALUS SYNDROME	0.50275482	23.183683808554257
GLOBAL DEVELOPMENTAL DELAY-OSTEOPENIA-ECTODERMAL DEFECT SYNDROME	0.50190476	23.14448473681129
17Q24.2 MICRODELETION SYNDROME	0.50190476	23.14448473681129
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.50151745	23.12662459461337
ANEURYSM OF SINUS OF VALSALVA	0.5	23.056649967626623
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.5	23.056649967626623
DEAFNESS, UNILATERAL	0.5	23.056649967626623
HYPOTRICHOSIS-INTELLECTUAL DISABILITY, LOPES TYPE	0.5	23.056649967626623
ACATALASEMIA	0.5	23.056649967626623
%608645 DEAFNESS, AUTOSOMAL DOMINANT 31; DFNA31	0.5	23.056649967626623
SHORT-RIB THORACIC DYSPLASIA 13 WITH OR WITHOUT POLYDACTYLY; SRTD13	0.5	23.056649967626623
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.5	23.056649967626623
DEAFNESS, UNILATERAL, WITH DELAYED ENDOLYMPHATIC HYDROPS	0.5	23.056649967626623
GLOMUVENOUS MALFORMATION	0.492857	22.72726266618911
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.42222256	19.470075548710458
FILIPPI SYNDROME; FLPIS	0.41641665	19.20234587948337
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.4040218140000001	18.6307790893671
SYNDACTYLY, TYPE V	0.400641	18.474878599359794
CAUDAL APPENDAGE-DEAFNESS SYNDROME	0.392857	18.115932672663785
ANEURYSM OR DILATATION OF ASCENDING AORTA	0.38998	17.983264708750056
FAMILIAL THORACIC AORTIC ANEURYSM AND AORTIC DISSECTION	0.38998	17.983264708750056
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.3627448	16.72735976235345
ACITRETIN/ETRETINATE EMBRYOPATHY	0.36256966	16.71928347900279
EPIDERMAL NEVUS SYNDROME	0.362099114	16.697585050171458
PFEIFFER SYNDROME TYPE 1	0.35194238999999994	16.229224989999867
SYMPHALANGISM WITH MULTIPLE ANOMALIES OF HANDS AND FEET	0.35109587	16.19018915933868
EARLOBES, THICKENED, WITH CONDUCTIVE DEAFNESS FROM INCUDOSTAPEDIALABNORMALITIES	0.35	16.139654977338633
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.34839566	16.06567356572051
CROUZON DISEASE	0.34483324	15.901398623765164
PELVIS-SHOULDER DYSPLASIA	0.34390032	15.858378603989568
OROFACIODIGITAL SYNDROME I; OFD1	0.34249413	15.793534542753616
22Q11.2 DELETION SYNDROME	0.341487744	15.747126763284975
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.3409091	15.72044357895724
DEAFNESS AND MYOPIA; DFNMYP	0.33818737	15.594935627124462
FRONTONASAL DYSPLASIA-BIFID NOSE-UPPER LIMB ANOMALIES SYNDROME	0.3360578	15.496734126981348
DISTAL MONOSOMY 10Q	0.333945274	15.399318581922328
DEAFNESS, AUTOSOMAL RECESSIVE 102; DFNB102	0.333333	15.371084607317767
HEMIHYPERPLASIA-MULTIPLE LIPOMATOSIS SYNDROME	0.333333	15.371084607317767
ARTHROGRYPOSIS, DISTAL, TYPE 4; DA4	0.333333	15.371084607317767
PLACENTAL INSUFFICIENCY	0.333333	15.371084607317767
POTOCKI-SHAFFER SYNDROME	0.333333	15.371084607317767
SPINOCEREBELLAR ATAXIA TYPE 42	0.333333	15.371084607317767
NEUROMYELITIS OPTICA	0.333333	15.371084607317767
HYPOGONADISM WITH LOW-GRADE MENTAL DEFICIENCY AND MICROCEPHALY	0.333333	15.371084607317767
HYDRANENCEPHALY	0.31258844399999997	14.41448467446611
MOHR-TRANEBJAERG SYNDROME	0.3125	14.410406229766636
AORTIC ANEURYSM, FAMILIAL THORACIC 8; AAT8	0.311111	14.346354856156573
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.310624374	14.323914925462278
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.30580070000000004	14.101479399510398
SAGLIKER SYNDROME	0.3020201	13.927143457775179
KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1	0.29120881	13.428599199318173
DISTAL MONOSOMY 15Q	0.289682064	13.358195903095227
FRONTORHINY	0.2857143	13.175229211690926
POTOCKI-LUPSKI SYNDROME	0.280345904	12.92767475677171
FG SYNDROME TYPE 1	0.279293044	12.879123907801882
FAMILIAL AORTIC DISSECTION	0.27886900000000003	12.85956983964414
AORTIC ANEURYSM, FAMILIAL THORACIC 6	0.2763158	12.741833362249446
ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 1	0.275641	12.710716107453141
16P12.1P12.3 TRIPLICATION SYNDROME	0.2631579	12.135079173031379
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.256101154	11.80966932816648
CHILDHOOD APRAXIA OF SPEECH	0.2555556	11.784512032933602
RING CHROMOSOME 7 SYNDROME	0.25524369	11.7701288335508
PGM3-CDG	0.25485437	11.752176003620006
OTOMANDIBULAR SYNDROME	0.25425858	11.724702160651582
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.25403633999999997	11.714453940873968
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.2534965	11.689560137036924
CENTRAL NEUROCYTOMA	0.25275482	11.655358824740944
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.25217257400000004	11.628509540306844
ALG13-CDG	0.25190476	11.616159752997984
AUTOSOMAL RECESSIVE PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.25151745	11.598299610800058
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.25151745	11.598299610800058
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA-DEAFNESS-NARCOLEPSY SYNDROME	0.25150376	11.597668319723947
ECTODERMAL DYSPLASIA, TRICHOODONTOONYCHIAL TYPE	0.25	11.528324983813311
ATAXIA-OCULOMOTOR APRAXIA TYPE 4	0.25	11.528324983813311
HYPERPARATHYROIDISM 2	0.25	11.528324983813311
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.25	11.528324983813311
DEND SYNDROME	0.25	11.528324983813311
PITUITARY APOPLEXY	0.25	11.528324983813311
HYPOTRICHOSIS WITH JUVENILE MACULAR DEGENERATION	0.25	11.528324983813311
SYNDACTYLY, TYPE III	0.25	11.528324983813311
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25	11.528324983813311
OSSICULAR MALFORMATIONS, FAMILIAL	0.25	11.528324983813311
DYSTONIA 6, TORSION	0.25	11.528324983813311
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.25	11.528324983813311
DYSPLASTIC CORTICAL HYPEROSTOSIS	0.25	11.528324983813311
MULTISYSTEMIC SMOOTH MUSCLE DYSFUNCTION SYNDROME	0.247619	11.418529216667473
UNDIFFERENTIATED PLEOMORPHIC SARCOMA	0.242857	11.198937682375796
NEUROGENIC ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.242857	11.198937682375796
TRISOMY 18	0.236292154	10.896210969749049
BENIGN SCHWANNOMA	0.23571430000000002	10.869564214928264
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.23376609999999998	10.779726283994401
SYNPOLYDACTYLY 1	0.23357275	10.770810277451922
AORTIC ANEURYSM, FAMILIAL THORACIC 10; AAT10	0.23327009999999998	10.756854087226516
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.23125	10.663700610027313
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.23122130000000002	10.66237715831917
MACROSOMIA-MICROPHTHALMIA-CLEFT PALATE SYNDROME	0.21978009999999998	10.13478567109995
6P22 MICRODELETION SYNDROME	0.21567577999999998	9.945521931909692
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.21037770400000003	9.701210164241928
DIFFUSE NEONATAL HEMANGIOMATOSIS	0.20840336	9.610166647194559
CLEFT VELUM	0.20485437	9.446511006857344
TREMOR, HEREDITARY ESSENTIAL, AND IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUS	0.20251889	9.338814317124559
EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2	0.20238130000000001	9.332469588186468
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.20151745000000001	9.292634614037398
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.20150376	9.292003322961284
COCKAYNE SYNDROME A; CSA	0.20150376	9.292003322961284
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.20054555400000001	9.247817282283526
HYDROCEPHALUS, NORMAL-PRESSURE	0.20054555400000001	9.247817282283526
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.20054555400000001	9.247817282283526
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.20054555400000001	9.247817282283526
CHROMOSOME 2Q35 DUPLICATION SYNDROME	0.2001145	9.227939959893234
FAMILIAL HYPERALDOSTERONISM TYPE I	0.2	9.22265998705065
POLYARTERITIS NODOSA	0.2	9.22265998705065
MALARIA	0.2	9.22265998705065
CONGENITAL AORTIC VALVE STENOSIS	0.2	9.22265998705065
BETA-THALASSEMIA	0.2	9.22265998705065
AORTIC ANEURYSM, FAMILIAL THORACIC 9; AAT9	0.2	9.22265998705065
ANEURYSM, INTRACRANIAL BERRY, 2	0.2	9.22265998705065
PROGRESSIVE NON-INFECTIOUS ANTERIOR VERTEBRAL FUSION	0.2	9.22265998705065
ANEURYSM, INTRACRANIAL BERRY, 3	0.2	9.22265998705065
JUVENILE HYALINE FIBROMATOSIS	0.2	9.22265998705065
POLYCYSTIC KIDNEYS	0.2	9.22265998705065
INFANTILE MYOFIBROMATOSIS	0.2	9.22265998705065
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.19496940000000001	8.990682420396363
OTODENTAL SYNDROME	0.1899228	8.757967040943115
ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 9	0.1888892	8.710304334130036
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.18174500000000002	8.380861696732602
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.18172966000000002	8.380154318711593
SCALP-EAR-NIPPLE SYNDROME; SENS	0.1798249	8.29231954952692
KBG SYNDROME	0.179738154	8.288319405210737
LIMB-MAMMARY SYNDROME	0.17674474	8.150283207598351
PALLISTER-HALL SYNDROME	0.17456549400000002	8.049790983167652
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.17322754399999998	7.988093693519277
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.168716314	7.780065991452366
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.167212554	7.71072265554173
ROSSELLI-GULIENETTI SYNDROME	0.16670935399999998	7.687518443014309
CEREBROOCULONASAL SYNDROME	0.166667	7.685565360308852
CHRONIC INTESTINAL PSEUDOOBSTRUCTION	0.166667	7.685565360308852
ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 2; ARVD2	0.166667	7.685565360308852
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.166667	7.685565360308852
DERMATOLEUKODYSTROPHY	0.166667	7.685565360308852
MUCOLIPIDOSIS TYPE II	0.166667	7.685565360308852
FECHTNER SYNDROME	0.166667	7.685565360308852
CLEFT LIP/PALATE-ECTODERMAL DYSPLASIA SYNDROME; CLPED1	0.16616379999999997	7.662361147781431
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.16519405999999998	7.617643236302218
CRANIOSYNOSTOSIS AND DENTAL ANOMALIES; CRSDA	0.16497541	7.607560563271376
JERVELL AND LANGE-NIELSEN SYNDROME	0.16369029999999998	7.548299900391584
MOSAIC TRISOMY 1	0.16338814000000002	7.534366305683148
FREE SIALIC ACID STORAGE DISEASE	0.157688254	7.2715257529683965
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.15605788999999998	7.196344288832757
SCLEROSTEOSIS 1; SOST1	0.15514110000000003	7.154068076585118
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.155134854	7.153780052913721
CURRY-JONES SYNDROME	0.153442894	7.07575819395527
DISTAL MONOSOMY 7Q36	0.14558179999999998	6.713257208514049
LÉRI-WEILL DYSCHONDROSTEOSIS	0.14558179999999998	6.713257208514049
SCHINZEL-GIEDION SYNDROME	0.14537588999999998	6.7037620189243805
CROUZON SYNDROME	0.14530237	6.700371769113142
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.14508859000000002	6.690513667852985
UNILATERAL POLYMICROGYRIA	0.14476176	6.675442458035145
PIEBALDISM	0.14437445	6.657582315837221
SARCOSINEMIA	0.143402554	6.6127649840833485
ADULT-ONSET MULTIPLE MITOCHONDRIAL DNA DELETION SYNDROME DUE TO DGUOK DEFICIENCY	0.14285699999999998	6.587607688850472
CATARACT-ATAXIA-DEAFNESS SYNDROME	0.14285699999999998	6.587607688850472
FAMILIAL MULTIPLE NEVI FLAMMEI	0.14285699999999998	6.587607688850472
DELAYED ENCEPHALOPATHY DUE TO CARBON MONOXIDE POISONING	0.14285699999999998	6.587607688850472
%603964 DEAFNESS, AUTOSOMAL DOMINANT 16; DFNA16	0.14285699999999998	6.587607688850472
INCLUSION BODY MYOPATHY WITH PAGET DISEASE OF BONE AND FRONTOTEMPORAL DEMENTIA	0.14285699999999998	6.587607688850472
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 3	0.14285699999999998	6.587607688850472
ALBINISM, OCULAR, WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.14285699999999998	6.587607688850472
ARNOLD-CHIARI MALFORMATION TYPE I	0.14285699999999998	6.587607688850472
CATARACT-ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.14285699999999998	6.587607688850472
LIPODYSTROPHY DUE TO PEPTIDIC GROWTH FACTORS DEFICIENCY	0.14285699999999998	6.587607688850472
DEAFNESS, AUTOSOMAL RECESSIVE, 24	0.14285699999999998	6.587607688850472
PACMAN DYSPLASIA	0.14285699999999998	6.587607688850472
SPASTIC TETRAPLEGIA-RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY SYNDROME	0.14285699999999998	6.587607688850472
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 46	0.14285699999999998	6.587607688850472
DEAFNESS, AUTOSOMAL RECESSIVE 48	0.14285699999999998	6.587607688850472
CDAGS SYNDROME	0.14249731399999999	6.5710213804499595
ISOLATED OXYCEPHALY	0.140448	6.476520749306447
FEINGOLD SYNDROME 1; FGLDS1	0.13967535	6.440891308111474
BRACHYDACTYLY, TYPE B2	0.13825575999999998	6.375429328656386
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.1381579	6.370916681124723
AUROCEPHALOSYNDACTYLY	0.13782591000000002	6.35560752667922
FETAL HYDANTOIN SYNDROME	0.135910254	6.267270306978452
DEAFNESS, AUTOSOMAL DOMINANT 39, WITH DENTINOGENESIS IMPERFECTA 1	0.1319443	6.0843870806470335
MONOSOMY 18Q	0.13111993400000002	6.046372844032611
LACRIMOAURICULODENTODIGITAL SYNDROME; LADD	0.12934820000000002	5.964672342685124
JAWAD SYNDROME	0.125545554	5.789319787139532
ZIMMERMANN-LABAND SYNDROME 1	0.12367655000000001	5.703133845107345
DESBUQUOIS DYSPLASIA 2; DBQD2	0.12124826400000002	5.591157564460769
SLC39A8-CDG	0.12096128999999999	5.577924246325148
LOEYS-DIETZ SYNDROME 3; LDS3	0.12081599999999999	5.571224444977555
DISTAL MONOSOMY 12Q	0.11833301400000001	5.456725766824522
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.1173081	5.40946360013468
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.116656814	5.379430653473049
GIANT CELL ARTERITIS	0.11596536999999998	5.3475458889126175
PETTIGREW SYNDROME	0.115915134	5.34522934117707
SYNDACTYLY TYPE 2	0.1158827	5.343733702406971
SYNDACTYLY TYPE 5	0.1158827	5.343733702406971
3Q13 MICRODELETION SYNDROME	0.1153846	5.320764667709222
MULTIPLE SYNOSTOSES SYNDROME 3; SYNS3	0.11500205	5.30312402481899
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.11367685400000001	5.2420148641979925
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.113415354	5.229956236264923
COFFIN-SIRIS SYNDROME 1; CSS1	0.113174004	5.21882679132555
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.113174004	5.21882679132555
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.11261476	5.193038205016559
DEAFNESS, X-LINKED 4	0.11261476	5.193038205016559
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.11165655399999999	5.1488521643388
185750 SYMPHALANGISM WITH MULTIPLE ANOMALIES OF HANDS AND FEET	0.11143449000000001	5.138612060501979
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 7	0.11111099999999999	5.123694869105922
AORTIC ANEURYSM, ABDOMINAL	0.11111099999999999	5.123694869105922
BASAN SYNDROME	0.11111099999999999	5.123694869105922
ARTHROGRYPOSIS, DISTAL, TYPE 7	0.11111099999999999	5.123694869105922
SECKEL SYNDROME 10; SCKL10	0.11111099999999999	5.123694869105922
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 17	0.11111099999999999	5.123694869105922
TRISOMY 18P	0.11068931	5.104249351656226
NAGER SYNDROME	0.10891672000000001	5.0225093773239955
CATARACT-GROWTH HORMONE DEFICIENCY-SENSORY NEUROPATHY-SENSORINEURAL HEARING LOSS-SKELETAL DYSPLASIA SYNDROME	0.10658909999999999	4.915175138128701
1P36 DELETION SYNDROME	0.106552974	4.91350924905524
POLAND SYNDROME	0.10584795000000001	4.880998265881688
KUFOR-RAKEB SYNDROME	0.1051948	4.8508793640289785
3MC SYNDROME 1	0.10454886999999999	4.821093400201799
COLE-CARPENTER SYNDROME 2; CLCRP2	0.10361556999999999	4.778055857372228
ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2	0.10361556999999999	4.778055857372228
SYNDACTYLY, MESOAXIAL SYNOSTOTIC, WITH PHALANGEAL REDUCTION	0.1027248	4.736979513188903
19P13.12 MICRODELETION SYNDROME	0.101033684	4.658996573855596
INCONTINENTIA PIGMENTI	0.10093130400000001	4.654275494208226
CORNEODERMATOOSSEOUS SYNDROME	0.10082991000000001	4.6495998822745905
CUTIS GYRATA-ACANTHOSIS NIGRICANS-CRANIOSYNOSTOSIS SYNDROME	0.10080572	4.648484401549156
CLEFT PALATE-STAPES FIXATION-OLIGODONTIA SYNDROME	0.1	4.611329993525325
CLEFT PALATE, DEAFNESS, AND OLIGODONTIA	0.1	4.611329993525325
METAPHYSEAL ANADYSPLASIA	0.1	4.611329993525325
PAGET DISEASE OF BONE 2, EARLY-ONSET; PDB2	0.1	4.611329993525325
DEAFNESS, PROGRESSIVE, WITH STAPES FIXATION	0.1	4.611329993525325
KAPOSI SARCOMA	0.1	4.611329993525325
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL DOMINANT	0.1	4.611329993525325
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.099432354	4.585153963270278
SCARF SYNDROME	0.09696969999999999	4.471592860731525
HOLOPROSENCEPHALY, SEMILOBAR, WITH CRANIOSYNOSTOSIS	0.09696969999999999	4.471592860731525
JACOBSEN SYNDROME	0.096097294	4.431363341188212
3P25.3 MICRODELETION SYNDROME	0.09590936000000001	4.42269708427818
CHARGE SYNDROME	0.09569690400000001	4.4129000370271365
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.09518137	4.389127063058315
WILLIAMS SYNDROME	0.09513766000000001	4.3871114507181455
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.09495115400000001	4.378511043600421
DISLOCATION OF THE HIP-DYSMORPHISM SYNDROME	0.0945378	4.359449926618984
MALE PSEUDOHERMAPHRODITISM/MENTAL RETARDATION SYNDROME, VERLOES TYPE	0.0944056	4.353353748367543
MOSAIC MONOSOMY X	0.09242655000000001	4.26209322213068
TURNER SYNDROME	0.09242655000000001	4.26209322213068
MONOSOMY X	0.09242655000000001	4.26209322213068
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.09242655000000001	4.26209322213068
SCLEROSTEOSIS	0.09241286000000001	4.261461931054567
MARINESCO-SJÖGREN SYNDROME	0.09145465400000001	4.217275890376808
X-LINKED INTELLECTUAL DISABILITY-CRANIOFACIOSKELETAL SYNDROME	0.09123237000000001	4.207025641614
X SMALL RINGS	0.091156554	4.2035295156661086
DISORDER OF SEX DEVELOPMENT-INTELLECTUAL DISABILITY SYNDROME	0.0909091	4.192118595143931
AUTOSOMAL DOMINANT COARCTATION OF AORTA	0.0909091	4.192118595143931
CONGENITAL HEART DEFECTS, HAMARTOMAS OF TONGUE, AND POLYSYNDACTYLY	0.0909091	4.192118595143931
BAZEX-DUPRÉ-CHRISTOL SYNDROME	0.0909091	4.192118595143931
CLEFT LIP/PALATE-DEAFNESS-SACRAL LIPOMA SYNDROME	0.0909091	4.192118595143931
HEART DEFECT-TONGUE HAMARTOMA-POLYSYNDACTYLY SYNDROME	0.0909091	4.192118595143931
FAMILIAL BICUSPID AORTIC VALVE	0.0909091	4.192118595143931
YEMENITE DEAF-BLIND HYPOPIGMENTATION SYNDROME	0.0909091	4.192118595143931
SYNOSTOSIS, CARPAL, WITH DYSPLASTIC ELBOW JOINTS AND BRACHYDACTYLY	0.0909091	4.192118595143931
TENDONS, EXTENSOR, OF FINGERS, ANOMALOUS INSERTION OF	0.0909091	4.192118595143931
DEAFNESS, AUTOSOMAL RECESSIVE 28	0.0909091	4.192118595143931
POSTAXIAL TETRAMELIC OLIGODACTYLY	0.0909091	4.192118595143931
MOEBIUS SYNDROME-AXONAL NEUROPATHY-HYPOGONADOTROPIC HYPOGONADISM SYNDROME	0.0909091	4.192118595143931
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.0909091	4.192118595143931
RARE CIRCULATORY SYSTEM DISEASE	0.0909091	4.192118595143931
19Q13.11 MICRODELETION SYNDROME	0.09077650000000001	4.186003971572516
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.09067078399999999	4.181129057956561
DOORS SYNDROME	0.09022695400000001	4.160662592046298
DOWN SYNDROME	0.08999678000000001	4.150048509347001
BECKWITH-WIEDEMANN SYNDROME	0.08921751000000001	4.114113798106455
CONGENITAL ENTEROVIRUS INFECTION	0.08784535000000002	4.050838972467299
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.08700084000000001	4.011895829538978
APERT SYNDROME	0.08684989000000001	4.004935026913752
3C SYNDROME	0.08607142400000002	3.969037390766355
FILIPPI SYNDROME	0.08604140400000002	3.9676530695022985
TRIPLOIDY	0.08552587000000002	3.943880095533478
HALLERMANN-STREIFF SYNDROME	0.08514241	3.926197489540305
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.08302421400000001	3.828520482070652
TOWNES-BROCKS SYNDROME	0.08302379000000001	3.8285009300314794
AICARDI-GOUTIÈRES SYNDROME	0.082011844	3.781836760615199
KAPUR-TORIELLO SYNDROME	0.08177747	3.771029002056174
NEONATAL MARFAN SYNDROME	0.08125	3.746705619739326
MARFAN SYNDROME; MFS	0.08125	3.746705619739326
15Q24 MICRODELETION SYNDROME	0.08084454400000002	3.7280087056007787
TRICHOHEPATOENTERIC SYNDROME 1	0.08081415	3.7266071379625463
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.08019345400000001	3.697984797145934
ISOLATED OPTIC NERVE HYPOPLASIA/APLASIA	0.07944199	3.663332312323389
TERMINAL OSSEOUS DYSPLASIA; TOD	0.07924110000000001	3.654068611499396
14Q11.2 MICRODELETION SYNDROME	0.07878154000000001	3.632876783381151
KENNERKNECHT SYNDROME	0.07878154000000001	3.632876783381151
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.07844055000000001	3.6171526092362294
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.07844055000000001	3.6171526092362294
CONGENITAL RUBELLA SYNDROME	0.07842686000000001	3.616521318160116
TRISOMY 13	0.07842686000000001	3.616521318160116
2P15P16.1 MICRODELETION SYNDROME	0.077915254	3.5929294772334397
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.07692310000000001	3.547177982249479
MEGALENCEPHALY	0.07692310000000001	3.547177982249479
ISOLATED AGAMMAGLOBULINEMIA	0.07692310000000001	3.547177982249479
IMMUNODEFICIENCY 36; IMD36	0.07692310000000001	3.547177982249479
ETHYLMALONIC ENCEPHALOPATHY	0.07692310000000001	3.547177982249479
BABESIOSIS	0.07692310000000001	3.547177982249479
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.07692310000000001	3.547177982249479
DDOST-CDG	0.07692310000000001	3.547177982249479
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.07692310000000001	3.547177982249479
TRIOPIA	0.07692310000000001	3.547177982249479
SQUAMOUS CELL CARCINOMA OF THE ESOPHAGUS	0.07692310000000001	3.547177982249479
ADENOCARCINOMA OF THE ESOPHAGUS	0.07692310000000001	3.547177982249479
2Q32Q33 MICRODELETION SYNDROME	0.076603714	3.532450039836358
MOSAIC TRISOMY 15	0.0760649	3.5076035482450445
FONTAINE PROGEROID SYNDROME; FPS	0.07593153999999999	3.5014538785656786
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.074953104	3.4563349658302296
CHROMOSOME 1P36 DELETION SYNDROME	0.074949864	3.456185558738439
PFEIFFER SYNDROME TYPE 2	0.073023914	3.3673736487281376
SHPRINTZEN-GOLDBERG SYNDROME	0.07263386000000001	3.349386971635193
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.072359164	3.3367198325961787
CARPENTER SYNDROME	0.07164644	3.3038537770131255
WORMIAN BONE-MULTIPLE FRACTURES-DENTINOGENESIS IMPERFECTA-SKELETAL DYSPLASIA	0.07142860000000001	3.2938084557552303
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.071400904	3.292531301800223
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.07077809	3.263811293014348
DEAFNESS, AUTOSOMAL DOMINANT 50	0.07021406000000001	3.237802008451868
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.07008302400000001	3.2317595060815516
ADAMS-OLIVER SYNDROME	0.06963773000000001	3.211225530300183
SIALURIA	0.06925905400000001	3.1937635303339014
CRANIOECTODERMAL DYSPLASIA 4	0.06911930000000001	3.1873190122147497
DEAFNESS, AUTOSOMAL RECESSIVE 30; DFNB30	0.0687103	3.168458672541231
COG5-CDG	0.06853462	3.1603574880086054
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.06835199	3.1519358160414304
VELOCARDIOFACIAL SYNDROME	0.0678733	3.1298618404954235
DISTAL MONOSOMY 17Q	0.06722686	3.1000523588852786
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.06719097	3.0983973525506023
DEAFNESS, SENSORINEURAL, WITH PERIPHERAL NEUROPATHY AND ARTERIAL DISEASE	0.06628780000000001	3.05674920344808
CHROMOSOME 18Q DELETION SYNDROME	0.06622996	3.054082010179825
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.065636974	3.0267374689044186
OROFACIODIGITAL SYNDROME IV; OFD4	0.0655401	3.022270289086491
KLEEBLATTSCHAEDEL SYNDROME	0.06509142	3.0015801736715413
FLOATING-HARBOR SYNDROME	0.06432046400000001	2.966028848406659
HEC SYNDROME	0.06395896000000001	2.949358706026865
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.063432554	2.9250843882611477
THANATOPHORIC DYSPLASIA	0.06331381	2.919608710573636
THANATOPHORIC DYSPLASIA TYPE 1	0.06331381	2.919608710573636
THANATOPHORIC DYSPLASIA TYPE 2	0.06331381	2.919608710573636
FLOATING-HARBOR SYNDROME	0.06313477	2.9113525853532285
17P11.2 MICRODUPLICATION SYNDROME	0.063113114	2.91035395572983
VASCULAR EHLERS-DANLOS SYNDROME	0.062839964	2.897758107852516
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0626959	2.891114841410644
MEIER-GORLIN SYNDROME 7	0.06259025400000001	2.8862431557256847
DEAFNESS, CONGENITAL NEUROSENSORY, AUTOSOMAL RECESSIVE 39	0.0625	2.882081245953328
DEAFNESS, CONGENITAL NEUROSENSORY, AUTOSOMAL RECESSIVE 40	0.0625	2.882081245953328
DEAFNESS, AUTOSOMAL RECESSIVE 85	0.0625	2.882081245953328
DEAFNESS, AUTOSOMAL RECESSIVE 12; DFNB12	0.0625	2.882081245953328
DEAFNESS, CONGENITAL NEUROSENSORY, AUTOSOMAL RECESSIVE 38	0.0625	2.882081245953328
DEAFNESS, AUTOSOMAL RECESSIVE 49	0.0625	2.882081245953328
DEAFNESS, AUTOSOMAL RECESSIVE 62	0.0625	2.882081245953328
DEAFNESS, AUTOSOMAL RECESSIVE 104; DFNB104	0.0625	2.882081245953328
DEAFNESS, AUTOSOMAL RECESSIVE 83	0.0625	2.882081245953328
DEAFNESS, AUTOSOMAL RECESSIVE 71	0.0625	2.882081245953328
DEAFNESS, AUTOSOMAL RECESSIVE 45	0.0625	2.882081245953328
DEAFNESS, AUTOSOMAL RECESSIVE 44	0.0625	2.882081245953328
MUCOPOLYSACCHARIDOSIS TYPE 2	0.062459284000000004	2.880203696833164
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.06230213	2.872956807295139
ALSTROM SYNDROME; ALMS	0.062262854	2.871145661326882
ANIRIDIA-RENAL AGENESIS-PSYCHOMOTOR RETARDATION SYNDROME	0.06136955	2.8299524660415205
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.061273814	2.8255377631589194
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.061111160000000005	2.8180372504712508
BEEMER-ERTBRUGGEN SYNDROME	0.061050110000000005	2.8152220335102034
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.060955524000000004	2.810860360922528
CEREBROCOSTOMANDIBULAR SYNDROME	0.06021077	2.7765172963425475
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.06021077	2.7765172963425475
COLE-CARPENTER SYNDROME	0.05999220400000001	2.7664384968288993
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.059578250000000006	2.7473497118675017
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.059236159999999996	2.7315748130926503
8Q24.3 MICRODELETION SYNDROME	0.05882595400000001	2.71265886077941
ARTHROGRYPOSIS-OCULOMOTOR LIMITATION-ELECTRORETINAL ANOMALIES SYNDROME	0.0588235	2.712545698741369
VON WILLEBRAND DISEASE	0.0588235	2.712545698741369
RHIZOMELIC DYSPLASIA, PATTERSON-LOWRY TYPE	0.0588235	2.712545698741369
BANGSTAD SYNDROME	0.0588235	2.712545698741369
ANOPHTHALMIA PLUS SYNDROME	0.0588235	2.712545698741369
ASCHER SYNDROME	0.0588235	2.712545698741369
RING CHROMOSOME 8 SYNDROME	0.0588235	2.712545698741369
OROMANDIBULAR-LIMB HYPOGENESIS SYNDROME	0.0588235	2.712545698741369
CRANIO-OSTEOARTHROPATHY	0.0588235	2.712545698741369
PEHO SYNDROME	0.058450864	2.695362223106696
CLASSICAL EHLERS-DANLOS SYNDROME	0.05840336	2.693171656906572
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.05834962400000001	2.6906937126212513
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.0582804	2.687501565546533
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.05746971	2.650117974422023
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.057181754	2.636839373025867
VENTRICULOMEGALY WITH DEFECTS OF THE RADIUS AND KIDNEY	0.05690770999999999	2.6242022998584096
LISSENCEPHALY 5; LIS5	0.056903869999999995	2.6240252247866587
ICF SYNDROME	0.056101154	2.587009341115832
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.056101154	2.587009341115832
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.056101154	2.587009341115832
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.056101154	2.587009341115832
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.055931973999999995	2.5792078930327857
THANATOPHORIC DYSPLASIA, TYPE I	0.055931973999999995	2.5792078930327857
ALKAPTONURIA	0.0557276	2.5697835334718184
PROTEUS-LIKE SYNDROME	0.055555600000000004	2.561852045882955
THAKKER-DONNAI SYNDROME	0.055555600000000004	2.561852045882955
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.055555600000000004	2.561852045882955
HYDROCEPHALY-LOW INSERTION UMBILICUS SYNDROME	0.055555600000000004	2.561852045882955
SPECIFIC LANGUAGE IMPAIRMENT 2; SLI2	0.055555600000000004	2.561852045882955
HYDROCEPHALUS, ENDOCARDIAL FIBROELASTOSIS, AND CATARACTS	0.055555600000000004	2.561852045882955
DYSPHASIA, FAMILIAL DEVELOPMENTAL	0.055555600000000004	2.561852045882955
FAMILIAL DEVELOPMENTAL DYSPHASIA	0.055555600000000004	2.561852045882955
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.05538642	2.5540505977999084
PORENCEPHALY	0.05515049	2.5431710869461845
TARP SYNDROME; TARPS	0.055073924	2.539640376023342
KRABBE DISEASE	0.054680914	2.5215173880157877
MEESTER-LOEYS SYNDROME; MRLS	0.054028940000000004	2.4914527154038013
SCHIZENCEPHALY	0.053177154	2.4521740521051516
COFFIN-SIRIS SYNDROME 7; CSS7	0.053001624000000004	2.444079784567517
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, RUSSE TYPE; HMSNR	0.0527472	2.43234745434479
CONGENITAL ERYTHROPOIETIC PORPHYRIA	0.0527472	2.43234745434479
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.0527472	2.43234745434479
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.0526316	2.4270167568722743
CLOVERLEAF SKULL-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.0526316	2.4270167568722743
MICROGASTRIA-LIMB REDUCTION DEFECTS ASSOCIATION; MLRD	0.0526316	2.4270167568722743
THANATOPHORIC DYSPLASIA, TYPE II	0.0526316	2.4270167568722743
LINEAR NEVUS SEBACEUS SYNDROME	0.0526316	2.4270167568722743
MICROMELIC BONE DYSPLASIA WITH CLOVERLEAF SKULL	0.0526316	2.4270167568722743
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS	0.0526316	2.4270167568722743
PORENCEPHALY, CEREBELLAR HYPOPLASIA, AND INTERNAL MALFORMATIONS	0.0526316	2.4270167568722743
15Q OVERGROWTH SYNDROME	0.05250238	2.421057996254641
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.052113179999999995	2.40311069991984
TIETZ SYNDROME	0.0520833	2.4017328345177753
TIMOTHY SYNDROME; TS	0.051836354	2.3903453395519643
%609166 BRANCHIOGENIC-DEAFNESS SYNDROME	0.05150376	2.3750083326732985
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.05130382	2.365788439484244
CRANIOECTODERMAL DYSPLASIA 3	0.051290800000000004	2.3651880443190874
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.051136299999999996	2.35806353947909
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.05094901	2.349426979534217
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.050889354000000005	2.3466760445132797
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.050545554	2.3308222919955393
FRAGILE X SYNDROME	0.05	2.3056649967626623
KAWASAKI DISEASE	0.05	2.3056649967626623
RESTRICTIVE DERMOPATHY	0.05	2.3056649967626623
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.05	2.3056649967626623
TAKAYASU ARTERITIS	0.05	2.3056649967626623
ACROOTOOCULAR SYNDROME	0.04983643	2.298122244292253
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.049682004	2.291001151836451
GORLIN-CHAUDHRY-MOSS SYNDROME	0.04944306999999999	2.279983116629721
GLYCOGEN STORAGE DISEASE II	0.04913645	2.2658438566035737
BLEPHAROCHEILODONTIC SYNDROME 1; BCDS1	0.049033860000000005	2.2611130931632166
CRANIOECTODERMAL DYSPLASIA 1	0.049033860000000005	2.2611130931632166
CRANIOSTENOSIS, SAGITTAL, WITH CONGENITAL HEART DISEASE, MENTAL DEFICIENCY, AND MANDIBULAR ANKYLOSIS	0.048972810000000006	2.2582978762021697
OROFACIODIGITAL SYNDROME TYPE 6	0.048926724000000005	2.2561726986613535
SILVER-RUSSELL SYNDROME; SRS	0.048095854	2.217858541144149
ELSAHY-WATERS SYNDROME; ESWS	0.04791490400000001	2.2095143395208656
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.047619	2.1958692296168243
ANEURYSM, INTRACRANIAL BERRY, 1	0.047619	2.1958692296168243
BODY SKIN HYPERLAXITY DUE TO VITAMIN K-DEPENDENT COAGULATION FACTOR DEFICIENCY	0.047619	2.1958692296168243
AUTOIMMUNE ENTEROPATHY AND ENDOCRINOPATHY-SUSCEPTIBILITY TO CHRONIC INFECTIONS SYNDROME	0.047619	2.1958692296168243
ANGIOPATHY, HEREDITARY, WITH NEPHROPATHY, ANEURYSMS, AND MUSCLE CRAMPS	0.047619	2.1958692296168243
FAMILIAL CERVICAL ARTERY DISSECTION	0.047619	2.1958692296168243
EHLERS-DANLOS SYNDROME, VASCULAR TYPE; EDSVASC	0.047619	2.1958692296168243
FAMILIAL ATRIAL MYXOMA	0.047619	2.1958692296168243
POLYCYSTIC KIDNEY DISEASE 3	0.047619	2.1958692296168243
INTERNAL CAROTID AGENESIS	0.047619	2.1958692296168243
OROFACIODIGITAL SYNDROME TYPE 2	0.04696217400000001	2.1655808152735516
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 49	0.04695826	2.165400327817605
DEAFNESS, MID-TONE NEURAL	0.04695826	2.165400327817605
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.046846214	2.1602335170130593
FIBULAR APLASIA, TIBIAL CAMPOMELIA, AND OLIGOSYNDACTYLY SYNDROME	0.046274	2.1338468412039084
CRANIOSYNOSTOSIS, SAGITTAL, WITH DANDY-WALKER MALFORMATION AND HYDROCEPHALUS	0.04623312	2.1319617295025557
MUENKE SYNDROME	0.046071193999999996	2.1244947872972393
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.046000054	2.121214287139846
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.045928614000000006	2.1179199529924713
FOCAL DERMAL HYPOPLASIA; FDH	0.045822060000000005	2.1130063964311705
SWEENEY-COX SYNDROME; SWCOS	0.045541304000000005	2.1000598107945483
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.04552761400000001	2.099428519718435
ACUTE MONOBLASTIC LEUKEMIA	0.0454545	2.0960569919069685
DEAFNESS, AUTOSOMAL RECESSIVE 112; DFNB112	0.0454545	2.0960569919069685
%606012 DEAFNESS, AUTOSOMAL DOMINANT 18; DFNA18	0.0454545	2.0960569919069685
PERRAULT SYNDROME 4	0.0454545	2.0960569919069685
DEAFNESS, AUTOSOMAL DOMINANT 65; DFNA65	0.0454545	2.0960569919069685
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.0454545	2.0960569919069685
DEAFNESS WITH ANHIDROTIC ECTODERMAL DYSPLASIA	0.0454545	2.0960569919069685
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.0454545	2.0960569919069685
POLYENDOCRINE-POLYNEUROPATHY SYNDROME	0.0454545	2.0960569919069685
PEROXISOME BIOGENESIS DISORDER 14B	0.0454545	2.0960569919069685
X-LINKED ADRENOLEUKODYSTROPHY	0.0454545	2.0960569919069685
BRANCHIOSKELETOGENITAL SYNDROME	0.0454193	2.0944338037492476
SPLIT-FOOT MALFORMATION WITH MESOAXIAL POLYDACTYLY; SFMMP	0.044982060000000004	2.0742712244855577
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.04427545	2.0416871056183084
DEAFNESS, AUTOSOMAL DOMINANT 20	0.0440891	2.0330938921753736
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.0440891	2.0330938921753736
NOONAN SYNDROME 3; NS3	0.044023854	2.030085183807798
HOLT-ORAM SYNDROME	0.043526800000000004	2.007164383621781
EPIDERMOLYSIS BULLOSA, LETHAL ACANTHOLYTIC; EBLA	0.043526800000000004	2.007164383621781
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.043526800000000004	2.007164383621781
GRANGE SYNDROME; GRNG	0.043526800000000004	2.007164383621781
FRASER SYNDROME 2; FRASRS2	0.043478300000000004	2.004927888574921
BLEPHAROCHEILODONTIC SYNDROME 2; BCDS2	0.043478300000000004	2.004927888574921
FRASER SYNDROME 3; FRASRS3	0.043478300000000004	2.004927888574921
CHROMOSOME 2Q31.1 DUPLICATION SYNDROME	0.043478300000000004	2.004927888574921
FEINGOLD SYNDROME 2; FGLDS2	0.043478300000000004	2.004927888574921
PILI TORTI-ONYCHODYSPLASIA SYNDROME	0.043478300000000004	2.004927888574921
CAMPTOSYNPOLYDACTYLY, COMPLEX	0.043478300000000004	2.004927888574921
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.043385974	2.0006704320450988
XQ12-Q13.3 DUPLICATION SYNDROME	0.043222550000000005	1.99313441211648
RAINE SYNDROME	0.042905724	1.9785245197511934
CONGENITAL ADRENAL HYPERPLASIA DUE TO CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY	0.04261951	1.965326247723525
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.04207243000000001	1.940098583594947
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.041924013999999996	1.9332546320717559
CROSSED POLYSYNDACTYLY	0.04156225	1.916572500233979
OTOFACIOCERVICAL SYNDROME 2	0.041269860000000005	1.9030894324659104
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.04095799000000001	1.8887080776151033
CRANIOFRONTONASAL SYNDROME; CFNS	0.040926294	1.887246470460355
7Q11.23 MICRODUPLICATION SYNDROME	0.04082567000000001	1.8826063657676706
FRONTONASAL DYSPLASIA-SEVERE MICROPHTHALMIA-SEVERE FACIAL CLEFTING SYNDROME	0.04056867	1.8707552476843101
47,XYY SYNDROME	0.04037388	1.8617728379899223
ARTERIAL TORTUOSITY SYNDROME	0.040334304	1.8599478580316846
SPLIT HAND/FOOT MALFORMATION 1 (SHFM1)	0.040302660000000004	1.8584886487685335
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.040284494	1.8576509545619093
49,XXXYY SYNDROME	0.040137950000000006	1.850893327136198
49,XYYYY SYNDROME	0.040137950000000006	1.850893327136198
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.039968699999999996	1.8430886511221558
MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY	0.03996526	1.842930021370379
FABRY DISEASE	0.03996526	1.842930021370379
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.039942860000000004	1.8418970834518293
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.039942860000000004	1.8418970834518293
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.0399267	1.8411518925248758
PITT-HOPKINS SYNDROME	0.039756354	1.833296676334105
FIBROCHONDROGENESIS	0.039605350000000004	1.8263333835906823
LEPRECHAUNISM	0.039605350000000004	1.8263333835906823
LARSEN SYNDROME	0.03924357	1.809650513940106
PINEOCYTOMA	0.03846912	1.7739380688052493
STURGE-WEBER SYNDROME	0.03846912	1.7739380688052493
PAPILLARY TUMOR OF THE PINEAL REGION	0.03846912	1.7739380688052493
BLACKFAN-DIAMOND ANEMIA	0.0384615	1.7735866854597426
245800 LAURENCE-MOON SYNDROME	0.0384615	1.7735866854597426
DERMOCHONDROCORNEAL DYSTROPHY	0.0384615	1.7735866854597426
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X	0.0384615	1.7735866854597426
EPISODIC ATAXIA, TYPE 1; EA1	0.0384615	1.7735866854597426
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH SEVERE PROXIMAL FEMORAL DYSPLASIA	0.0384615	1.7735866854597426
HALLERMANN-STREIFF SYNDROME; HSS	0.0384615	1.7735866854597426
MUCOLIPIDOSIS III GAMMA	0.0384615	1.7735866854597426
WIDOW'S PEAK SYNDROME	0.0384615	1.7735866854597426
MYCETOMA	0.0384615	1.7735866854597426
DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE	0.0384615	1.7735866854597426
WILSON DISEASE	0.0384615	1.7735866854597426
HYPERTRICHOSIS-ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.0384615	1.7735866854597426
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.038439100000000004	1.7725537475411932
MECKEL SYNDROME, TYPE 1; MKS1	0.038345080000000004	1.7682181750812807
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.037777304	1.7420361500972419
20Q11.2 MICRODELETION SYNDROME	0.037777304	1.7420361500972419
VAN MALDERGEM SYNDROME 2; VMLDS2	0.03755469	1.7317706839454556
VAN MALDERGEM SYNDROME 1; VMLDS1	0.03755469	1.7317706839454556
WEAVER SYNDROME	0.037417674	1.7254524240415268
SLC35A2-CDG	0.037275064	1.71887620633776
PEROXISOME BIOGENESIS DISORDER 11B	0.03723175000000001	1.7168788548643652
FATCO SYNDROME	0.036978609999999995	1.7052057341187545
KOOLEN-DE VRIES SYNDROME; KDVS	0.036779514	1.6960247605548457
SPLIT-FOOT DEFORMITY WITH MANDIBULOFACIAL DYSOSTOSIS	0.03676474	1.6953434826616023
WAARDENBURG SYNDROME TYPE 1	0.03674451	1.6944106106039123
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.03660322399999999	1.6878954469092593
MOSAIC TRISOMY 9	0.036259854	1.672061523110492
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.036259854	1.672061523110492
XP21 MICRODELETION SYNDROME	0.036259854	1.672061523110492
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.036259854	1.672061523110492
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.036259854	1.672061523110492
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.036259854	1.672061523110492
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.036259854	1.672061523110492
GERMAN SYNDROME	0.036259854	1.672061523110492
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.036259854	1.672061523110492
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.036257054	1.671932405870673
THUMBS, CONGENITAL CLASPED	0.0361093	1.6651189813520397
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.03610437	1.6648916427833589
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.035899270000000004	1.6554338049666388
X-LINKED INTELLECTUAL DISABILITY-DYSMORPHISM-CEREBRAL ATROPHY SYNDROME	0.035714300000000004	1.6469042278776151
INSULINOMA	0.035714300000000004	1.6469042278776151
603463 HYPOSPADIAS, HYPERTELORISM, UPPER LID COLOBOMA, AND MIXED-TYPE HEARINGLOSS	0.035714300000000004	1.6469042278776151
OTOSCLEROSIS 4	0.035714300000000004	1.6469042278776151
MUCOLIPIDOSIS TYPE III	0.035714300000000004	1.6469042278776151
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.035714300000000004	1.6469042278776151
CHARGE SYNDROME	0.035714300000000004	1.6469042278776151
TRICHO-DENTO-OSSEOUS SYNDROME	0.035714300000000004	1.6469042278776151
HARLEQUIN ICHTHYOSIS	0.035714300000000004	1.6469042278776151
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.035714300000000004	1.6469042278776151
BRANCHIOGENIC DEAFNESS SYNDROME	0.035714300000000004	1.6469042278776151
CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT	0.035714300000000004	1.6469042278776151
NIJMEGEN BREAKAGE SYNDROME	0.035714300000000004	1.6469042278776151
MCCUNE-ALBRIGHT SYNDROME	0.035714300000000004	1.6469042278776151
BONE DYSPLASIA, LETHAL HOLMGREN TYPE	0.035714300000000004	1.6469042278776151
ATYPICAL WERNER SYNDROME	0.035714300000000004	1.6469042278776151
EPIPHYSEAL CHONDRODYSPLASIA, MIURA TYPE; ECDM	0.035714300000000004	1.6469042278776151
WAGR SYNDROME	0.035714300000000004	1.6469042278776151
ALKAPTONURIA	0.035714300000000004	1.6469042278776151
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.035714300000000004	1.6469042278776151
CALVARIAL DOUGHNUT LESIONS WITH BONE FRAGILITY; CDL	0.035714300000000004	1.6469042278776151
CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE	0.03571149999999999	1.6467751106377957
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.035512914	1.637617654856854
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.035292053999999996	1.6274330714331537
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.03525367	1.625663058528439
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.03522575	1.6243755751942468
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.034957614	1.6120109394028077
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.034906309999999996	1.6096451426629292
FRONTOOCULAR SYNDROME	0.03473960399999999	1.601957778883923
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.03441206	1.5868536441699308
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.034345054	1.583763776394469
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.03400482	1.5680744639042983
SILVER-RUSSELL SYNDROME	0.033855460000000004	1.5611869814259687
RHOMBENCEPHALOSYNAPSIS	0.03384896	1.5608872449763893
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.03376889	1.557194953050574
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.03376889	1.557194953050574
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.033453854	1.5426676034921714
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.033453854	1.5426676034921714
%600384 APHALANGIA, PARTIAL, WITH SYNDACTYLY AND DUPLICATION OF METATARSALIV	0.033453500000000004	1.5426512793839946
BRACHYDACTYLY, TYPE B1	0.033453500000000004	1.5426512793839946
%263450 POLYDACTYLY, POSTAXIAL, TYPE A5; PAPA5	0.033453500000000004	1.5426512793839946
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.033302849999999995	1.5357043107487482
PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES	0.03322017000000001	1.531891663110102
DERMOCHONDROCORNEAL DYSTROPHY	0.0331536	1.5288219007334118
X-LINKED INTELLECTUAL DISABILITY, CILLIERS TYPE	0.033027799999999996	1.5230208476015568
X-LINKED INTELLECTUAL DISABILITY, VAN ESCH TYPE	0.033027799999999996	1.5230208476015568
BUSCHKE-OLLENDORFF SYNDROME	0.0329724	1.520466170785144
BARATELA-SCOTT SYNDROME	0.032945684	1.519234207864074
ROBERTS SYNDROME	0.032721174	1.5088813108956098
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.032712174	1.5084662911961926
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.032673930000000004	1.5067027341534691
OROFACIODIGITAL SYNDROME TYPE 1	0.032312400000000005	1.490031392827877
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.03216662	1.4833089959633157
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.03216662	1.4833089959633157
LOEYS-DIETZ SYNDROME	0.03212975	1.4816087985947028
OLIVER SYNDROME	0.0318623	1.4692757965270193
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.031862114	1.4692672194532312
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.031862114	1.4692672194532312
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.031862114	1.4692672194532312
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.031795554	1.4661979182095408
HYDROXYKYNURENINURIA	0.031795554	1.4661979182095408
PHACE SYNDROME	0.031795554	1.4661979182095408
KAGAMI-OGATA SYNDROME	0.031676214	1.460694756995268
DUANE-RADIAL RAY SYNDROME; DRRS	0.031538460000000004	1.4543424654759871
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.03131656	1.4441099242203543
WAARDENBURG SYNDROME, TYPE 1; WS1	0.03125	1.441040622976664
RETINITIS PUNCTATA ALBESCENS	0.03125	1.441040622976664
PERRAULT SYNDROME 3	0.03125	1.441040622976664
USHER SYNDROME, TYPE IIC	0.03125	1.441040622976664
DEAFNESS, AUTOSOMAL RECESSIVE 63	0.03125	1.441040622976664
USHER SYNDROME, TYPE IF	0.03125	1.441040622976664
DEAFNESS, AUTOSOMAL RECESSIVE 109; DFNB109	0.03125	1.441040622976664
USHER SYNDROME, TYPE IE; USH1E	0.03125	1.441040622976664
CONTRACTURAL ARACHNODACTYLY, CONGENITAL	0.03125	1.441040622976664
%226500 EPIDERMOLYSIS BULLOSA DYSTROPHICA NEUROTROPHICA;;EPIDERMOLYSIS BULLOSA WITH CONGENITAL DEAFNESS;;EPIDERMOLYSIS BULLOSA PROGRESSIVA, RECESSIVE; EBR3	0.03125	1.441040622976664
AL AMYLOIDOSIS	0.03125	1.441040622976664
%300700 ALBINISM-DEAFNESS SYNDROME; ADFN;;ALDS	0.03125	1.441040622976664
DEAFNESS, AUTOSOMAL RECESSIVE 108; DFNB108	0.03125	1.441040622976664
JERVELL AND LANGE-NIELSEN SYNDROME 2	0.03125	1.441040622976664
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.03125	1.441040622976664
NORMOSMIC CONGENITAL HYPOGONADOTROPIC HYPOGONADISM	0.03125	1.441040622976664
DEAFNESS-OLIGODONTIA SYNDROME	0.03125	1.441040622976664
DEAFNESS, X-LINKED 3	0.03125	1.441040622976664
WOLFRAM-LIKE SYNDROME	0.03125	1.441040622976664
CLASSIC CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY	0.03125	1.441040622976664
EHLERS-DANLOS SYNDROME, TYPE I	0.03125	1.441040622976664
LMNA-RELATED CARDIOCUTANEOUS PROGERIA SYNDROME	0.03125	1.441040622976664
CONGENITAL ADRENAL HYPERPLASIA DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY	0.03125	1.441040622976664
WAARDENBURG SYNDROME, TYPE 2D; WS2D	0.03125	1.441040622976664
MARFANOID HABITUS WITH SITUS INVERSUS	0.03125	1.441040622976664
AORTIC VALVE DISEASE 3; AOVD3	0.03125	1.441040622976664
CONGENITAL ADRENAL HYPERPLASIA DUE TO 11-BETA-HYDROXYLASE DEFICIENCY	0.03125	1.441040622976664
WILDERVANCK SYNDROME	0.03125	1.441040622976664
JERVELL AND LANGE-NIELSEN SYNDROME 1	0.03125	1.441040622976664
PENDRED SYNDROME	0.03125	1.441040622976664
USHER SYNDROME, TYPE IIA	0.03125	1.441040622976664
USHER SYNDROME, TYPE IC	0.03125	1.441040622976664
CAP MYOPATHY	0.03125	1.441040622976664
HOMOZYGOUS 11P15-P14 DELETION SYNDROME	0.03125	1.441040622976664
AORTO-VENTRICULAR TUNNEL	0.03125	1.441040622976664
DISTAL 7Q11.23 MICRODUPLICATION SYNDROME	0.030975379999999997	1.4283769885484445
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.030915559999999998	1.4256184909463177
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.03082581	1.4214798222771285
HENNEKAM SYNDROME	0.030801969999999998	1.4203804812066723
ENCEPHALOPATHY WITH INTRACRANIAL CALCIFICATION, GROWTH HORMONE DEFICIENCY, MICROCEPHALY, AND RETINAL DEGENERATION	0.030555040000000002	1.4089937240536603
MELAS	0.03033845	1.3990060444206835
FRONTONASAL DYSPLASIA-ALOPECIA-GENITAL ANOMALIES SYNDROME	0.030302999999999997	1.397371327937979
LEUKOCYTE ADHESION DEFICIENCY	0.030302999999999997	1.397371327937979
%241310 HYPOMANDIBULAR FACIOCRANIAL DYSOSTOSIS	0.030302999999999997	1.397371327937979
FGFR2-RELATED BENT BONE DYSPLASIA	0.030302999999999997	1.397371327937979
BENT BONE DYSPLASIA SYNDROME; BBDS	0.030302999999999997	1.397371327937979
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.03020685	1.3929375341492043
ACRORENAL-MANDIBULAR SYNDROME	0.030080239999999998	1.3870991292444017
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.029957354	1.3814324502685584
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.029957354	1.3814324502685584
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.029957354	1.3814324502685584
MEIER-GORLIN SYNDROME 1; MGORS1	0.029883250000000004	1.3780152702901565
TRICHOTHIODYSTROPHY	0.029711694	1.370104257006464
TEMTAMY SYNDROME	0.029586154	1.3643151933325925
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.029515204	1.3610434547021861
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.0294118	1.356275155035681
MUSICAL PERFECT PITCH	0.0294118	1.356275155035681
ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.0294118	1.356275155035681
AICARDI SYNDROME; AIC	0.0294118	1.356275155035681
FRYNS MICROPHTHALMIA SYNDROME	0.0294118	1.356275155035681
EAR FOLDING	0.0294118	1.356275155035681
HEMIPARKINSONISM-HEMIATROPHY SYNDROME	0.0294118	1.356275155035681
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	0.0294118	1.356275155035681
EAR ANTITRAGUS, TAG AT BASE OF	0.0294118	1.356275155035681
MALAN OVERGROWTH SYNDROME	0.0294118	1.356275155035681
EAR MALFORMATION	0.0294118	1.356275155035681
GLUTARIC ACIDEMIA I; GA1	0.0294118	1.356275155035681
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.0294118	1.356275155035681
AREDYLD	0.0294118	1.356275155035681
DARWINIAN TUBERCLE OF PINNA	0.0294118	1.356275155035681
DARWINIAN POINT OF PINNA	0.0294118	1.356275155035681
EXCHONDROSIS OF PINNA, POSTERIOR	0.0294118	1.356275155035681
OSSIFIED EAR CARTILAGES	0.0294118	1.356275155035681
ANOPHTHALMIA-MEGALOCORNEA-CARDIOPATHY-SKELETAL ANOMALIES SYNDROME	0.0294118	1.356275155035681
FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, GRN-RELATED	0.0294118	1.356275155035681
HAIRY EARS, Y-LINKED	0.0294118	1.356275155035681
EAR WAX, WET/DRY	0.0294118	1.356275155035681
EAR WITHOUT HELIX	0.0294118	1.356275155035681
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.0294118	1.356275155035681
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.0294118	1.356275155035681
OTOONYCHOPERONEAL SYNDROME	0.0294118	1.356275155035681
X-LINKED PARKINSONISM-SPASTICITY SYNDROME	0.0294118	1.356275155035681
OSTEOMA OF MIDDLE EAR	0.0294118	1.356275155035681
BLAU SYNDROME	0.0294118	1.356275155035681
TEMTAMY SYNDROME; TEMTYS	0.029380244	1.3548200037429243
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.028989054	1.3367809419412526
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.028911354000000004	1.3331979385362838
183802 SPLIT-HAND WITH OBSTRUCTIVE UROPATHY, SPINA BIFIDA, AND DIAPHRAGMATICDEFECTS	0.028395820000000002	1.3094249645674627
WYBURN-MASON SYNDROME	0.028176254	1.2993000517538789
DEAFNESS, X-LINKED 2	0.02811017	1.2962527004409576
CORNELIA DE LANGE SYNDROME 1	0.028036639999999998	1.2928619894967184
AUTOSOMAL DOMINANT HYPER-IGE SYNDROME	0.028036150000000003	1.2928393939797505
AARSKOG-SCOTT SYNDROME	0.027980874000000003	1.2902904352125293
OSTEOGENESIS IMPERFECTA, TYPE I	0.02783325	1.2834830054228874
SMITH-LEMLI-OPITZ SYNDROME	0.027465104	1.2665065785049234
CORNELIA DE LANGE SYNDROME	0.02735812	1.2615731932246503
SCLEROSTEOSIS 2; SOST2	0.027158450000000004	1.2523657506265784
WAARDENBURG SYNDROME TYPE 3	0.027158450000000004	1.2523657506265784
TIBIAL HEMIMELIA	0.027158450000000004	1.2523657506265784
FANCONI ANEMIA	0.027153453999999997	1.2521353685801018
CINCA SYNDROME; CINCA	0.02714685	1.2518308363473294
BEEMER LETHAL MALFORMATION SYNDROME	0.02711723	1.2504649604032472
WHITE-SUTTON SYNDROME; WHSUS	0.026873364	1.239219494401237
PHACE ASSOCIATION	0.026861354	1.2386656736690145
DEAFNESS, AUTOSOMAL RECESSIVE 79; DFNB79	0.02666432	1.2295797857295716
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.02664585	1.2287280730797676
JOHANSON-BLIZZARD SYNDROME; JBS	0.02645076	1.219731829395399
RIN2 SYNDROME	0.0263158	1.2135083784361371
CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 2; CHTD2	0.0263158	1.2135083784361371
BLAU SYNDROME	0.0263158	1.2135083784361371
EHLERS-DANLOS SYNDROME, AUTOSOMAL DOMINANT, TYPE UNSPECIFIED	0.0263158	1.2135083784361371
AORTIC ANEURYSM, FAMILIAL THORACIC 4	0.0263158	1.2135083784361371
JUVENILE POLYPOSIS/HEREDITARY HEMORRHAGIC TELANGIECTASIA SYNDROME; JPHT	0.0263158	1.2135083784361371
CONGENITAL CONTRACTURAL ARACHNODACTYLY	0.0263158	1.2135083784361371
AUTOSOMAL DOMINANT CUTIS LAXA	0.0263158	1.2135083784361371
AORTIC VALVE DISEASE 2; AOVD2	0.0263158	1.2135083784361371
PERIVENTRICULAR NODULAR HETEROTOPIA	0.0263158	1.2135083784361371
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 1	0.0263158	1.2135083784361371
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.0263158	1.2135083784361371
MARFANOID HYPERMOBILITY SYNDROME	0.0263158	1.2135083784361371
SAETHRE-CHOTZEN SYNDROME	0.02623934	1.2099825555230879
XQ21 MICRODELETION SYNDROME	0.026233224	1.2097005265806837
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.026189964	1.2077056652254847
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.026186554000000004	1.2075484188727057
CREE MENTAL RETARDATION SYNDROME	0.026186554000000004	1.2075484188727057
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.026120300000000003	1.2044932282987955
INFANTILE SIALIC ACID STORAGE DISEASE	0.025989434	1.1984585651894684
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.025833529999999997	1.1912693172763624
ROBERTS SYNDROME; RBS	0.02582788	1.1910087771317286
DUBOWITZ SYNDROME	0.02565847	1.1831967229896971
SPONDYLOCOSTAL DYSOSTOSIS-HYPOSPADIAS-INTELLECTUAL DISABILITY SYNDROME	0.025641000000000004	1.1823911236398286
POPLITEAL PTERYGIUM SYNDROME	0.025641000000000004	1.1823911236398286
ALOPECIA-CONTRACTURES-DWARFISM MENTAL RETARDATION SYNDROME	0.025641000000000004	1.1823911236398286
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.025641000000000004	1.1823911236398286
MILLER-DIEKER SYNDROME	0.0254521	1.173680321282059
SMITH-MAGENIS SYNDROME	0.025395823999999997	1.1710852492149026
DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY	0.024977020000000003	1.1517728147488189
WITTEVEEN-KOLK SYNDROME	0.024889664	1.147744541319675
DEAFNESS, AUTOSOMAL DOMINANT 41; DFNA41	0.02477325	1.1423763076210123
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J	0.02475956	1.1417450165448988
CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS	0.02475956	1.1417450165448988
221745 DEAFNESS, SENSORINEURAL, AUTOSOMAL-MITOCHONDRIAL TYPE	0.02475956	1.1417450165448988
BAND HETEROTOPIA; BH	0.024687163999999998	1.138406598082786
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.024640870000000002	1.1362718289755835
14Q22Q23 MICRODELETION SYNDROME	0.024398634	1.1251015276524674
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.024271514	1.1192396049646982
COWDEN SYNDROME 5; CWS5	0.02424475	1.118005428605231
COWDEN SYNDROME 6; CWS6	0.02424475	1.118005428605231
MEDULLOBLASTOMA	0.024133673999999997	1.1128833477016227
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.024052334	1.1091324918848895
OHDO SYNDROME	0.02402246	1.1077549031626235
ALSTRÖM SYNDROME	0.023801354	1.0975589758671396
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.023801354	1.0975589758671396
RELAPSING POLYCHONDRITIS	0.02372596	1.0940823097318209
PETERS-PLUS SYNDROME; PTRPLS	0.023687964	1.092330188787481
ISOTRETINOIN-LIKE SYNDROME	0.023588119999999997	1.0877260524687455
FRASER SYNDROME	0.02354977	1.085957607416229
DE BARSY SYNDROME	0.023283613999999998	1.0736842759586613
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.023283613999999998	1.0736842759586613
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.023272854	1.073188096851358
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.0232558	1.0724016806342624
DEAFNESS, AUTOSOMAL DOMINANT 22; DFNA22	0.0232558	1.0724016806342624
FIBROMATOSIS, GINGIVAL, WITH PROGRESSIVE DEAFNESS	0.0232558	1.0724016806342624
OCULOPHARYNGODISTAL MYOPATHY	0.0232558	1.0724016806342624
DEAFNESS, AUTOSOMAL DOMINANT 70	0.0232558	1.0724016806342624
OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALDOMINANT	0.0232558	1.0724016806342624
FLYNN-AIRD SYNDROME	0.0232558	1.0724016806342624
258650 OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALRECESSIVE	0.0232558	1.0724016806342624
DEAFNESS, AUTOSOMAL RECESSIVE 111; DFNB111	0.0232558	1.0724016806342624
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.0232558	1.0724016806342624
ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.0232558	1.0724016806342624
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 5	0.0232558	1.0724016806342624
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.0232558	1.0724016806342624
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 4	0.0232558	1.0724016806342624
MUCKLE-WELLS SYNDROME	0.0232558	1.0724016806342624
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.0232558	1.0724016806342624
COCHLEOSACCULAR DEGENERATION-CATARACT SYNDROME	0.0232558	1.0724016806342624
FLYNN-AIRD SYNDROME	0.0232558	1.0724016806342624
USHER SYNDROME, TYPE IV; USH4	0.0232558	1.0724016806342624
263540 POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES	0.02323564	1.0714720365075676
ADNP SYNDROME	0.02307606	1.0641132761038998
ACROCALLOSAL SYNDROME; ACLS	0.02293765	1.0577307342598616
2Q31.1 MICRODELETION SYNDROME	0.022881184	1.0551269006657176
OCCIPITAL HORN SYNDROME	0.022767754	1.0498962690540619
CURRARINO SYNDROME	0.022767754	1.0498962690540619
COACH SYNDROME	0.022767754	1.0498962690540619
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.022767754	1.0498962690540619
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.022767754	1.0498962690540619
CHROMOSOME 17Q12 DELETION SYNDROME	0.022738059999999997	1.0485269807257842
BETHLEM MYOPATHY 1	0.0227273	1.048030801618481
AMYLOIDOSIS	0.0227273	1.048030801618481
ACUTE RESPIRATORY CORONAVIRUS INFECTION	0.0227273	1.048030801618481
140450 HEART-HAND SYNDROME, SPANISH TYPE	0.0227273	1.048030801618481
PREPAPILLARY VASCULAR LOOPS	0.0227273	1.048030801618481
MUSCULAR HYPERTONIA, LETHAL	0.0227273	1.048030801618481
%113950 BUNDLE BRANCH BLOCK, FAMILIAL ISOLATED COMPLETE RIGHT	0.0227273	1.048030801618481
WATSON SYNDROME	0.0227273	1.048030801618481
150590 LEG ULCERS, FAMILIAL, OF JUVENILE ONSET	0.0227273	1.048030801618481
CRANIOFACIOFRONTODIGITAL SYNDROME	0.0227273	1.048030801618481
VENULAR INSUFFICIENCY, SYSTEMIC	0.0227273	1.048030801618481
SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS	0.0227273	1.048030801618481
CONGENITAL ATRANSFERRINEMIA	0.0227273	1.048030801618481
THUMB DEFORMITY	0.0227273	1.048030801618481
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.0227273	1.048030801618481
HEMANGIOPERICYTOMA, MALIGNANT	0.0227273	1.048030801618481
MITOCHONDRIAL MYOPATHY WITH REVERSIBLE CYTOCHROME C OXIDASE DEFICIENCY	0.0227273	1.048030801618481
SIRENOMELIA	0.0227273	1.048030801618481
ARTERIES, ANOMALIES OF	0.0227273	1.048030801618481
ISPD-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R20	0.0227273	1.048030801618481
GLYCOGEN STORAGE DISEASE DUE TO MUSCLE GLYCOGEN PHOSPHORYLASE DEFICIENCY	0.0227273	1.048030801618481
HYPOADRENOCORTICISM, FAMILIAL	0.0227273	1.048030801618481
NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	0.0227273	1.048030801618481
ATROPHODERMA VERMICULATA; AVA	0.0227273	1.048030801618481
COCAINE EMBRYOFETOPATHY	0.0227273	1.048030801618481
PARIS-TROUSSEAU THROMBOCYTOPENIA	0.0227273	1.048030801618481
CHROMOSOME 10Q26 DELETION SYNDROME	0.022676524	1.0456893527009685
MARSHALL-SMITH SYNDROME	0.022572770000000002	1.0409049133794863
PHELAN-MCDERMID SYNDROME	0.022369354	1.031524730359857
HUNTER-MACDONALD SYNDROME	0.02224083	1.0255980645989784
CARDIOMYOPATHY, DILATED, 1B; CMD1B	0.0222222	1.0247389738211847
CAROLI DISEASE, ISOLATED	0.0222222	1.0247389738211847
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.0222222	1.0247389738211847
TELANGIECTASIA, HEREDITARY BENIGN	0.0222222	1.0247389738211847
SENIOR-LOKEN SYNDROME 8; SLSN8	0.0222222	1.0247389738211847
VASCULAR HYALINOSIS	0.0222222	1.0247389738211847
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.0222222	1.0247389738211847
CHEILITIS GLANDULARIS	0.0222222	1.0247389738211847
VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA	0.0222222	1.0247389738211847
MENKES DISEASE	0.0222222	1.0247389738211847
GASTRITIS, FAMILIAL GIANT HYPERTROPHIC	0.0222222	1.0247389738211847
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.0222222	1.0247389738211847
ANEURYSM OF INTERVENTRICULAR SEPTUM	0.0222222	1.0247389738211847
POLYARTERITIS NODOSA, CHILDHOOD-ONSET	0.0222222	1.0247389738211847
PSEUDOXANTHOMA ELASTICUM	0.0222222	1.0247389738211847
ISOLATED POLYCYSTIC LIVER DISEASE	0.0222222	1.0247389738211847
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.0222222	1.0247389738211847
VEIN OF GALEN ANEURYSMAL MALFORMATION	0.0222222	1.0247389738211847
MULTIPLE OSTEOCHONDROMAS	0.0222222	1.0247389738211847
HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 4; HNFJ4	0.0222222	1.0247389738211847
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.02176966	1.003870861068485
MESOAXIAL SYNOSTOTIC SYNDACTYLY WITH PHALANGEAL REDUCTION	0.02173065	1.0020719812380108
FRONTONASAL DYSPLASIA	0.02164245	0.9980047881837215
ACROCRANIOFACIAL DYSOSTOSIS	0.021557640000000003	0.9940939192162127
CURRY-JONES SYNDROME	0.02153373	0.9929913502147608
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.02147704	0.9903771872414313
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.021378854	0.9858495067739885
DISTAL TRISOMY 17Q	0.021378854	0.9858495067739885
N SYNDROME	0.021378854	0.9858495067739885
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.02133419	0.9837899023456803
2Q37 MICRODELETION SYNDROME	0.021325614	0.9833944346854356
YUNIS-VARON SYNDROME	0.0211648	0.9759787704696479
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.021082574	0.9721870582691716
DEAFNESS, SENSORINEURAL, AND MALE INFERTILITY	0.0208333	0.9606922115411113
JUVENILE-ONSET DIABETES MELLITUS-CENTRAL AND PERIPHERAL NEURODEGENERATION SYNDROME	0.0208333	0.9606922115411113
DEAFNESS, AUTOSOMAL RECESSIVE 94; DFNB94	0.0208333	0.9606922115411113
DILATED CARDIOMYOPATHY WITH ATAXIA	0.0208333	0.9606922115411113
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.0208333	0.9606922115411113
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.0208333	0.9606922115411113
DEAFNESS, AUTOSOMAL RECESSIVE 37; DFNB37	0.0208333	0.9606922115411113
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 11	0.0208333	0.9606922115411113
RAMOS-ARROYO SYNDROME	0.0208333	0.9606922115411113
WOODHOUSE-SAKATI SYNDROME	0.0208333	0.9606922115411113
DEAFNESS, AUTOSOMAL RECESSIVE 101; DFNB101	0.0208333	0.9606922115411113
MICROCEPHALY-FACIAL DYSMORPHISM-OCULAR ANOMALIES-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.0208333	0.9606922115411113
AUTOSOMAL RECESSIVE SPASTIC ATAXIA WITH LEUKOENCEPHALOPATHY	0.0208333	0.9606922115411113
MYOCLONUS-CEREBELLAR ATAXIA-DEAFNESS SYNDROME	0.0208333	0.9606922115411113
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.0208333	0.9606922115411113
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.0208333	0.9606922115411113
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.0208333	0.9606922115411113
DEAFNESS, AUTOSOMAL RECESSIVE 77; DFNB77	0.0208333	0.9606922115411113
SPASTIC PARAPLEGIA, SENSORINEURAL DEAFNESS, MENTAL RETARDATION, AND	0.0208333	0.9606922115411113
FRONTOTEMPORAL DEMENTIA WITH MOTOR NEURON DISEASE	0.0208333	0.9606922115411113
OCULODENTODIGITAL DYSPLASIA	0.02078006	0.9582371394525585
MYHRE SYNDROME	0.020776464	0.9580713160259914
WARSAW BREAKAGE SYNDROME; WABS	0.020776464	0.9580713160259914
PETERS PLUS SYNDROME	0.020751374	0.9569143333306157
HAMAMY SYNDROME; HMMS	0.02068577	0.9538891164016634
OROFACIODIGITAL SYNDROME TYPE 4	0.020633434000000003	0.9514757307362521
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.020627064	0.9511819890156644
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.02061822	0.950774162991037
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	0.02038535	0.9400357588351147
SPLIT-HAND/FOOT MALFORMATION 1; SHFM1	0.020380020000000002	0.9397899749464599
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.02037166	0.9394044677590011
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.020159220000000002	0.9296081583207559
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.019924754	0.9187961573381368
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.01991904	0.9185326659423068
ACRO-RENAL-OCULAR SYNDROME	0.01955902	0.9019309556996168
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.019460814	0.8974023529661753
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.019413454	0.8952184270812418
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.019413454	0.8952184270812418
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.019291480000000003	0.8895938034349394
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.019254904	0.8879071633765074
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.019020153999999997	0.8770820662167066
FIBULAR HEMIMELIA	0.019014839999999998	0.8768370201408507
LETTERER-SIWE DISEASE	0.0188679	0.8700611318483646
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.0188679	0.8700611318483646
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0188679	0.8700611318483646
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.0188679	0.8700611318483646
CIRCUMVALLATE PLACENTA SYNDROME	0.0188679	0.8700611318483646
PACHYDERMODACTYLY, FAMILIAL	0.0188679	0.8700611318483646
NEPHROSIALIDOSIS	0.0188679	0.8700611318483646
PALMARIS LONGUS MUSCLE, ABSENCE OF	0.0188679	0.8700611318483646
VAN DEN BOSCH SYNDROME	0.0188679	0.8700611318483646
275220 TIBIAL HEMIMELIA;;THM;;TIBIA, ABSENCE OF	0.0188679	0.8700611318483646
TOE, MISSHAPEN	0.0188679	0.8700611318483646
PUBIC BONE DYSPLASIA	0.0188679	0.8700611318483646
248100 MACROSOMIA ADIPOSA CONGENITA	0.0188679	0.8700611318483646
COPPER DEFICIENCY, FAMILIAL BENIGN	0.0188679	0.8700611318483646
SPINAL ARACHNOIDITIS	0.0188679	0.8700611318483646
KNUCKLE PADS	0.0188679	0.8700611318483646
TRACHEOBRONCHOMEGALY	0.0188679	0.8700611318483646
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.0188679	0.8700611318483646
SCAPULA, CONTOUR OF VERTEBRAL BORDER OF	0.0188679	0.8700611318483646
TRACHEOPATHIA OSTEOPLASTICA	0.0188679	0.8700611318483646
TOES, RELATIVE LENGTH OF FIRST AND SECOND	0.0188679	0.8700611318483646
THROMBOCYTOPENIA 3	0.0188679	0.8700611318483646
THALIDOMIDE SUSCEPTIBILITY	0.0188679	0.8700611318483646
HYPERBILIRUBINEMIA, ROTOR TYPE	0.0188679	0.8700611318483646
DOUBLE NAIL FOR FIFTH TOE	0.0188679	0.8700611318483646
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.0188679	0.8700611318483646
MEGAEPIPHYSEAL DWARFISM	0.0188679	0.8700611318483646
%122450 CORNEAL HYPESTHESIA, FAMILIAL;;TRIGEMINAL ANESTHESIA, FAMILIAL	0.0188679	0.8700611318483646
256020 NAIL-PATELLA-LIKE RENAL DISEASE;;GLOMERULAR BASEMENT MEMBRANE DISEASE, NAIL-PATELLA SYNDROME TYPE	0.0188679	0.8700611318483646
THROMBOCYTHEMIA, ESSENTIAL	0.0188679	0.8700611318483646
MONOPHALANGY OF GREAT TOE	0.0188679	0.8700611318483646
RAYNAUD DISEASE	0.0188679	0.8700611318483646
CARPAL DISPLACEMENT	0.0188679	0.8700611318483646
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	0.0188679	0.8700611318483646
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.0188679	0.8700611318483646
TOE, FIFTH, NUMBER OF PHALANGES IN	0.0188679	0.8700611318483646
HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY	0.0188679	0.8700611318483646
HHHH SYNDROME	0.0188679	0.8700611318483646
VESICOURETERAL REFLUX 1	0.0188679	0.8700611318483646
MICROPHTHALMIA, SYNDROMIC 4	0.0188679	0.8700611318483646
PRIMARY HYPEROXALURIA TYPE 1	0.0188679	0.8700611318483646
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.0188679	0.8700611318483646
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.018862570000000002	0.8698153479597098
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.01875885	0.8650324764904254
FIBULAR APLASIA OR HYPOPLASIA, FEMORAL BOWING AND POLY-, SYN-, AND OLIGODACTYLY	0.01875645	0.8649218045705808
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.018717404	0.8631212646613087
MULCHANDANI-BHOJ-CONLIN SYNDROME	0.01871346	0.8629393938063642
BARTSOCAS-PAPAS SYNDROME	0.0186954	0.8621065876095334
MICROPHTHALMIA WITH LIMB ANOMALIES	0.01868051	0.8614199605734976
PEDIATRIC-ONSET GRAVES DISEASE	0.018653914	0.8601935312484197
TEMPLE SYNDROME	0.0186185	0.8585604748445124
CENANI-LENZ SYNDROME	0.01860939	0.8581403826821022
PFEIFFER SYNDROME TYPE 3	0.01860939	0.8581403826821022
PRADER-WILLI SYNDROME; PWS	0.018337264000000002	0.8455917548239217
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.018327754	0.8451532173415374
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.018327754	0.8451532173415374
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.018327754	0.8451532173415374
OROFACIODIGITAL SYNDROME VI	0.018308424	0.8442618472537889
PROTEUS SYNDROME	0.018277750000000002	0.8428473678915751
259610 OSTEOLYSIS SYNDROME, RECESSIVE;;OSTEOLYSIS, DISTAL, WITH SHORT STATURE, MENTAL RETARDATION, AND CHARACTERISTICFACIAL APPEARANCE	0.01817675	0.8381899245981144
CRANIOMETADIAPHYSEAL DYSPLASIA, WORMIAN BONE TYPE	0.01817675	0.8381899245981144
%608572 BURN-MCKEOWN SYNDROME	0.01801227	0.8306052090247639
OCULOFACIOCARDIODENTAL SYNDROME	0.017932014	0.8269043400251601
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.017926684000000002	0.8266585561365053
DIAPHRAGMATIC DEFECTS, LIMB DEFICIENCIES, AND OSSIFICATION DEFECTS OF SKULL	0.017890239999999998	0.8249780030336649
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.01785056	0.8231482272922341
JOUBERT SYNDROME 2	0.017586074	0.8109519050455587
DEXTROCARDIA	0.017586074	0.8109519050455587
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.017521664000000003	0.8079817473967292
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.7950578495036753
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.7950578495036753
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.7950578495036753
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0172414	0.7950578495036753
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.7950578495036753
JUMPING FRENCHMAN OF MAINE	0.0172414	0.7950578495036753
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.7950578495036753
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.7950578495036753
ERYTHERMALGIA, PRIMARY	0.0172414	0.7950578495036753
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	0.7950578495036753
RHEUMATOID ARTHRITIS	0.0172414	0.7950578495036753
DIASTEMATOMYELIA	0.0172414	0.7950578495036753
PALMOMENTAL REFLEX	0.0172414	0.7950578495036753
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.7950578495036753
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0172414	0.7950578495036753
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0172414	0.7950578495036753
ENDOCARDIAL FIBROELASTOSIS	0.0172414	0.7950578495036753
CERVICAL RIB	0.0172414	0.7950578495036753
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.7950578495036753
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.7950578495036753
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.7950578495036753
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	0.7950578495036753
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.7950578495036753
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.7950578495036753
ALCOHOL DEPENDENCE	0.0172414	0.7950578495036753
SICKLE CELL ANEMIA	0.0172414	0.7950578495036753
269800 SENILE PLAQUE FORMATION	0.0172414	0.7950578495036753
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.7950578495036753
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.7950578495036753
GRANULOMAS, CONGENITAL CEREBRAL	0.0172414	0.7950578495036753
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0172414	0.7950578495036753
TRANSSEXUALITY	0.0172414	0.7950578495036753
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.7950578495036753
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.7950578495036753
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0172414	0.7950578495036753
MOTION SICKNESS	0.0172414	0.7950578495036753
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0172414	0.7950578495036753
CONGENITAL TRACHEAL STENOSIS	0.0172414	0.7950578495036753
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.7950578495036753
MYOPATHY, CONGENITAL	0.0172414	0.7950578495036753
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.7950578495036753
CARDIAC ARRHYTHMIA	0.0172414	0.7950578495036753
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	0.7950578495036753
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0172414	0.7950578495036753
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.7950578495036753
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0172414	0.7950578495036753
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.7950578495036753
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0172414	0.7950578495036753
DEAFNESS-GENITAL ANOMALIES-METACARPAL AND METATARSAL SYNOSTOSIS SYNDROME	0.01722354	0.7942342659668317
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.017125664	0.7897208806223688
ACROCARDIOFACIAL SYNDROME	0.01709194	0.7881657556953523
JACKSON-WEISS SYNDROME	0.01704895	0.7861833449311357
236640 HYDROCEPHALUS WITH ASSOCIATED MALFORMATIONS	0.01704052	0.7857946098126815
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.016976110000000003	0.782824452163852
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.016929014000000003	0.7806527001901012
CHOREOACANTHOCYTOSIS	0.01680459	0.7749150989589573
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.016736014	0.7717528333025974
HAREL-YOON SYNDROME; HAYOS	0.016736014	0.7717528333025974
CRI-DU-CHAT SYNDROME	0.01672922	0.7714395395428372
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.0166544	0.7679893424416816
HYDROLETHALUS	0.016652689999999998	0.7679104886987922
YUNIS-VARON SYNDROME	0.016521374	0.7618550746044945
15Q11Q13 MICRODUPLICATION SYNDROME	0.016517574	0.7616798440647405
SIMPSON-GOLABI-BEHMEL SYNDROME	0.016471244	0.7595434148787403
MEND SYNDROME	0.016458274	0.75894532537858
MEND SYNDROME; MEND	0.016458274	0.75894532537858
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.016458274	0.75894532537858
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.016428254	0.7575610041145239
MAN1B1-CDG	0.016428254	0.7575610041145239
POSTAXIAL ACROFACIAL DYSOSTOSIS	0.016196830000000002	0.7468892797903078
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.01619046	0.7465955380697202
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.01619046	0.7465955380697202
RUBINSTEIN-TAYBI SYNDROME	0.016130264000000002	0.7438197018668178
ACROCRANIOFACIAL DYSOSTOSIS	0.016063130000000002	0.7407239315889644
LAURIN-SANDROW SYNDROME	0.015955709999999998	0.7357704409099194
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.01592171	0.7342025887121209
PSEUDOTRISOMY 13 SYNDROME	0.015912719999999998	0.7337880301457028
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.01589169	0.7328182674480646
CRANIOFRONTONASAL DYSPLASIA	0.015890460000000002	0.7327615480891443
BRACHYDACTYLY, TYPE A2; BDA2	0.0158827	0.7324037088816466
MULTINUCLEATED NEURONS, ANHYDRAMNIOS, RENAL DYSPLASIA, CEREBELLAR HYPOPLASIA, AND HYDRANENCEPHALY; MARCH	0.0158827	0.7324037088816466
BRACHYDACTYLY TYPE A7	0.0158827	0.7324037088816466
AYMÉ-GRIPP SYNDROME	0.015861774	0.7314387419672015
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.01580474	0.7288087160186943
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.015803150000000002	0.7287353958717974
COCKAYNE SYNDROME	0.01578946	0.7281041047956838
FOUNTAIN SYNDROME	0.01578946	0.7281041047956838
TEMPLE SYNDROME	0.01578774	0.728024789919795
CONGENITAL TOXOPLASMOSIS	0.015740074	0.7258267533650813
CEREBROFACIOARTICULAR SYNDROME	0.015731314	0.7254228008576484
CRANE-HEISE SYNDROME	0.01571978	0.7248909300561952
RING CHROMOSOME 22 SYNDROME	0.015608214	0.7197462536356187
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.015608214	0.7197462536356187
MICROPHTHALMIA, LENZ TYPE	0.015584710000000002	0.7186624066339407
C SYNDROME	0.01557225	0.7180878349167472
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.015564764000000002	0.717742630753432
ISOLATED CLOVERLEAF SKULL SYNDROME	0.01555295	0.7171978482279968
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.015431334000000001	0.7115897331430712
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.015431064000000001	0.7115772825520887
MOEBIUS SYNDROME; MBS	0.01527282	0.7042801295171344
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.015229894	0.7023006700041138
3Q29 MICRODUPLICATION SYNDROME	0.015229894	0.7023006700041138
ANTLEY-BIXLER SYNDROME	0.015199510000000001	0.700899563498881
17Q12 MICRODUPLICATION SYNDROME	0.015105649999999998	0.696571369166958
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.015105503999999999	0.6965646366251675
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.01506266	0.6945889584027416
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.01504923	0.6939696567846112
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.014964304000000001	0.6900534386743098
INTELLECTUAL DISABILITY-POLYDACTYLY-UNCOMBABLE HAIR SYNDROME	0.01493211	0.6885688670961944
MICROPHTHALMIA, SYNDROMIC 1	0.014885510000000001	0.6864199873192115
1Q21.1 MICRODELETION SYNDROME	0.014881874	0.6862523193606469
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.014831254	0.6839180641179243
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.014831254	0.6839180641179243
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.014831254	0.6839180641179243
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.014831254	0.6839180641179243
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.014831254	0.6839180641179243
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.014831254	0.6839180641179243
JOUBERT SYNDROME 1	0.014831254	0.6839180641179243
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.014831254	0.6839180641179243
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.014831254	0.6839180641179243
BAKER-GORDON SYNDROME; BAGOS	0.014831254	0.6839180641179243
FOCAL DERMAL HYPOPLASIA	0.01471834	0.6787112269690352
DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.01471834	0.6787112269690352
EEC SYNDROME	0.01470465	0.6780799358929216
XP22.13P22.2 DUPLICATION SYNDROME	0.01467535	0.6767288162048186
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.01466166	0.676097525128705
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.014659634000000001	0.6760040995830363
MULTIPLE PTERYGIUM-MALIGNANT HYPERTHERMIA SYNDROME	0.014593370000000001	0.6729484478761266
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.014526804	0.6698788699526366
SUMMITT SYNDROME	0.014386700000000002	0.6634182121785079
CRANIOECTODERMAL DYSPLASIA	0.0143867	0.6634182121785078
ZTTK SYNDROME; ZTTKS	0.014372903999999999	0.662782033092601
CINCA SYNDROME	0.014343724	0.6614364470004904
SPASTIC PARAPLEGIA 73, AUTOSOMAL DOMINANT; SPG73	0.0142857	0.6587607688850472
EXOSTOSES, MULTIPLE, TYPE I	0.0142857	0.6587607688850472
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 19	0.0142857	0.6587607688850472
139750 HAND AND FOOT DEFORMITY WITH FLAT FACIES	0.0142857	0.6587607688850472
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.0142857	0.6587607688850472
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.0142857	0.6587607688850472
PERIPHERAL NEUROPATHY, MYOPATHY, HOARSENESS, AND HEARING LOSS; PNMHH	0.0142857	0.6587607688850472
HYPOPHOSPHATASIA, ADULT	0.0142857	0.6587607688850472
ARTHROPATHY, PROGRESSIVE PSEUDORHEUMATOID, OF CHILDHOOD	0.0142857	0.6587607688850472
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE C; CMTDIC	0.0142857	0.6587607688850472
MYOPATHY, DISTAL 3	0.0142857	0.6587607688850472
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IC; HSAN1C	0.0142857	0.6587607688850472
NEUROMYOTONIA AND AXONAL NEUROPATHY, AUTOSOMAL RECESSIVE	0.0142857	0.6587607688850472
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.0142857	0.6587607688850472
NEUROPATHY, CONGENITAL HYPOMYELINATING, 2; CHN2	0.0142857	0.6587607688850472
NEUROPATHY, HEREDITARY SENSORY, WITH SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE	0.0142857	0.6587607688850472
HEART-HAND SYNDROME, SLOVENIAN TYPE	0.0142857	0.6587607688850472
AUTOSOMAL RECESSIVE SPASTIC ATAXIA OF CHARLEVOIX-SAGUENAY	0.0142857	0.6587607688850472
MYASTHENIC SYNDROME, CONGENITAL, 23, PRESYNAPTIC; CMS23	0.0142857	0.6587607688850472
FIBULO-ULNAR HYPOPLASIA-RENAL ANOMALIES SYNDROME	0.01425131	0.6571749325002738
VACTERL/VATER ASSOCIATION	0.01425131	0.6571749325002738
COSTELLO SYNDROME; CSTLO	0.014222624	0.6558521263783311
HARTSFIELD SYNDROME; HRTFDS	0.014172004	0.6535178711356087
MONOSOMY 13Q14	0.014067260000000002	0.6486877796471906
HENNEKAM-BEEMER SYNDROME	0.013989109999999999	0.6450840252572504
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.013913614000000001	0.6416026555653386
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.013913614000000001	0.6416026555653386
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.013913614000000001	0.6416026555653386
KBG SYNDROME	0.013913614000000001	0.6416026555653386
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.013913614000000001	0.6416026555653386
SCHISIS ASSOCIATION	0.01389787	0.6408766477711579
LOWER LIMB MALFORMATION-HYPOSPADIAS SYNDROME	0.01389787	0.6408766477711579
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.01389787	0.6408766477711579
AUTOSOMAL DOMINANT MYOPIA-MIDFACIAL RETRUSION-SENSORINEURAL HEARING LOSS-RHIZOMELIC DYSPLASIA SYNDROME	0.01379817	0.6362791517676133
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.013746444	0.6338938952151623
SOTOS SYNDROME	0.013732764000000001	0.6332630652720481
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.013732764000000001	0.6332630652720481
ABRUZZO-ERICKSON SYNDROME	0.013711069999999999	0.6322626833432525
ADAMS-OLIVER SYNDROME 3; AOS3	0.013703454	0.6319114844509458
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.013657830000000001	0.6298076112546999
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.013631764000000001	0.6286056219785875
SUMMITT SYNDROME	0.01362645	0.6283605759027315
ACROCEPHALOPOLYSYNDACTYLY TYPE III	0.01362645	0.6283605759027315
CRANIOFRONTONASAL DYSPLASIA-POLAND ANOMALY SYNDROME	0.01362645	0.6283605759027315
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.013620264	0.628075319029332
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.013574240000000001	0.6259530005131121
TARP SYNDROME	0.013466514	0.6209853991642869
C SYNDROME	0.013454054	0.6204108274470936
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE SYNDROME	0.01342712	0.6191688118266375
CAMPOMELIC DYSPLASIA	0.0134219	0.6189281004009755
WAHAB SYNDROME	0.013368060000000001	0.6164453603324614
201020 ACROCEPHALOPOLYSYNDACTYLY TYPE IV;;ACPS IV;;GOODMAN SYNDROME	0.013368060000000001	0.6164453603324614
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.013368060000000001	0.6164453603324614
20P13 MICRODELETION SYNDROME	0.01330827	0.6136882461293327
4Q21 MICRODELETION SYNDROME	0.01329404	0.6130320538712539
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.013206814	0.6090097751711017
AUTOSOMAL DOMINANT POPLITEAL PTERYGIUM SYNDROME	0.01320089	0.6087365999822851
DYSOSTOSIS WITH BRACHYDACTYLY	0.01320089	0.6087365999822851
NEVUS COMEDONICUS SYNDROME	0.01320089	0.6087365999822851
ZLOTOGORA-OGUR SYNDROME	0.01320089	0.6087365999822851
APLASIA CUTIS CONGENITA	0.01320089	0.6087365999822851
APHALANGY-HEMIVERTEBRAE-UROGENITAL-INTESTINAL DYSGENESIS SYNDROME	0.01320089	0.6087365999822851
ACROPECTOROVERTEBRAL DYSPLASIA, F-FORM OF	0.01320089	0.6087365999822851
CAMPTOBRACHYDACTYLY	0.01320089	0.6087365999822851
ADULT SYNDROME	0.01320089	0.6087365999822851
SPLIT-HAND/FOOT MALFORMATION 6	0.01320089	0.6087365999822851
SYNDACTYLY TYPE 1	0.01320089	0.6087365999822851
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.0131579	0.6067541892180686
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.0131579	0.6067541892180686
ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO	0.013086210000000001	0.6034483267457104
SHORT-RIB THORACIC DYSPLASIA 18 WITH POLYDACTYLY; SRTD18	0.01308621	0.6034483267457103
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.012919074	0.5957411342477318
FACIOCARDIORENAL SYNDROME	0.0129085	0.5952535322142165
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.01286777	0.5933753375078535
COFFIN-SIRIS SYNDROME 6; CSS6	0.012860244	0.5930282888125409
LAURENCE-MOON SYNDROME	0.01284622	0.5923815958942489
TYSHCHENKO SYNDROME	0.012839964	0.592093111089854
15Q26 OVERGROWTH SYNDROME	0.01281222	0.5908137436964502
6Q25 MICRODELETION SYNDROME	0.012787514	0.5896744685082499
TRISOMY 12P	0.012655914	0.5836059582367706
TRISOMY 1Q	0.01262665	0.5822564986274653
HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA	0.01255383	0.5788985281261803
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.012528054	0.5777099117070491
AMINOPTERIN/METHOTREXATE EMBRYOFETOPATHY	0.01249382	0.5761312689970657
HYPERTELORISM, TEEBI TYPE	0.0124638	0.5747469477330094
LOWRY-MACLEAN SYNDROME	0.01245982	0.574563416799267
CROUZON SYNDROME WITH ACANTHOSIS NIGRICANS	0.01245982	0.574563416799267
DUBOWITZ SYNDROME	0.012442060000000001	0.573744444592417
ATELOSTEOGENESIS, TYPE I; AO1	0.01229441	0.5669358158569768
BLOMSTRAND LETHAL CHONDRODYSPLASIA	0.01229441	0.5669358158569768
HOLOPROSENCEPHALY-CAUDAL DYSGENESIS SYNDROME	0.01229441	0.5669358158569768
BOHRING-OPITZ SYNDROME	0.012249104	0.5648466066901102
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.012238750000000001	0.5643691495825807
8Q22.1 MICRODELETION SYNDROME	0.012207454	0.5629259877478069
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.012207309999999999	0.5629193474326162
LATHOSTEROLOSIS	0.012207309999999999	0.5629193474326162
FRONTOMETAPHYSEAL DYSPLASIA	0.01217208	0.5612947758758973
CORNELIA DE LANGE SYNDROME 3	0.012140744	0.5598497695091261
CHAR SYNDROME	0.012140744	0.5598497695091261
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.01205475	0.5558843023944939
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.012042213999999999	0.5553062260665056
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA	0.01204106	0.5552530113183803
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.012040564	0.5552301391216126
PRIMARY CILIARY DYSKINESIA	0.01203284	0.5548739599929126
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.012028524	0.5546749349903921
SMITH-MAGENIS SYNDROME; SMS	0.011981163999999999	0.5524910091054585
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.011915064	0.5494429199797382
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.011896924	0.5486064247189127
WEAVER SYNDROME	0.011888014	0.5481955552164897
GABRIELE-DE VRIES SYNDROME	0.01182934	0.5454899034560886
BARDET-BIEDL SYNDROME 1; BBS1	0.011780264	0.543226847148466
5Q14.3 MICRODELETION SYNDROME	0.01177659	0.543057426884504
CARDIOFACIOCUTANEOUS SYNDROME	0.011703734	0.5396977963044212
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.011703734	0.5396977963044212
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.01170355	0.5396893114572331
SHORT-RIB THORACIC DYSPLASIA 19 WITH OR WITHOUT POLYDACTYLY; SRTD19	0.01170355	0.5396893114572331
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.01170355	0.5396893114572331
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.01170355	0.5396893114572331
ROIFMAN SYNDROME; RFMN	0.011673714000000002	0.538313475040365
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.011673714000000002	0.538313475040365
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.011673714000000002	0.538313475040365
CRANIOSYNOSTOSIS, HERRMANN-OPITZ TYPE	0.0116619	0.5377686925149296
CRANIOSYNOSTOSIS, PHILADELPHIA TYPE	0.0116619	0.5377686925149296
KABUKI SYNDROME	0.011631840000000001	0.5363825267188761
ERMINE PHENOTYPE	0.0115815	0.5340611832001354
FEINGOLD SYNDROME	0.0115815	0.5340611832001354
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.011502374	0.5304124222294585
CROUZON SYNDROME-ACANTHOSIS NIGRICANS SYNDROME	0.01150024	0.5303140164473967
OROFACIODIGITAL SYNDROME XVII	0.01149666	0.5301489308336286
BOHRING-OPITZ SYNDROME	0.011448564000000001	0.5279310655599427
MULTIPLE EPIPHYSEAL DYSPLASIA, AL-GAZALI TYPE	0.01140351	0.5258534769446597
ACROFACIAL DYSOSTOSIS, RODRÍGUEZ TYPE	0.01134246	0.5230382599836125
SHORT STATURE-CRANIOFACIAL ANOMALIES-GENITAL HYPOPLASIA SYNDROME	0.01134246	0.5230382599836125
TRISOMY 20P	0.01134246	0.5230382599836125
VERLOOVE VANHORICK-BRUBAKK SYNDROME	0.01134246	0.5230382599836125
MONOSOMY 5P	0.01134246	0.5230382599836125
ABLEPHARON MACROSTOMIA SYNDROME	0.011320704	0.5220350190302211
16P11.2P12.2 MICRODELETION SYNDROME	0.011320704	0.5220350190302211
8P23.1 DUPLICATION SYNDROME	0.011320704	0.5220350190302211
AUTOSOMAL RECESSIVE OMODYSPLASIA	0.01130846	0.5214704077858138
CRANIOFACIAL DYSSYNOSTOSIS	0.01129357	0.5207837807497779
48,XXYY SYNDROME	0.011283754	0.5203311325976135
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.01123471	0.5180695519155889
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.01115818	0.514540501071544
VELO-FACIAL-SKELETAL SYNDROME	0.011128160000000002	0.5131561798074877
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.011128160000000002	0.5131561798074877
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.011115064000000001	0.5125522800315357
RITSCHER-SCHINZEL SYNDROME 1	0.011112874	0.5124512919046774
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.011101374	0.511920988955422
233270 GOMBO SYNDROME;;GROWTH RETARDATION, OCULAR ABNORMALITIES, MICROCEPHALY, BRACHYDACTYLY,AND OLIGOPHRENIA	0.01105007	0.5095551922155438
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.010964060000000001	0.5055889872881126
TURNPENNY-FRY SYNDROME; TPFS	0.010955484000000001	0.505193519627868
HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	0.010950370000000001	0.504957696211999
GAUCHER DISEASE, PERINATAL LETHAL	0.010922250000000001	0.5036609902178197
TORIELLO-LACASSIE-DROSTE SYNDROME	0.010903010000000001	0.5027737703270655
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.010894434000000001	0.5023783026668208
LATERAL MENINGOCELE SYNDROME	0.010794734	0.49778080666327595
BOWEN-CONRADI SYNDROME	0.0107382	0.49517383736473636
BLEPHARO-CHEILO-ODONTIC SYNDROME	0.010702320000000001	0.4935192921630595
ECTODERMAL DYSPLASIA SYNDROME	0.010702320000000001	0.4935192921630595
48,XXXY SYNDROME	0.010669624	0.4920115717083765
6Q16 MICRODELETION SYNDROME	0.010669624	0.4920115717083765
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.01066852	0.49196066262524796
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.010653314	0.4912594637864325
17Q21.31 MICRODUPLICATION SYNDROME	0.010623294	0.48987514252237613
COHEN SYNDROME	0.010622064	0.48981842316345575
EAR-PATELLA-SHORT STATURE SYNDROME	0.010601754000000001	0.4888818620417708
BRANCHIOOCULOFACIAL SYNDROME	0.010600380000000001	0.4888185023676598
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.010569924000000001	0.4874140757048317
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.01056732	0.4872939966718003
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.01055582	0.4867636937225449
BLOOM SYNDROME	0.0105373	0.485909675407744
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.010451994000000001	0.48197593424346735
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.01044351	0.48158470900681655
ADAMS-OLIVER SYNDROME 1; AOS1	0.010417384	0.48037995293270813
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.010409930000000001	0.4800362243949908
FRONTONASAL DYSPLASIA 1; FND1	0.010409930000000001	0.4800362243949908
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.010348880000000001	0.47722100743394363
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.01033139	0.47641448581807594
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.010262814	0.4732522201617161
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.010262814	0.4732522201617161
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.010250554	0.4726868711045099
ACHONDROPLASIA	0.010128080000000001	0.4670391908082397
OCULOCEREBROCUTANEOUS SYNDROME	0.01012022	0.4666767402707485
MOEBIUS SYNDROME	0.0100902	0.4652924190066922
GORDON SYNDROME	0.0100902	0.4652924190066922
AUTOSOMAL RECESSIVE MALIGNANT OSTEOPETROSIS	0.01008622	0.4651088880729499
URBAN-ROGERS-MEYER SYNDROME	0.01007774	0.464717847289499
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.01007774	0.464717847289499
THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME	0.01007651	0.4646611279305786
PROXIMAL SYMPHALANGISM	0.01007651	0.4646611279305786
RADIO-ULNAR SYNOSTOSIS-AMEGAKARYOCYTIC THROMBOCYTOPENIA SYNDROME	0.01007651	0.4646611279305786
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.009992164000000001	0.4607716555342398
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.009992164000000001	0.4607716555342398
PIERPONT SYNDROME	0.009983154000000001	0.4603561747018232
DISTAL MONOSOMY 9P	0.009931114000000001	0.45795643857319257
PELIZAEUS-MERZBACHER DISEASE	0.00992081	0.4574812871306597
POPOV-CHANG SYNDROME; POPCHAS	0.009916224000000001	0.4572698115371566
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00990712	0.4568499960545461
ZELLWEGER SYNDROME	0.00990712	0.4568499960545461
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00990712	0.4568499960545461
FAMILIAL SCAPHOCEPHALY SYNDROME, MCGILLIVRAY TYPE	0.00987183	0.45522265769983095
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.009856004000000002	0.4544928686150558
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.009850290000000001	0.45422937721922574
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.009832150000000001	0.45339288195840016
CAMPOMELIC DYSPLASIA	0.00976678	0.4503784555416326
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.00976678	0.4503784555416326
HYPERTELORISM-HYPOSPADIAS-POLYSYNDACTYLY SYNDROME	0.009739000000000001	0.4490974280694313
CAMPTODACTYLY-JOINT CONTRACTURES-FACIAL SKELETAL DEFECTS SYNDROME	0.009739000000000001	0.4490974280694313
DISTAL MONOSOMY 10P	0.00973676	0.44899413427757634
MOSAIC TRISOMY 8	0.00973676	0.44899413427757634
MESOMELIA-SYNOSTOSES SYNDROME	0.00973676	0.44899413427757634
KEIPERT SYNDROME	0.00972307	0.4483628432014627
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.00971726	0.4480949249288389
HYPOMANDIBULAR FACIOCRANIAL DYSOSTOSIS	0.009705	0.4475295758716327
608432 CRANIOSYNOSTOSIS, CALCIFICATION OF BASAL GANGLIA, AND FACIAL DYSMORPHISM	0.009705	0.4475295758716327
HYPOPHOSPHATASIA, CHILDHOOD	0.009705	0.4475295758716327
MENTAL RETARDATION, X-LINKED 91; MRX91	0.009597614	0.4425776530447856
19P13.3 MICRODUPLICATION SYNDROME	0.009597614	0.4425776530447856
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.009597614	0.4425776530447856
SCHAAF-YANG SYNDROME; SHFYNG	0.009597614	0.4425776530447856
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.009597614	0.4425776530447856
BARAITSER-WINTER SYNDROME 2; BRWS2	0.00953085	0.43949894468790834
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.009462274	0.43633667903154844
XYLT1-CDG	0.009446610000000001	0.4356143603013627
CODAS SYNDROME	0.009422574	0.43450598102411886
LATHOSTEROLOSIS	0.009415943999999999	0.4342002498455481
FRANK-TER HAAR SYNDROME; FTHS	0.009385560000000001	0.43279914334031544
NEU-LAXOVA SYNDROME	0.009385560000000001	0.43279914334031544
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.00931626	0.4296034916548024
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00931626	0.4296034916548024
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.009315764	0.4295806194580345
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.009315764	0.4295806194580345
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.009315764	0.4295806194580345
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.009310450000000001	0.4293355733821786
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.009272530000000001	0.42758695704863375
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.009257699999999999	0.4269030968105939
ABLEPHARON-MACROSTOMIA SYNDROME	0.009257699999999999	0.4269030968105939
DISTAL MONOSOMY 6P	0.009211454	0.42477054114178825
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.009148324	0.42185940851687564
CRANIOTELENCEPHALIC DYSPLASIA	0.009114324	0.42029155631907705
CUTIS LAXA	0.009114324	0.42029155631907705
HEMIFACIAL MICROSOMIA	0.00911295	0.420228196644966
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; FOP	0.009082930000000001	0.4188438753809098
20Q11.2 MICRODUPLICATION SYNDROME	0.009066164000000002	0.41807073979419535
21Q22.11Q22.12 MICRODELETION SYNDROME	0.00905206	0.4174203578119085
PITT-HOPKINS SYNDROME	0.00905206	0.4174203578119085
SHORT SYNDROME	0.00896408	0.4133633096836048
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.008948914	0.4126639553767869
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.008948914	0.4126639553767869
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.008948914	0.4126639553767869
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.008948914	0.4126639553767869
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.008948914	0.4126639553767869
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.008948914	0.4126639553767869
KAGAMI-OGATA SYNDROME	0.008948914	0.4126639553767869
GALLOWAY-MOWAT SYNDROME	0.008948914	0.4126639553767869
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.008948914	0.4126639553767869
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.008948914	0.4126639553767869
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.008948914	0.4126639553767869
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.008948914	0.4126639553767869
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.008948914	0.4126639553767869
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3; EEC3	0.008870389999999999	0.40904295461267093
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.008860254000000001	0.40857555020452735
SHASHI-PENA SYNDROME; SHAPNS	0.008860254000000001	0.40857555020452735
DEAFNESS, CONGENITAL, AND ONYCHODYSTROPHY, AUTOSOMAL DOMINANT	0.0088567	0.4084116635365574
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.008794884	0.40556112378775977
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.008794884	0.40556112378775977
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.008794884	0.40556112378775977
JOUBERT SYNDROME WITH RENAL DEFECT	0.008794884	0.40556112378775977
49,XXXXY SYNDROME	0.008764864	0.40417680252370347
DISTAL TRISOMY 18Q	0.008764864	0.40417680252370347
15Q13.3 MICRODELETION SYNDROME	0.008764864	0.40417680252370347
TETRASOMY X	0.008764864	0.40417680252370347
BALLER-GEROLD SYNDROME	0.00874542	0.4032801755197624
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.008740190000000002	0.40303900296110107
CHROMOSOME 16P13.2 DELETION SYNDROME	0.008671614000000001	0.39987673730474116
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.008620004	0.3974968298950827
SHORT RIB-POLYDACTYLY SYNDROME	0.00860277	0.3967021132839985
WHITE FORELOCK WITH MALFORMATIONS	0.00857275	0.3953177920199422
MESOMELIC DYSPLASIA, NIEVERGELT TYPE	0.00857275	0.3953177920199422
INTELLECTUAL DISABILITY-SPASTICITY-ECTRODACTYLY SYNDROME	0.00857275	0.3953177920199422
ALOPECIA-CONTRACTURES-DWARFISM-INTELLECTUAL DISABILITY SYNDROME	0.00857275	0.3953177920199422
PFEIFFER SYNDROME	0.00857275	0.3953177920199422
AUTOSOMAL RECESSIVE FACIODIGITOGENITAL SYNDROME	0.00857275	0.3953177920199422
DIAPHRAGMATIC DEFECT-LIMB DEFICIENCY-SKULL DEFECT SYNDROME	0.00857275	0.3953177920199422
HYPOPLASTIC TIBIAE-POSTAXIAL POLYDACTYLY SYNDROME	0.00857275	0.3953177920199422
MONOSOMY 22	0.00857275	0.3953177920199422
CEREBROOCULONASAL SYNDROME	0.00856877	0.3951342610861999
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.008538750000000001	0.3937499398221436
SECKEL SYNDROME	0.008538750000000001	0.3937499398221436
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.00840336	0.38750666014390966
RESTRICTIVE DERMOPATHY, LETHAL	0.00840336	0.38750666014390966
INDOMETHACIN EMBRYOFETOPATHY	0.00840336	0.38750666014390966
BRONCHOPULMONARY DYSPLASIA	0.00840336	0.38750666014390966
CONGENITAL ANALBUMINEMIA	0.00840336	0.38750666014390966
GMS SYNDROME	0.00840336	0.38750666014390966
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.00840336	0.38750666014390966
ICHTHYOSIS-PREMATURITY SYNDROME	0.00840336	0.38750666014390966
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.00840336	0.38750666014390966
NEMALINE MYOPATHY 10	0.00840336	0.38750666014390966
OMPHALOCELE	0.00840336	0.38750666014390966
CONGENITAL HERPES SIMPLEX VIRUS INFECTION	0.00840336	0.38750666014390966
RETINOPATHY OF PREMATURITY	0.00840336	0.38750666014390966
DOUBLE UTERUS-HEMIVAGINA-RENAL AGENESIS SYNDROME	0.00840336	0.38750666014390966
PEMPHIGOID GESTATIONIS	0.00840336	0.38750666014390966
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.00840336	0.38750666014390966
EBSTEIN MALFORMATION	0.00840336	0.38750666014390966
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.00840336	0.38750666014390966
EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA	0.00840336	0.38750666014390966
KNIEST-LIKE DYSPLASIA, LETHAL	0.00840336	0.38750666014390966
DIAMOND-BLACKFAN ANEMIA 1	0.00840336	0.38750666014390966
PTOSIS-VOCAL CORD PARALYSIS SYNDROME	0.00840336	0.38750666014390966
PULMONARY ATRESIA-INTACT VENTRICULAR SEPTUM SYNDROME	0.00840336	0.38750666014390966
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.00840336	0.38750666014390966
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.00840336	0.38750666014390966
BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT	0.00840336	0.38750666014390966
CONGENITAL PULMONARY AIRWAY MALFORMATION	0.00840336	0.38750666014390966
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.00840336	0.38750666014390966
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.00840336	0.38750666014390966
CORNEODERMATOOSSEOUS SYNDROME	0.00840336	0.38750666014390966
FIBULAR APLASIA-ECTRODACTYLY SYNDROME	0.00840336	0.38750666014390966
RENAL TUBULAR DYSGENESIS	0.00840336	0.38750666014390966
SEVERE CONGENITAL NEMALINE MYOPATHY	0.00840336	0.38750666014390966
INTERMEDIATE NEMALINE MYOPATHY	0.00840336	0.38750666014390966
DIETHYLSTILBESTROL SYNDROME	0.00840336	0.38750666014390966
MICROFORM HOLOPROSENCEPHALY	0.00840336	0.38750666014390966
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.00836684	0.3858226024302742
MOWAT-WILSON SYNDROME	0.00836684	0.3858226024302742
JOUBERT SYNDROME 17; JBTS17	0.008358054	0.3854174509770431
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.008358054	0.3854174509770431
OROFACIODIGITAL SYNDROME VIII; OFD8	0.008358054	0.3854174509770431
16P13.2 MICRODELETION SYNDROME	0.008314324000000001	0.38340091637087453
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.008284304000000001	0.3820165951068182
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.008264264	0.3810924845761157
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.008264264	0.3810924845761157
SAY-BARBER-MILLER SYNDROME	0.008264264	0.3810924845761157
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.008264264	0.3810924845761157
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.008264264	0.3810924845761157
VACTERL WITH HYDROCEPHALUS	0.00824933	0.3804038285548826
VACTERL ASSOCIATION, X-LINKED, WITH OR WITHOUT HYDROCEPHALUS; VACTERLX	0.00824933	0.3804038285548826
ACALVARIA	0.00824933	0.3804038285548826
STEINERT MYOTONIC DYSTROPHY	0.00824933	0.3804038285548826
241800 HYPOTHALAMIC HAMARTOMASCONGENITAL HYPOTHALAMIC HAMARTOMA SYNDROME, INCLUDED; CHHS, INCLUDED	0.00824933	0.3804038285548826
VACTERL ASSOCIATION WITH HYDROCEPHALUS	0.00824933	0.3804038285548826
ISOLATED SPINA BIFIDA	0.00824933	0.3804038285548826
INIENCEPHALY	0.00824933	0.3804038285548826
INTELLECTUAL DISABILITY-MYOPATHY-SHORT STATURE-ENDOCRINE DEFECT SYNDROME	0.00821931	0.37901950729082634
EYE DEFECTS-ARACHNODACTYLY-CARDIOPATHY SYNDROME	0.00821931	0.37901950729082634
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.00821931	0.37901950729082634
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.00821931	0.37901950729082634
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.00821931	0.37901950729082634
POSTAXIAL POLYDACTYLY-DENTAL AND VERTEBRAL ANOMALIES SYNDROME	0.00821931	0.37901950729082634
H SYNDROME	0.00816332	0.3764376236274515
NEUROFIBROMATOSIS TYPE 1	0.00816332	0.3764376236274515
METAPHYSEAL CHONDRODYSPLASIA, JANSEN TYPE	0.0081333	0.3750533023633951
PALLISTER-KILLIAN SYNDROME	0.0081333	0.3750533023633951
LARSEN-LIKE SYNDROME	0.008124724	0.37465783470315045
NOONAN SYNDROME	0.008119610000000001	0.3744220112872816
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.008064704	0.3718901144410366
FEMORAL-FACIAL SYNDROME	0.0080134	0.36952431770115834
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.0080134	0.36952431770115834
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.008005874	0.3691772690058456
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.008005874	0.3691772690058456
6Q TERMINAL DELETION SYNDROME	0.008005874	0.3691772690058456
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.008005874	0.3691772690058456
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.008005874	0.3691772690058456
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.008005874	0.3691772690058456
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.008005874	0.3691772690058456
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.008005874	0.3691772690058456
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.008005874	0.3691772690058456
LAMB-SHAFFER SYNDROME	0.008005874	0.3691772690058456
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.008005874	0.3691772690058456
AL KAISSI SYNDROME; ALKAS	0.008005874	0.3691772690058456
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.008005874	0.3691772690058456
MONOSOMY 18P	0.007944824	0.3663620520447984
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.007944824	0.3663620520447984
COFFIN-SIRIS SYNDROME 2; CSS2	0.007944824	0.3663620520447984
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.007944824	0.3663620520447984
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.007933104	0.3658216041695572
TETRASOMY 9P	0.007929934	0.36567542500876243
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.00792015	0.365224252482196
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.007918814	0.36516264511348245
OROFACIODIGITAL SYNDROME IX; OFD9	0.007898493999999999	0.36422562285879806
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.007898493999999999	0.36422562285879806
PALLISTER-HALL SYNDROME	0.007898493999999999	0.36422562285879806
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.007897264000000001	0.36416890349987785
3MC SYNDROME 2	0.007876954	0.3632323423781928
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.007876954	0.3632323423781928
CRANIOSYNOSTOSIS 6; CRS6	0.007863264	0.36260105130207915
ROTHMUND-THOMSON SYNDROME	0.007863264	0.36260105130207915
SPINAL MUSCULAR ATROPHY WITH MENTAL RETARDATION	0.0078125	0.360260155744166
%613576 ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 2; EDSS2	0.0078125	0.360260155744166
BARDET-BIEDL SYNDROME 6; BBS6	0.0078125	0.360260155744166
%263630 POLYSYNDACTYLY WITH CARDIAC MALFORMATION;;BONNEAU SYNDROME	0.0078125	0.360260155744166
BARTSOCAS-PAPAS SYNDROME; BPS	0.0078125	0.360260155744166
SPLIT-HAND/FOOT MALFORMATION 4; SHFM4	0.0078125	0.360260155744166
ULNAR HYPOPLASIA WITH LOBSTER-CLAW DEFORMITY OF FEET	0.0078125	0.360260155744166
SCHIZOPHRENIA 1; SCZD1	0.0078125	0.360260155744166
HALLUX VARUS AND PREAXIAL POLYSYNDACTYLY	0.0078125	0.360260155744166
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.0078125	0.360260155744166
ADAMS-OLIVER SYNDROME 6; AOS6	0.0078125	0.360260155744166
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 33	0.0078125	0.360260155744166
TEEBI-SHALTOUT SYNDROME; TBSH	0.0078125	0.360260155744166
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.0078125	0.360260155744166
GRANGE SYNDROME	0.0078125	0.360260155744166
613005 SANTOS SYNDROME;;FIBULAR AGENESIS/HYPOPLASIA, OLIGODACTYLOUS CLUBFEET, AND ANONYCHIA/NAILHYPOPLASIA SYNDROME	0.0078125	0.360260155744166
CHROMOSOME XP11.23-P11.22 DUPLICATION SYNDROME	0.0078125	0.360260155744166
CAMPTOBRACHYDACTYLY	0.0078125	0.360260155744166
BARDET-BIEDL SYNDROME 4; BBS4	0.0078125	0.360260155744166
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.0078125	0.360260155744166
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.0078125	0.360260155744166
MENTAL RETARDATION, AUTOSOMAL DOMINANT 4; MRD4	0.0078125	0.360260155744166
%173800 POLAND SYNDROME;;POLAND SYNDACTYLY;;POLAND ANOMALY;;POLAND SEQUENCEPECTORALIS MUSCLE, ABSENCE OF, INCLUDED	0.0078125	0.360260155744166
ADAMS-OLIVER SYNDROME 5; AOS5	0.0078125	0.360260155744166
CLEFT-LIMB-HEART MALFORMATION SYNDROME	0.0078125	0.360260155744166
BARDET-BIEDL SYNDROME 5; BBS5	0.0078125	0.360260155744166
%217100 CONSTRICTING BANDS, CONGENITAL;;AMNIOTIC BAND SEQUENCE; ABS;;STREETER ANOMALYADAM COMPLEX, INCLUDED;;TERMINAL TRANSVERSE DEFECTS OF ARM, INCLUDED;;AMPUTATION, CONGENITAL, INCLUDED	0.0078125	0.360260155744166
POLYDACTYLY, POSTAXIAL, TYPE A1; PAPA1	0.0078125	0.360260155744166
TUKEL SYNDROME	0.0078125	0.360260155744166
ECTODERMAL DYSPLASIA, ECTRODACTYLY, AND MACULAR DYSTROPHY SYNDROME	0.0078125	0.360260155744166
228940 FIBULOULNAR APLASIA OR HYPOPLASIA WITH RENAL ABNORMALITIES	0.0078125	0.360260155744166
1Q44 MICRODELETION SYNDROME	0.007724024	0.3561802354190945
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.007724024	0.3561802354190945
DISTAL TRISOMY 5Q	0.00771871	0.35593518934323853
9Q21.13 MICRODELETION SYNDROME	0.00771871	0.35593518934323853
CRANIOSYNOSTOSIS 7	0.00771871	0.35593518934323853
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.007618564	0.3513171268079227
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.007618564	0.3513171268079227
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.00760919	0.3508848607343296
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.007604874	0.35068583573180906
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.007604874	0.35068583573180906
DEAFNESS, CONDUCTIVE, WITH PTOSIS AND SKELETAL ANOMALIES	0.0075791700000000005	0.3495005394702733
ZUNICH NEUROECTODERMAL SYNDROME	0.0075791700000000005	0.3495005394702733
CONDUCTIVE DEAFNESS-PTOSIS-SKELETAL ANOMALIES SYNDROME	0.0075791700000000005	0.3495005394702733
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.0075791700000000005	0.3495005394702733
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.007557514	0.34850190984687546
COFFIN-SIRIS SYNDROME	0.007557514	0.34850190984687546
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.007557514	0.34850190984687546
COFFIN-SIRIS SYNDROME 4; CSS4	0.007557514	0.34850190984687546
COFFIN-SIRIS SYNDROME 3; CSS3	0.007557514	0.34850190984687546
DUANE RETRACTION SYNDROME	0.007543824	0.34787061877076186
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.007543824	0.34787061877076186
TRISOMY 17P	0.007542624	0.34781528281083957
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.007532840000000001	0.34736411028427305
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.00746032	0.3440199737729685
SPINOCEREBELLAR ATAXIA 47; SCA47	0.00746032	0.3440199737729685
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.00739927	0.3412047568119213
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.0073875500000000005	0.3406643089366801
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.0073875500000000005	0.3406643089366801
ALLAN-HERNDON-DUDLEY SYNDROME	0.0073875500000000005	0.3406643089366801
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.00737326	0.3400053498806053
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.0073654	0.33964289934311426
BARDET-BIEDL SYNDROME	0.0073654	0.33964289934311426
HEREDITARY ACROKERATOTIC POIKILODERMA	0.0073654	0.33964289934311426
8Q21.11 MICRODELETION SYNDROME	0.0073654	0.33964289934311426
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.0073654	0.33964289934311426
JUBERG-HAYWARD SYNDROME	0.00735294	0.33906832762592093
ULNAR/FIBULAR RAY DEFECT AND BRACHYDACTYLY	0.00735294	0.33906832762592093
SYNPOLYDACTYLY 2	0.00735294	0.33906832762592093
2Q24 MICRODELETION SYNDROME	0.00735294	0.33906832762592093
JEUNE SYNDROME	0.00735294	0.33906832762592093
LINEAR VERRUCOUS NEVUS SYNDROME	0.00735294	0.33906832762592093
BRACHYDACTYLY-SYNDACTYLY, ZHAO TYPE	0.00735294	0.33906832762592093
APHALANGY-SYNDACTYLY-MICROCEPHALY SYNDROME	0.00735294	0.33906832762592093
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.00735294	0.33906832762592093
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.00735294	0.33906832762592093
ISOLATED SPLIT HAND-SPLIT FOOT MALFORMATION	0.00735171	0.3390116082670006
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.00735171	0.3390116082670006
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.00735171	0.3390116082670006
X-LINKED HYPOPHOSPHATEMIA	0.0073314	0.3380750471453156
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1A; CPSKF1A	0.0073314	0.3380750471453156
OSTEOPETROSIS AND RELATED DISORDERS	0.0073314	0.3380750471453156
3MC SYNDROME	0.0073314	0.3380750471453156
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.0073314	0.3380750471453156
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.0073314	0.3380750471453156
METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE	0.0073314	0.3380750471453156
AUTOSOMAL RECESSIVE HYPOPHOSPHATEMIC RICKETS	0.00731771	0.33744375606920196
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE	0.00731771	0.33744375606920196
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.00731771	0.33744375606920196
SHORT STATURE-DEAFNESS-NEUTROPHIL DYSFUNCTION-DYSMORPHISM SYNDROME	0.00731771	0.33744375606920196
RECOMBINANT CHROMOSOME 8 SYNDROME	0.007306694000000001	0.33693577195711527
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.0073046840000000005	0.3368430842242454
OPTIC PATHWAY GLIOMA	0.007191424	0.3316202918735786
TENORIO SYNDROME; TNORS	0.00717847	0.33102294018621736
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.0071614040000000006	0.33023597060952237
MASA SYNDROME	0.007148450000000001	0.32963861892216106
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.00707301	0.3261598315750455
3MC SYNDROME 3	0.00707301	0.3261598315750455
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.00707301	0.3261598315750455
ESOPHAGEAL ATRESIA	0.00707301	0.3261598315750455
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.00705932	0.32552854049893193
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00705932	0.32552854049893193
184000 SPONDYLOEPIPHYSEAL DYSPLASIA, MYOPIA, AND SENSORINEURAL DEAFNESS	0.00705932	0.32552854049893193
KEIPERT SYNDROME; KPTS	0.00705932	0.32552854049893193
AXENFELD-RIEGER SYNDROME	0.00701196	0.3233446146139983
CAT-EYE SYNDROME	0.00701196	0.3233446146139983
ERYTHROKERATODERMIA VARIABILIS	0.00701196	0.3233446146139983
FANCONI ANEMIA	0.00701196	0.3233446146139983
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.00701196	0.3233446146139983
THALIDOMIDE EMBRYOPATHY	0.00701196	0.3233446146139983
184705 STEINFELD SYNDROME	0.00701196	0.3233446146139983
FACIOSCAPULOHUMERAL DYSTROPHY	0.00699827	0.32271332353788473
ZIMMERMANN-LABAND SYNDROME	0.00699827	0.32271332353788473
KALLMANN SYNDROME	0.00699827	0.32271332353788473
HOLOPROSENCEPHALY 3; HPE3	0.006955494	0.32074078101985437
OGDEN SYNDROME	0.006955494	0.32074078101985437
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.006903684	0.31835165095020884
DISTAL MONOSOMY 19P13.3	0.006903684	0.31835165095020884
IMMUNODEFICIENCY 23; IMD23	0.006903684	0.31835165095020884
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.006903684	0.31835165095020884
GAUCHER DISEASE	0.00679116	0.3131627979882944
CONGENITAL HYDROCEPHALUS	0.00677747	0.3125315069121808
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.006766854000000001	0.3120419681200682
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.006766854000000001	0.3120419681200682
DISTAL MONOSOMY 3P	0.0067611400000000006	0.31177847672423814
ATYPICAL RETT SYNDROME	0.0067611400000000006	0.31177847672423814
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.00675913	0.31168578899136823
MEIER-GORLIN SYNDROME 6; MGORS6	0.00675913	0.31168578899136823
CLEFT LIP/PALATE	0.00675913	0.31168578899136823
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.006692564000000001	0.3086162110678782
MONOSOMY 22Q13.3	0.006692564000000001	0.3086162110678782
PYCNODYSOSTOSIS	0.00664587	0.3064629966407014
MENINGIOMA	0.00664587	0.3064629966407014
WHIPPLE DISEASE	0.00664587	0.3064629966407014
DESBUQUOIS SYNDROME	0.00661585	0.3050786753766452
TETRALOGY OF FALLOT	0.00661585	0.3050786753766452
TETRALOGY OF FALLOT	0.00661585	0.3050786753766452
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.00661585	0.3050786753766452
FIBROCHONDROGENESIS 1; FBCG1	0.00661585	0.3050786753766452
PEHO-LIKE SYNDROME; PEHOL	0.006560944000000001	0.3025467785304002
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.006560944000000001	0.3025467785304002
LISSENCEPHALY 8; LIS8	0.006560944000000001	0.3025467785304002
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.006560944000000001	0.3025467785304002
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.006560944000000001	0.3025467785304002
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.006560944000000001	0.3025467785304002
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.006560944000000001	0.3025467785304002
MENTAL RETARDATION, X-LINKED 103	0.006560944000000001	0.3025467785304002
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.006560944000000001	0.3025467785304002
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.006560944000000001	0.3025467785304002
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.006560944000000001	0.3025467785304002
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.006560944000000001	0.3025467785304002
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.006560944000000001	0.3025467785304002
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.006560944000000001	0.3025467785304002
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.006560944000000001	0.3025467785304002
KLEEFSTRA SYNDROME	0.006486654	0.2991210214782102
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.006486654	0.2991210214782102
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.006486654	0.2991210214782102
HSD10 DISEASE	0.006486654	0.2991210214782102
16P13.11 MICRODELETION SYNDROME	0.006472964	0.2984897304020966
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.006472964	0.2984897304020966
BILATERAL POLYMICROGYRIA	0.006472964	0.2984897304020966
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.00640994	0.2955834857869772
MICROHYDRANENCEPHALY; MHAC	0.00640994	0.2955834857869772
MCKUSICK-KAUFMAN SYNDROME	0.006393504	0.29482556758924133
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.006393504	0.29482556758924133
OSTEOGENESIS IMPERFECTA, TYPE XVI; OI16	0.00637182	0.2938256467934453
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.006359504	0.29325771539144274
AU-KLINE SYNDROME; AUKS	0.006359504	0.29325771539144274
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.006359504	0.29325771539144274
LOWRY-MACLEAN SYNDROME	0.006359504	0.29325771539144274
CRANIOTELENCEPHALIC DYSPLASIA	0.006359504	0.29325771539144274
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.006359504	0.29325771539144274
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.006359504	0.29325771539144274
16P13.11 MICRODUPLICATION SYNDROME	0.006359504	0.29325771539144274
RETINITIS PIGMENTOSA	0.00635813	0.29319435571733166
CRANIOMETAPHYSEAL DYSPLASIA	0.00635813	0.29319435571733166
BRITTLE CORNEA SYNDROME	0.00635813	0.29319435571733166
OCULOAURICULOVERTEBRAL SPECTRUM WITH RADIAL DEFECTS	0.00635813	0.29319435571733166
BRANCHIOOTIC SYNDROME	0.00635813	0.29319435571733166
STICKLER SYNDROME, TYPE I	0.00635813	0.29319435571733166
X-LINKED MANDIBULOFACIAL DYSOSTOSIS	0.00635813	0.29319435571733166
DISTAL LIMB DEFICIENCIES-MICROGNATHIA SYNDROME	0.00635813	0.29319435571733166
KLIPPEL-FEIL SYNDROME, AUTOSOMAL RECESSIVE	0.00635813	0.29319435571733166
DEAFNESS, AUTOSOMAL DOMINANT 23; DFNA23	0.00635813	0.29319435571733166
RAMON SYNDROME	0.00635813	0.29319435571733166
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.006341364	0.2924212201306173
OKAMOTO SYNDROME	0.006341364	0.2924212201306173
SAUL-WILSON SYNDROME; SWILS	0.006341364	0.2924212201306173
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.006341364	0.2924212201306173
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.00625132	0.2882689941512473
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.00625132	0.2882689941512473
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.006221300000000001	0.28688467288719105
17Q23.1Q23.2 MICRODELETION SYNDROME	0.0061470100000000005	0.28345891583500105
MICROTRIPLICATION 11Q24.1	0.0061470100000000005	0.28345891583500105
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.006101114	0.28134249982117265
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.006101114	0.28134249982117265
GOLDBERG-SHPRINTZEN SYNDROME	0.006101114	0.28134249982117265
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.006101114	0.28134249982117265
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.006101114	0.28134249982117265
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.006101114	0.28134249982117265
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.006101114	0.28134249982117265
CHROMOSOME 18P DELETION SYNDROME	0.006101114	0.28134249982117265
MATERNAL PHENYLKETONURIA	0.006101114	0.28134249982117265
19P13.13 MICRODELETION SYNDROME	0.006101114	0.28134249982117265
W SYNDROME	0.006101114	0.28134249982117265
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.006101114	0.28134249982117265
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.006101114	0.28134249982117265
MOSAIC TRISOMY 14	0.006040064	0.27852728286012546
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.006040064	0.27852728286012546
SRD5A3-CDG	0.006040064	0.27852728286012546
MONOSOMY 9P	0.006040064	0.27852728286012546
DISTAL TRISOMY 6P	0.006040064	0.27852728286012546
TRISOMY 8Q	0.006040064	0.27852728286012546
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.006040064	0.27852728286012546
TETRASOMY 5P	0.006025174	0.2778406558240895
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.006015390000000001	0.27738948329752305
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.006015390000000001	0.27738948329752305
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.006015390000000001	0.27738948329752305
MOWAT-WILSON SYNDROME; MOWS	0.006015390000000001	0.27738948329752305
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.006015390000000001	0.27738948329752305
CHRISTIANSON SYNDROME	0.006015390000000001	0.27738948329752305
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.006015390000000001	0.27738948329752305
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.006015390000000001	0.27738948329752305
CHOPS SYNDROME; CHOPS	0.005954054	0.2745610779326943
WOLF-HIRSCHHORN SYNDROME	0.005954054	0.2745610779326943
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.005946814	0.27422721764116303
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.005946814	0.27422721764116303
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.005946814	0.27422721764116303
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.0059411	0.27396372624533305
16Q24.3 MICRODELETION SYNDROME	0.0059411	0.27396372624533305
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 53	0.0059411	0.27396372624533305
DONNAI-BARROW SYNDROME	0.005940364	0.2739297868565807
CHOROIDAL ATROPHY-ALOPECIA SYNDROME	0.00584795	0.2696682723563642
HEREDITARY SPASTIC PARAPLEGIA	0.00584795	0.2696682723563642
BRACHYDACTYLY TYPE A5	0.00584795	0.2696682723563642
KINDLER SYNDROME	0.00584795	0.2696682723563642
BLOOM SYNDROME	0.00584795	0.2696682723563642
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.00584795	0.2696682723563642
TERMINAL TRANSVERSE LIMB DEFECT	0.00584795	0.2696682723563642
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.00584795	0.2696682723563642
FACIAL DYSMORPHISM-ANOREXIA-CACHEXIA-EYE AND SKIN ANOMALIES SYNDROME	0.00584795	0.2696682723563642
CHARLIE M SYNDROME	0.00584795	0.2696682723563642
BRACHYDACTYLY-SYNDACTYLY SYNDROME	0.00584795	0.2696682723563642
BRACHYDACTYLY TYPE B2	0.00584795	0.2696682723563642
SYNDACTYLY TYPE 3	0.00584795	0.2696682723563642
ECTRODACTYLY-POLYDACTYLY SYNDROME	0.00584795	0.2696682723563642
EEM SYNDROME	0.00584795	0.2696682723563642
HOLT-ORAM SYNDROME	0.00584795	0.2696682723563642
CRANIODIGITAL-INTELLECTUAL DISABILITY SYNDROME	0.00584795	0.2696682723563642
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA, CANTU TYPE	0.00584795	0.2696682723563642
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.00584795	0.2696682723563642
BOOMERANG DYSPLASIA	0.00584795	0.2696682723563642
TIBIAL APLASIA-ECTRODACTYLY SYNDROME	0.00584795	0.2696682723563642
HYPOGLOSSIA-HYPODACTYLY SYNDROME	0.00584795	0.2696682723563642
BRACHYDACTYLY TYPE B	0.00584795	0.2696682723563642
FEMUR-FIBULA-ULNA COMPLEX	0.00584795	0.2696682723563642
ACROPECTORAL SYNDROME	0.00584795	0.2696682723563642
ACRO-RENAL-MANDIBULAR SYNDROME	0.00584795	0.2696682723563642
ACROPECTOROVERTEBRAL DYSPLASIA	0.00584795	0.2696682723563642
HIDROTIC ECTODERMAL DYSPLASIA	0.00584795	0.2696682723563642
SPLIT-HAND/FOOT MALFORMATION 2	0.00584795	0.2696682723563642
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.005819264	0.2683454662344215
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.005819264	0.2683454662344215
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.005819264	0.2683454662344215
MONOSOMY 9Q22.3	0.005819264	0.2683454662344215
ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ACCIID	0.00581395	0.2681004201585656
SCARF SYNDROME	0.00581395	0.2681004201585656
OSTEOGLOSPHONIC DYSPLASIA	0.00581395	0.2681004201585656
HARTSFIELD SYNDROME	0.00581395	0.2681004201585656
CHOANAL ATRESIA	0.00581395	0.2681004201585656
INTELLECTUAL DISABILITY-HYPOTONIA-BRACHYCEPHALY-PYLORIC STENOSIS-CRYPTORCHIDISM SYNDROME	0.00581395	0.2681004201585656
CRANIORHINY	0.00581395	0.2681004201585656
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.00581395	0.2681004201585656
CRANIOSYNOSTOSIS 1	0.00581395	0.2681004201585656
HYPER-IGE RECURRENT INFECTION SYNDROME, AUTOSOMAL DOMINANT	0.00581395	0.2681004201585656
HYPOPHOSPHATEMIC RICKETS	0.00581395	0.2681004201585656
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.00581395	0.2681004201585656
FRONTONASAL DYSPLASIA 2; FND2	0.00581395	0.2681004201585656
HYPOPHOSPHATASIA, INFANTILE	0.00581395	0.2681004201585656
METAPHYSEAL ACROSCYPHODYSPLASIA	0.00581395	0.2681004201585656
HYPERTELORISM, TEEBI TYPE; TBHS	0.00581395	0.2681004201585656
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.00581395	0.2681004201585656
MUCOLIPIDOSIS III ALPHA/BETA	0.00581395	0.2681004201585656
HYPOPHOSPHATASIA	0.00581395	0.2681004201585656
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.00581395	0.2681004201585656
CRANIOSYNOSTOSIS WITH FIBULAR APLASIA	0.00581395	0.2681004201585656
CRANIOSYNOSTOSIS WITH ANOMALIES OF THE CRANIAL BASE AND DIGITS	0.00581395	0.2681004201585656
VAN DEN ENDE-GUPTA SYNDROME; VDEGS	0.00581395	0.2681004201585656
SYMPHALANGISM, DISTAL	0.00581395	0.2681004201585656
ACROCEPHALOPOLYDACTYLOUS DYSPLASIA	0.00581395	0.2681004201585656
CRANIOSYNOSTOSIS, ADELAIDE TYPE	0.00581395	0.2681004201585656
ADDUCTED THUMBS SYNDROME	0.00581395	0.2681004201585656
PROGNATHISM, MANDIBULAR	0.00581395	0.2681004201585656
ACROCEPHALOSYNDACTYLY	0.00581395	0.2681004201585656
HUNTER-MCALPINE CRANIOSYNOSTOSIS SYNDROME	0.00581395	0.2681004201585656
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.00581395	0.2681004201585656
MACHADO-JOSEPH DISEASE TYPE 2	0.00579581	0.2672639248977401
20Q13.33 MICRODELETION SYNDROME	0.00579581	0.2672639248977401
CHITAYAT SYNDROME	0.00579581	0.2672639248977401
MACHADO-JOSEPH DISEASE TYPE 1	0.00579581	0.2672639248977401
MACHADO-JOSEPH DISEASE TYPE 3	0.00579581	0.2672639248977401
SPINOCEREBELLAR ATAXIA TYPE 3	0.00579581	0.2672639248977401
17P13.3 MICRODUPLICATION SYNDROME	0.005789244000000001	0.26696114497036527
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.005559504000000001	0.25636707544324017
TRANSKETOLASE DEFICIENCY	0.005559504000000001	0.25636707544324017
CHROMOSOME 1P35 DELETION SYNDROME	0.005559504000000001	0.25636707544324017
YOU-HOOVER-FONG SYNDROME; YHFS	0.005559504000000001	0.25636707544324017
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.005559504000000001	0.25636707544324017
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.005559504000000001	0.25636707544324017
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.005559504000000001	0.25636707544324017
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.005559504000000001	0.25636707544324017
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.005559504000000001	0.25636707544324017
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.005559504000000001	0.25636707544324017
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.005559504000000001	0.25636707544324017
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.005559504000000001	0.25636707544324017
OPTIC ATROPHY 11; OPA11	0.005559504000000001	0.25636707544324017
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.005559504000000001	0.25636707544324017
AL-GAZALI-BAKALINOVA SYNDROME; AGBK	0.00555556	0.25618520458829547
201310 ACRORENAL SYNDROME, AUTOSOMAL RECESSIVE	0.00555556	0.25618520458829547
109300 BANKI SYNDROME	0.00555556	0.25618520458829547
RUIJS-AALFS SYNDROME; RJALS	0.00555556	0.25618520458829547
%607004 BRACHYDACTYLY, TYPE A1, B; BDA1B	0.00555556	0.25618520458829547
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.00555556	0.25618520458829547
ACROFACIAL DYSOSTOSIS SYNDROME OF RODRIGUEZ	0.00555556	0.25618520458829547
SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY; SPSMA	0.00555556	0.25618520458829547
ANTENATAL MULTIMINICORE DISEASE WITH ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.00555556	0.25618520458829547
%165660 OSLAM SYNDROME;;OSTEOSARCOMA, LIMB ANOMALIES, AND MACROCYTOSIS;;OSTEOSARCOMA, LIMB ANOMALIES, AND ERYTHROID MACROCYTOSIS WITH MEGALOBLASTICMARROW	0.00555556	0.25618520458829547
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR I RESISTANCE	0.00555556	0.25618520458829547
HYPERTELORISM AND OTHER FACIAL DYSMORPHISM, BRACHYDACTYLY, GENITAL ABNORMALITIES, MENTAL RETARDATION, AND RECURRENT INFLAMMATORY EPISODES	0.00555556	0.25618520458829547
COFFIN-SIRIS SYNDROME 10; CSS10	0.00555556	0.25618520458829547
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.00555556	0.25618520458829547
311450 PALLISTER W SYNDROME;;W SYNDROME	0.00555556	0.25618520458829547
ARTHROGRYPOSIS, DISTAL, TYPE 2B2; DA2B2	0.00555556	0.25618520458829547
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.00555556	0.25618520458829547
MEIER-GORLIN SYNDROME 5; MGORS5	0.00555556	0.25618520458829547
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.00555556	0.25618520458829547
HYPOGONADOTROPIC HYPOGONADISM 9 WITH OR WITHOUT ANOSMIA; HH9	0.00555556	0.25618520458829547
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 2; PRAAS2	0.00555556	0.25618520458829547
SECKEL SYNDROME 7; SCKL7	0.00555556	0.25618520458829547
MCDONOUGH SYNDROME	0.00555556	0.25618520458829547
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00555556	0.25618520458829547
DISPROPORTIONATE SHORT STATURE WITH PTOSIS AND VALVULAR HEART LESIONS	0.00555556	0.25618520458829547
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.00555556	0.25618520458829547
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.0055458140000000005	0.2557357843671265
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.0055458140000000005	0.2557357843671265
PONTINE TEGMENTAL CAP DYSPLASIA	0.0055458140000000005	0.2557357843671265
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.0055458140000000005	0.2557357843671265
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.0055458140000000005	0.2557357843671265
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.0055458140000000005	0.2557357843671265
SALT-AND-PEPPER SYNDROME	0.0055458140000000005	0.2557357843671265
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.0055458140000000005	0.2557357843671265
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.0055458140000000005	0.2557357843671265
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.00549451	0.25336998762724827
RENAL AGENESIS, BILATERAL	0.00549451	0.25336998762724827
46,XY PARTIAL GONADAL DYSGENESIS	0.00549451	0.25336998762724827
FAMILIAL VISCERAL MYOPATHY	0.00549451	0.25336998762724827
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.00549451	0.25336998762724827
HOLZGREVE SYNDROME	0.00549451	0.25336998762724827
X-LINKED EHLERS-DANLOS SYNDROME	0.00549451	0.25336998762724827
NEUROFACIODIGITORENAL SYNDROME	0.00549451	0.25336998762724827
PHENYLKETONURIA	0.00549451	0.25336998762724827
SHORT RIB-POLYDACTYLY SYNDROME, VERMA-NAUMOFF TYPE	0.00549451	0.25336998762724827
TRISOMY 18-LIKE SYNDROME	0.00549451	0.25336998762724827
601165 CLEFT LIP/PALATE WITH CHARACTERISTIC FACIES, INTESTINAL MALROTATION,AND LETHAL CONGENITAL HEART DISEASE	0.00549451	0.25336998762724827
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC TYPE; AMCN	0.00549451	0.25336998762724827
FACIOCARDIOMELIC DYSPLASIA, LETHAL	0.00549451	0.25336998762724827
CONGENITAL DIAPHRAGMATIC HERNIA	0.00549451	0.25336998762724827
233430 GONADAL DYSGENESIS, XY TYPE, WITH ASSOCIATED ANOMALIES	0.00549451	0.25336998762724827
DISTAL TRISOMY 15Q	0.00549451	0.25336998762724827
CHST3-RELATED SKELETAL DYSPLASIA	0.00549451	0.25336998762724827
TRISOMY 4P	0.00549451	0.25336998762724827
MATTHEW-WOOD SYNDROME	0.00549451	0.25336998762724827
MCDONOUGH SYNDROME	0.00549451	0.25336998762724827
LARYNX ATRESIA	0.00549451	0.25336998762724827
ACHONDROGENESIS	0.00549451	0.25336998762724827
CONGENITAL HEART DEFECT-ROUND FACE-DEVELOPMENTAL DELAY SYNDROME	0.00549451	0.25336998762724827
HEART-HAND SYNDROME TYPE 2	0.00549451	0.25336998762724827
ACHONDROGENESIS TYPE 1A	0.00549451	0.25336998762724827
ACQUIRED VON WILLEBRAND SYNDROME	0.00549451	0.25336998762724827
CAUDAL REGRESSION SEQUENCE	0.00549451	0.25336998762724827
ISOLATED HEMIHYPERPLASIA	0.00549451	0.25336998762724827
PSEUDODIASTROPHIC DYSPLASIA	0.00549451	0.25336998762724827
CAMPOMELIA, CUMMING TYPE	0.00549451	0.25336998762724827
NON-DISTAL TRISOMY 10Q	0.00549451	0.25336998762724827
212135 CARDIOSKELETAL SYNDROME, KUWAITI TYPE	0.00549451	0.25336998762724827
ACHONDROGENESIS TYPE 1B	0.00549451	0.25336998762724827
AUTOSOMAL DOMINANT SPONDYLOCOSTAL DYSOSTOSIS	0.00549451	0.25336998762724827
ACHONDROGENESIS TYPE 2	0.00549451	0.25336998762724827
JACOBSEN SYNDROME	0.00547962	0.2526833605912124
METATROPIC DYSPLASIA	0.00547962	0.2526833605912124
MENTAL RETARDATION, BUENOS AIRES TYPE	0.00547962	0.2526833605912124
DESANTO-SHINAWI SYNDROME	0.005471524	0.25231002731493657
CAMURATI-ENGELMANN DISEASE	0.0054085	0.24940378269981714
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY	0.0054085	0.24940378269981714
JOINT LAXITY, SHORT STATURE, AND MYOPIA; JLSM	0.0054085	0.24940378269981714
ISOLATED BRACHYCEPHALY	0.0054085	0.24940378269981714
WALDENSTRÖM MACROGLOBULINEMIA	0.0054085	0.24940378269981714
PROLIDASE DEFICIENCY	0.0054085	0.24940378269981714
THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL RECESSIVE	0.0054085	0.24940378269981714
MELNICK-NEEDLES SYNDROME	0.0054085	0.24940378269981714
CAMURATI-ENGELMANN DISEASE	0.0054085	0.24940378269981714
KNIEST DYSPLASIA	0.0054085	0.24940378269981714
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.005399924	0.24900831503957244
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.005399924	0.24900831503957244
TREACHER-COLLINS SYNDROME	0.005399924	0.24900831503957244
OTOFACIOCERVICAL SYNDROME	0.005399924	0.24900831503957244
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.005399924	0.24900831503957244
ZECHI-CEIDE SYNDROME	0.005399924	0.24900831503957244
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.005399924	0.24900831503957244
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.00539481	0.24877249162370352
HYPEROSTOSIS CRANIALIS INTERNA; HCIN	0.00539481	0.24877249162370352
MARSHALL SYNDROME	0.00539481	0.24877249162370352
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.00539481	0.24877249162370352
STICKLER SYNDROME TYPE 1	0.00539481	0.24877249162370352
GRANULOMATOSIS WITH POLYANGIITIS	0.00539481	0.24877249162370352
MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL	0.00539481	0.24877249162370352
STICKLER SYNDROME	0.00539481	0.24877249162370352
MASA SYNDROME	0.00527371	0.24318817100154438
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.00527371	0.24318817100154438
DESMOSTEROLOSIS	0.00527371	0.24318817100154438
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.00527371	0.24318817100154438
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.00527371	0.24318817100154438
MUSCULAR HYPERTROPHY-HEPATOMEGALY-POLYHYDRAMNIOS SYNDROME	0.00527371	0.24318817100154438
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.00527371	0.24318817100154438
NASU-HAKOLA DISEASE	0.00527371	0.24318817100154438
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.0052436900000000005	0.24180384973748809
WARBURG MICRO SYNDROME 3; WARBM3	0.0052436900000000005	0.24180384973748809
CATEL-MANZKE SYNDROME	0.0052436900000000005	0.24180384973748809
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.0052436900000000005	0.24180384973748809
WIEDEMANN-STEINER SYNDROME; WDSTS	0.005175114000000001	0.23864158408112815
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.005175114000000001	0.23864158408112815
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.005175114000000001	0.23864158408112815
3Q29 MICRODELETION SYNDROME	0.005175114000000001	0.23864158408112815
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.005175114000000001	0.23864158408112815
12Q14 MICRODELETION SYNDROME	0.005175114000000001	0.23864158408112815
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.005175114000000001	0.23864158408112815
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.005175114000000001	0.23864158408112815
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.005175114000000001	0.23864158408112815
11Q22.2Q22.3 MICRODELETION SYNDROME	0.005175114000000001	0.23864158408112815
PITT-HOPKINS-LIKE SYNDROME	0.0050139500000000005	0.231209780210363
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.0050139500000000005	0.231209780210363
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.0050139500000000005	0.231209780210363
OPTICOCOCHLEODENTATE DEGENERATION	0.0050139500000000005	0.231209780210363
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.0050139500000000005	0.231209780210363
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13; COXPD13	0.00500026	0.23057848913424936
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.00500026	0.23057848913424936
AMISH INFANTILE EPILEPSY SYNDROME	0.00500026	0.23057848913424936
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.00500026	0.23057848913424936
GABRIELE-DE VRIES SYNDROME; GADEVS	0.004969204	0.2291463944914601
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.004969204	0.2291463944914601
LUSCAN-LUMISH SYNDROME; LLS	0.004969204	0.2291463944914601
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.004969204	0.2291463944914601
CHROMOSOME 19P13.13 DELETION SYNDROME	0.004969204	0.2291463944914601
MEHMO SYNDROME; MEHMO	0.004969204	0.2291463944914601
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.004969204	0.2291463944914601
TREACHER COLLINS SYNDROME 3; TCS3	0.00485437	0.2238510198066953
DEAFNESS, CONDUCTIVE, WITH MALFORMED EXTERNAL EAR	0.00485437	0.2238510198066953
TREACHER COLLINS SYNDROME 2; TCS2	0.00485437	0.2238510198066953
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.00485437	0.2238510198066953
NATIVE AMERICAN MYOPATHY	0.00485437	0.2238510198066953
ATRESIA OF EXTERNAL AUDITORY CANAL AND CONDUCTION DEAFNESS	0.00485437	0.2238510198066953
NON-FUNCTIONING PARAGANGLIOMA	0.00485437	0.2238510198066953
FAMILIAL EXPANSILE OSTEOLYSIS	0.00485437	0.2238510198066953
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00485437	0.2238510198066953
DIAMOND-BLACKFAN ANEMIA 10	0.00485437	0.2238510198066953
MULTIPLE EPIPHYSEAL DYSPLASIA, BEIGHTON TYPE	0.00485437	0.2238510198066953
MULLERIAN DUCT APLASIA, UNILATERAL RENAL AGENESIS, AND CERVICOTHORACICSOMITE ANOMALIES	0.00485437	0.2238510198066953
PIGMENTED VILLONODULAR SYNOVITIS	0.00485437	0.2238510198066953
ISOLATED CLEFT LIP	0.00485437	0.2238510198066953
COOPER-JABS SYNDROME	0.00485437	0.2238510198066953
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.00485437	0.2238510198066953
JOHNSON NEUROECTODERMAL SYNDROME	0.00485437	0.2238510198066953
ALOPECIA ANTIBODY DEFICIENCY	0.00485437	0.2238510198066953
NEPHROSIS-DEAFNESS-URINARY TRACT-DIGITAL MALFORMATIONS SYNDROME	0.00485437	0.2238510198066953
OTOSCLEROSIS	0.00485437	0.2238510198066953
OTOFACIOCERVICAL SYNDROME	0.00485437	0.2238510198066953
RHYNS SYNDROME; RHYNS	0.00485437	0.2238510198066953
124490 DEAFNESS, CONDUCTIVE STAPEDIAL, WITH EAR MALFORMATION AND FACIAL PALSY	0.00485437	0.2238510198066953
DIAMOND-BLACKFAN ANEMIA 14 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA14	0.00485437	0.2238510198066953
PARAGANGLIOMAS 1	0.00485437	0.2238510198066953
BRANCHIO-OCULO-FACIAL SYNDROME	0.00485437	0.2238510198066953
OSTEOPETROSIS, AUTOSOMAL DOMINANT 1; OPTA1	0.00485437	0.2238510198066953
MANDIBULOFACIAL DYSOSTOSIS WITH PTOSIS, AUTOSOMAL DOMINANT	0.00485437	0.2238510198066953
CILIARY DYSKINESIA, PRIMARY, 38; CILD38	0.00485437	0.2238510198066953
METAPHYSEAL DYSOSTOSIS-INTELLECTUAL DISABILITY-CONDUCTIVE DEAFNESS SYNDROME	0.00485437	0.2238510198066953
SPORADIC PHEOCHROMOCYTOMA/SECRETING PARAGANGLIOMA	0.00485437	0.2238510198066953
HEREDITARY PHEOCHROMOCYTOMA-PARAGANGLIOMA	0.00485437	0.2238510198066953
PHAVER SYNDROME	0.00485437	0.2238510198066953
PHOCOMELIA-ECTRODACTYLY-DEAFNESS-SINUS ARRHYTHMIA SYNDROME	0.00485437	0.2238510198066953
CRANIODIAPHYSEAL DYSPLASIA	0.00485437	0.2238510198066953
MICROTIA WITH MEATAL ATRESIA AND CONDUCTIVE DEAFNESS	0.00485437	0.2238510198066953
PHOCOMELIA-ECTRODACTYLY, EAR MALFORMATION, DEAFNESS, AND SINUS ARRHYTHMIA	0.00485437	0.2238510198066953
AGNATHIA-OTOCEPHALY COMPLEX	0.00485437	0.2238510198066953
LATERAL MENINGOCELE SYNDROME	0.00485437	0.2238510198066953
133705 EXTERNAL AUDITORY CANAL, BILATERAL ATRESIA OF, WITH CONGENITAL VERTICALTALUS;;RASMUSSEN SYNDROME	0.00485437	0.2238510198066953
HEMIFACIAL MICROSOMIA WITH RADIAL DEFECTS	0.00485437	0.2238510198066953
CILIARY DYSKINESIA, PRIMARY, 33	0.00485437	0.2238510198066953
MANDIBULOFACIAL DYSOSTOSIS WITH ALOPECIA; MFDA	0.00485437	0.2238510198066953
DEAFNESS-EAR MALFORMATION-FACIAL PALSY SYNDROME	0.00485437	0.2238510198066953
OCULOAURICULOFRONTONASAL SYNDROME	0.00485437	0.2238510198066953
CARDIOSPONDYLOCARPOFACIAL SYNDROME	0.00485437	0.2238510198066953
MULTIPLE SYNOSTOSES SYNDROME	0.00485437	0.2238510198066953
WAARDENBURG SYNDROME	0.00485437	0.2238510198066953
HURLER SYNDROME	0.004817824	0.22216576314726152
HURLER SYNDROME	0.004817824	0.22216576314726152
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.004817824	0.22216576314726152
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.004817824	0.22216576314726152
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.004817824	0.22216576314726152
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.004817824	0.22216576314726152
FRIED SYNDROME	0.004817824	0.22216576314726152
BRESEK SYNDROME	0.004817824	0.22216576314726152
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.004817824	0.22216576314726152
CRANIOPHARYNGIOMA	0.004817824	0.22216576314726152
OTOPALATODIGITAL SYNDROME TYPE 2	0.004817824	0.22216576314726152
MULTIPLE SULFATASE DEFICIENCY	0.004804134	0.2215344720711479
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.004804134	0.2215344720711479
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.0047878040000000005	0.22078144188320523
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.0047878040000000005	0.22078144188320523
RECOMBINANT 8 SYNDROME	0.0047878040000000005	0.22078144188320523
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.004774114	0.22015015080709158
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.0046295600000000004	0.21348428884825102
8P INVERTED DUPLICATION/DELETION SYNDROME	0.0046295600000000004	0.21348428884825102
2Q23.1 MICRODELETION SYNDROME	0.0046295600000000004	0.21348428884825102
FRAXE INTELLECTUAL DISABILITY	0.0046295600000000004	0.21348428884825102
WIEDEMANN-STEINER SYNDROME	0.0046295600000000004	0.21348428884825102
129540 ECTODERMAL DYSPLASIA SYNDROME WITH DISTINCTIVE FACIAL APPEARANCE ANDPREAXIAL POLYDACTYLY OF FEET	0.0046295600000000004	0.21348428884825102
BRACHYDACTYLY, TYPE A1, D	0.0046295600000000004	0.21348428884825102
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.004581894	0.2112862522935372
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.004581894	0.2112862522935372
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.004581894	0.2112862522935372
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.004581894	0.2112862522935372
NARP SYNDROME	0.004581894	0.2112862522935372
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.004581894	0.2112862522935372
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.004581894	0.2112862522935372
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.004581894	0.2112862522935372
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.004581894	0.2112862522935372
BARAITSER-WINTER SYNDROME 1; BRWS1	0.004568204	0.21065496121742358
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.004568204	0.21065496121742358
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.004568204	0.21065496121742358
FRIAS SYNDROME	0.004436604	0.20458645094594427
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.004436604	0.20458645094594427
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.004436604	0.20458645094594427
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.004436604	0.20458645094594427
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.004436604	0.20458645094594427
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.004436604	0.20458645094594427
HOLOPROSENCEPHALY 11	0.004436604	0.20458645094594427
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.004436604	0.20458645094594427
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.004436604	0.20458645094594427
OCULOECTODERMAL SYNDROME; OES	0.004436604	0.20458645094594427
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.004436604	0.20458645094594427
OGDEN SYNDROME; OGDNS	0.004436604	0.20458645094594427
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.00442365	0.20398909925858302
SOTOS SYNDROME 2	0.00442365	0.20398909925858302
FAMILIAL MULTIPLE LIPOMATOSIS	0.00442365	0.20398909925858302
HUNTINGTON DISEASE-LIKE 1	0.00442365	0.20398909925858302
PRADER-WILLI SYNDROME	0.00442365	0.20398909925858302
CHROMOSOME 3Q13.31 DELETION SYNDROME	0.00442365	0.20398909925858302
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.00427227	0.19700846791438437
MYCOPHENOLATE MOFETIL EMBRYOPATHY	0.00427227	0.19700846791438437
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.00427227	0.19700846791438437
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.00427227	0.19700846791438437
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.00427227	0.19700846791438437
ARACHNOIDITIS	0.00427227	0.19700846791438437
DIABETIC EMBRYOPATHY	0.00427227	0.19700846791438437
KRABBE DISEASE	0.00427227	0.19700846791438437
GAUCHER DISEASE-OPHTHALMOPLEGIA-CARDIOVASCULAR CALCIFICATION SYNDROME	0.00427227	0.19700846791438437
ACROOSTEOLYSIS DOMINANT TYPE	0.00427227	0.19700846791438437
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR	0.00427227	0.19700846791438437
MUCOPOLYSACCHARIDOSIS, TYPE II	0.00427227	0.19700846791438437
ALBERS-SCHÖNBERG OSTEOPETROSIS	0.00427227	0.19700846791438437
VON HIPPEL-LINDAU DISEASE	0.00425858	0.19637717683827072
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2A2	0.00425858	0.19637717683827072
MUCOPOLYSACCHARIDOSIS TYPE 1	0.00425858	0.19637717683827072
EXTERNAL AUDITORY CANAL ATRESIA-VERTICAL TALUS-HYPERTELORISM SYNDROME	0.00424225	0.1956241466503281
RENPENNING SYNDROME 1; RENS1	0.00424225	0.1956241466503281
CLEIDOCRANIAL DYSPLASIA	0.00424225	0.1956241466503281
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	0.00424225	0.1956241466503281
WILLIAMS-BEUREN SYNDROME; WBS	0.00422856	0.19499285557421445
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.00422856	0.19499285557421445
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.00422856	0.19499285557421445
WT LIMB-BLOOD SYNDROME	0.00422856	0.19499285557421445
RENPENNING SYNDROME	0.00422856	0.19499285557421445
X-LINKED DOMINANT CHONDRODYSPLASIA PUNCTATA	0.00422856	0.19499285557421445
SPASTIC PARAPLEGIA-NEPHRITIS-DEAFNESS SYNDROME	0.00422856	0.19499285557421445
NAIL-PATELLA SYNDROME	0.00422856	0.19499285557421445
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.004042054000000001	0.18639244845649014
RAYNAUD-CLAES SYNDROME; MRXSRC	0.004042054000000001	0.18639244845649014
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.004042054000000001	0.18639244845649014
JOUBERT SYNDROME 24	0.004042054000000001	0.18639244845649014
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.004042054000000001	0.18639244845649014
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.004042054000000001	0.18639244845649014
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.004042054000000001	0.18639244845649014
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.004042054000000001	0.18639244845649014
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.004042054000000001	0.18639244845649014
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.004042054000000001	0.18639244845649014
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.004042054000000001	0.18639244845649014
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.004042054000000001	0.18639244845649014
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.004042054000000001	0.18639244845649014
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.004042054000000001	0.18639244845649014
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.004042054000000001	0.18639244845649014
MENTAL RETARDATION, X-LINKED 98; MRX98	0.004042054000000001	0.18639244845649014
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.004042054000000001	0.18639244845649014
INFANTILE DYSTONIA-PARKINSONISM	0.004042054000000001	0.18639244845649014
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.004042054000000001	0.18639244845649014
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.004042054000000001	0.18639244845649014
ANGELMAN SYNDROME	0.004042054000000001	0.18639244845649014
COFFIN-SIRIS SYNDROME 5	0.004042054000000001	0.18639244845649014
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.004042054000000001	0.18639244845649014
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.004042054000000001	0.18639244845649014
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.004042054000000001	0.18639244845649014
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.004042054000000001	0.18639244845649014
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.004042054000000001	0.18639244845649014
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.004042054000000001	0.18639244845649014
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.004042054000000001	0.18639244845649014
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.004042054000000001	0.18639244845649014
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.004042054000000001	0.18639244845649014
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.004042054000000001	0.18639244845649014
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.004042054000000001	0.18639244845649014
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.004042054000000001	0.18639244845649014
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.004042054000000001	0.18639244845649014
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.004042054000000001	0.18639244845649014
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.004042054000000001	0.18639244845649014
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.004042054000000001	0.18639244845649014
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.004042054000000001	0.18639244845649014
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.004042054000000001	0.18639244845649014
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.004042054000000001	0.18639244845649014
MENTAL RETARDATION, X-LINKED 104; MRX104	0.004042054000000001	0.18639244845649014
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.004042054000000001	0.18639244845649014
MENTAL RETARDATION, X-LINKED 101; MRX101	0.004042054000000001	0.18639244845649014
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.004042054000000001	0.18639244845649014
FOIX-CHAVANY-MARIE SYNDROME	0.004042054000000001	0.18639244845649014
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.004042054000000001	0.18639244845649014
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.004042054000000001	0.18639244845649014
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.004042054000000001	0.18639244845649014
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.004042054000000001	0.18639244845649014
MUCOLIPIDOSIS IV; ML4	0.004042054000000001	0.18639244845649014
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.004042054000000001	0.18639244845649014
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.004042054000000001	0.18639244845649014
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.004042054000000001	0.18639244845649014
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.004042054000000001	0.18639244845649014
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.004042054000000001	0.18639244845649014
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.004042054000000001	0.18639244845649014
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.004042054000000001	0.18639244845649014
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.004042054000000001	0.18639244845649014
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.004042054000000001	0.18639244845649014
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.004042054000000001	0.18639244845649014
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.004042054000000001	0.18639244845649014
HADZISELIMOVIC SYNDROME	0.004042054000000001	0.18639244845649014
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.004042054000000001	0.18639244845649014
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.004042054000000001	0.18639244845649014
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.004042054000000001	0.18639244845649014
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.004042054000000001	0.18639244845649014
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.004042054000000001	0.18639244845649014
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.004042054000000001	0.18639244845649014
OROFACIODIGITAL SYNDROME XIV; OFD14	0.004042054000000001	0.18639244845649014
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.004042054000000001	0.18639244845649014
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.004042054000000001	0.18639244845649014
AICARDI-GOUTIERES SYNDROME 7	0.004042054000000001	0.18639244845649014
COG4-CDG	0.004042054000000001	0.18639244845649014
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.004042054000000001	0.18639244845649014
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.004042054000000001	0.18639244845649014
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.004042054000000001	0.18639244845649014
AL-RAQAD SYNDROME; ARS	0.004042054000000001	0.18639244845649014
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.004042054000000001	0.18639244845649014
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.004042054000000001	0.18639244845649014
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.004042054000000001	0.18639244845649014
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.004042054000000001	0.18639244845649014
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.004042054000000001	0.18639244845649014
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.004042054000000001	0.18639244845649014
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.004042054000000001	0.18639244845649014
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.004042054000000001	0.18639244845649014
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.004042054000000001	0.18639244845649014
XQ28 (MECP2) DUPLICATION	0.004042054000000001	0.18639244845649014
HOLMES-GANG SYNDROME	0.004042054000000001	0.18639244845649014
IMMUNODEFICIENCY 49; IMD49	0.004042054000000001	0.18639244845649014
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.004042054000000001	0.18639244845649014
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.004042054000000001	0.18639244845649014
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.004042054000000001	0.18639244845649014
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.004042054000000001	0.18639244845649014
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.004042054000000001	0.18639244845649014
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.004042054000000001	0.18639244845649014
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.004042054000000001	0.18639244845649014
XYLOSIDASE DEFICIENCY	0.00403634	0.18612895706066007
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.00403634	0.18612895706066007
SIFRIM-HITZ-WEISS SYNDROME	0.00403634	0.18612895706066007
MENTAL RETARDATION, X-LINKED 102	0.00403634	0.18612895706066007
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.00403634	0.18612895706066007
XFE PROGEROID SYNDROME; XFEPS	0.00403634	0.18612895706066007
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.00403634	0.18612895706066007
GOLDENHAR SYNDROME	0.00403634	0.18612895706066007
COFFIN-LOWRY SYNDROME	0.00402265	0.18549766598454645
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.00402265	0.18549766598454645
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.00402265	0.18549766598454645
ATAXIA-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00402265	0.18549766598454645
COFFIN-LOWRY SYNDROME; CLS	0.00402265	0.18549766598454645
HISTIDINURIA-RENAL TUBULAR DEFECT SYNDROME	0.00402265	0.18549766598454645
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.003967764	0.18296669140430016
GENITOPATELLAR SYNDROME	0.003967764	0.18296669140430016
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.003967764	0.18296669140430016
SIALIDOSIS TYPE 2	0.003967764	0.18296669140430016
22Q11.2 MICRODUPLICATION SYNDROME	0.003967764	0.18296669140430016
PELIZAEUS-MERZBACHER DISEASE	0.003967764	0.18296669140430016
EMANUEL SYNDROME	0.003967764	0.18296669140430016
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.003967764	0.18296669140430016
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.003954074	0.18233540032818654
NOONAN SYNDROME 6; NS6	0.003954074	0.18233540032818654
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.003954074	0.18233540032818654
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.003954074	0.18233540032818654
GALACTOSE EPIMERASE DEFICIENCY	0.003954074	0.18233540032818654
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.003954074	0.18233540032818654
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.003954074	0.18233540032818654
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.003954074	0.18233540032818654
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.003954074	0.18233540032818654
LETHAL OSTEOSCLEROTIC BONE DYSPLASIA	0.00389105	0.1794291557130671
CHERUBISM	0.00389105	0.1794291557130671
JUVENILE NASOPHARYNGEAL ANGIOFIBROMA	0.00389105	0.1794291557130671
DWARFISM, FAMILIAL, WITH MUSCLE SPASMS	0.00389105	0.1794291557130671
DYSOSTOSIS, STANESCU TYPE	0.00389105	0.1794291557130671
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.00389105	0.1794291557130671
MICROCEPHALY-CERVICAL SPINE FUSION ANOMALIES SYNDROME	0.00389105	0.1794291557130671
MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY	0.00389105	0.1794291557130671
AXIAL SPONDYLOMETAPHYSEAL DYSPLASIA	0.00389105	0.1794291557130671
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.00389105	0.1794291557130671
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.00389105	0.1794291557130671
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.00389105	0.1794291557130671
CAFFEY DISEASE	0.00389105	0.1794291557130671
MICROCEPHALIC OSTEODYSPLASTIC DYSPLASIA, SAUL-WILSON TYPE	0.00389105	0.1794291557130671
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.00389105	0.1794291557130671
KOSAKI OVERGROWTH SYNDROME; KOGS	0.00389105	0.1794291557130671
ATELOSTEOGENESIS TYPE I	0.00389105	0.1794291557130671
BECKWITH-WIEDEMANN SYNDROME	0.00389105	0.1794291557130671
AUTOSOMAL RECESSIVE DISTAL OSTEOLYSIS SYNDROME	0.00389105	0.1794291557130671
MULTICENTRIC CARPO-TARSAL OSTEOLYSIS WITH OR WITHOUT NEPHROPATHY	0.00389105	0.1794291557130671
RETINOBLASTOMA	0.00389105	0.1794291557130671
ERDHEIM-CHESTER DISEASE	0.00389105	0.1794291557130671
LOEYS-DIETZ SYNDROME 5	0.00389105	0.1794291557130671
CHERUBISM	0.00389105	0.1794291557130671
DESBUQUOIS DYSPLASIA 1	0.00389105	0.1794291557130671
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.00389105	0.1794291557130671
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY; MADA	0.00389105	0.1794291557130671
CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA	0.00389105	0.1794291557130671
MELNICK-NEEDLES SYNDROME	0.00389105	0.1794291557130671
SLC39A13-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.00389105	0.1794291557130671
JUVENILE XANTHOGRANULOMA	0.00389105	0.1794291557130671
CRANIOFACIOFRONTODIGITAL SYNDROME	0.00389105	0.1794291557130671
DYSSEGMENTAL DYSPLASIA WITH GLAUCOMA	0.00389105	0.1794291557130671
NESTOR-GUILLERMO PROGERIA SYNDROME; NGPS	0.00389105	0.1794291557130671
MACHADO-JOSEPH DISEASE; MJD	0.00389105	0.1794291557130671
FAMILIAL GESTATIONAL HYPERTHYROIDISM	0.00389105	0.1794291557130671
MULTICENTRIC CARPOTARSAL OSTEOLYSIS SYNDROME; MCTO	0.00389105	0.1794291557130671
VASCULAR MALFORMATION, PRIMARY INTRAOSSEOUS	0.00389105	0.1794291557130671
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.00389105	0.1794291557130671
MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY; MADB	0.00389105	0.1794291557130671
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.00389105	0.1794291557130671
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.00389105	0.1794291557130671
RICHARDS-RUNDLE SYNDROME; RRNS	0.003566764	0.1644752581302636
HALL-RIGGS SYNDROME	0.0034965000000000005	0.16123515322361298
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.0034965000000000005	0.16123515322361298
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.0034965000000000005	0.16123515322361298
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.0034965000000000005	0.16123515322361298
CHILDHOOD DISINTEGRATIVE DISORDER	0.0034965000000000005	0.16123515322361298
HYPERURICEMIA, INFANTILE, WITH ABNORMAL BEHAVIOR AND NORMAL HYPOXANTHINEGUANINE PHOSPHORIBOSYLTRANSFERASE	0.0034965000000000005	0.16123515322361298
MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE; MCPH21	0.0034965000000000005	0.16123515322361298
MENTAL RETARDATION, X-LINKED 105; MRX105	0.0034965000000000005	0.16123515322361298
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.0034965000000000005	0.16123515322361298
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.0034965000000000005	0.16123515322361298
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.0034965000000000005	0.16123515322361298
INTELLECTUAL DISABILITY-CATARACTS-KYPHOSIS SYNDROME	0.0034965000000000005	0.16123515322361298
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.0034965000000000005	0.16123515322361298
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.0034965000000000005	0.16123515322361298
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.0034965000000000005	0.16123515322361298
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.0034965000000000005	0.16123515322361298
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.0034965000000000005	0.16123515322361298
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.0034965000000000005	0.16123515322361298
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.0034965000000000005	0.16123515322361298
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.0034965000000000005	0.16123515322361298
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 29	0.0034965000000000005	0.16123515322361298
MUCOLIPIDOSIS TYPE IV	0.0034965000000000005	0.16123515322361298
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.0034965000000000005	0.16123515322361298
ADENYLOSUCCINATE LYASE DEFICIENCY	0.0034965000000000005	0.16123515322361298
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.0034965000000000005	0.16123515322361298
TEMPLE-BARAITSER SYNDROME	0.0034965000000000005	0.16123515322361298
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.0034965000000000005	0.16123515322361298
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.0034965000000000005	0.16123515322361298
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.0034965000000000005	0.16123515322361298
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.0034965000000000005	0.16123515322361298
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.0034965000000000005	0.16123515322361298
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.0034965000000000005	0.16123515322361298
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.0034965000000000005	0.16123515322361298
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.0034965000000000005	0.16123515322361298
14Q12 MICRODELETION SYNDROME	0.0034965000000000005	0.16123515322361298
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.0034965000000000005	0.16123515322361298
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.0034965000000000005	0.16123515322361298
ANGELMAN SYNDROME	0.0034965000000000005	0.16123515322361298
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.0034965000000000005	0.16123515322361298
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.0034965000000000005	0.16123515322361298
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4	0.0034965000000000005	0.16123515322361298
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.0034965000000000005	0.16123515322361298
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.0034965000000000005	0.16123515322361298
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.0034965000000000005	0.16123515322361298
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.0034965000000000005	0.16123515322361298
WARBURG MICRO SYNDROME 2; WARBM2	0.0034965000000000005	0.16123515322361298
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.00342221	0.157809396171423
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.00342221	0.157809396171423
KLEEFSTRA SYNDROME	0.00342221	0.157809396171423
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.00342221	0.157809396171423
13Q12.3 MICRODELETION SYNDROME	0.00342221	0.157809396171423
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.00342221	0.157809396171423
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, OHDO TYPE	0.00342221	0.157809396171423
CRIGLER-NAJJAR SYNDROME TYPE 1	0.00342221	0.157809396171423
CEREBELLAR ATAXIA WITH NEUROPATHY AND BILATERAL VESTIBULAR AREFLEXIA SYNDROME	0.00340852	0.15717810509530938
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.00340852	0.15717810509530938
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00340852	0.15717810509530938
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.00340852	0.15717810509530938
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 4	0.00340852	0.15717810509530938
HOLOPROSENCEPHALY 5; HPE5	0.003300374	0.1521911361605115
GRACILE BONE DYSPLASIA; GCLEB	0.003300374	0.1521911361605115
HOLOPROSENCEPHALY 7	0.003300374	0.1521911361605115
JOUBERT SYNDROME	0.003300374	0.1521911361605115
1Q21.1 MICRODUPLICATION SYNDROME	0.003300374	0.1521911361605115
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.003300374	0.1521911361605115
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.003300374	0.1521911361605115
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.003300374	0.1521911361605115
WALKER-WARBURG SYNDROME	0.003300374	0.1521911361605115
GRISCELLI SYNDROME	0.003300374	0.1521911361605115
OXOGLUTARIC ACIDURIA	0.003300374	0.1521911361605115
JOUBERT SYNDROME WITH OCULAR DEFECT	0.003300374	0.1521911361605115
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.003300374	0.1521911361605115
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.003300374	0.1521911361605115
JOUBERT SYNDROME 14	0.003300374	0.1521911361605115
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.003300374	0.1521911361605115
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.003300374	0.1521911361605115
MIRAGE SYNDROME; MIRAGE	0.003300374	0.1521911361605115
CHROMOSOME 17P13.1 DELETION SYNDROME	0.003300374	0.1521911361605115
MARDEN-WALKER SYNDROME	0.003300374	0.1521911361605115
LIGNEOUS CONJUNCTIVITIS	0.003300374	0.1521911361605115
HOLOPROSENCEPHALY	0.003300374	0.1521911361605115
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.003300374	0.1521911361605115
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.003300374	0.1521911361605115
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.003300374	0.1521911361605115
MELANOSIS, NEUROCUTANEOUS; NCMS	0.003300374	0.1521911361605115
L1 SYNDROME	0.003300374	0.1521911361605115
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.003300374	0.1521911361605115
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.0032703540000000005	0.1508068148964552
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.0032703540000000005	0.1508068148964552
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.0032703540000000005	0.1508068148964552
%300712 CRANIOFACIOSKELETAL SYNDROME	0.0032703540000000005	0.1508068148964552
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.0032703540000000005	0.1508068148964552
2Q23.1 MICRODUPLICATION SYNDROME	0.0032703540000000005	0.1508068148964552
PENTASOMY X	0.0032703540000000005	0.1508068148964552
RUVALCABA SYNDROME	0.0032703540000000005	0.1508068148964552
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.0032703540000000005	0.1508068148964552
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.0032703540000000005	0.1508068148964552
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.0032703540000000005	0.1508068148964552
LIG4 SYNDROME	0.0032703540000000005	0.1508068148964552
TRISOMY 9P	0.0032703540000000005	0.1508068148964552
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.0032703540000000005	0.1508068148964552
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.0032703540000000005	0.1508068148964552
CATEL-MANZKE SYNDROME; CATMANS	0.0032703540000000005	0.1508068148964552
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.0032703540000000005	0.1508068148964552
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.0032703540000000005	0.1508068148964552
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.0032703540000000005	0.1508068148964552
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.0032703540000000005	0.1508068148964552
DPAGT1-CDG	0.0032703540000000005	0.1508068148964552
TRISOMY X	0.0032703540000000005	0.1508068148964552
MIETENS SYNDROME	0.0032703540000000005	0.1508068148964552
CHAR SYNDROME	0.0032703540000000005	0.1508068148964552
CHROMOSOME 16P13.3 DELETION SYNDROME	0.0032703540000000005	0.1508068148964552
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.0032703540000000005	0.1508068148964552
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.0032703540000000005	0.1508068148964552
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.0030644440000000004	0.1413116253067872
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.0030644440000000004	0.1413116253067872
ACROMELIC FRONTONASAL DYSPLASIA	0.0030644440000000004	0.1413116253067872
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.0030644440000000004	0.1413116253067872
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.0030644440000000004	0.1413116253067872
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.0030644440000000004	0.1413116253067872
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.0030644440000000004	0.1413116253067872
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.0030644440000000004	0.1413116253067872
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.0030644440000000004	0.1413116253067872
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.0030644440000000004	0.1413116253067872
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.0030644440000000004	0.1413116253067872
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.0030644440000000004	0.1413116253067872
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.0030644440000000004	0.1413116253067872
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.0030644440000000004	0.1413116253067872
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.0030644440000000004	0.1413116253067872
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.0030644440000000004	0.1413116253067872
20P12.3 MICRODELETION SYNDROME	0.0030644440000000004	0.1413116253067872
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.0030644440000000004	0.1413116253067872
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.0030644440000000004	0.1413116253067872
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.0030644440000000004	0.1413116253067872
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.0030644440000000004	0.1413116253067872
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.0030644440000000004	0.1413116253067872
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.0030644440000000004	0.1413116253067872
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.0030644440000000004	0.1413116253067872
HOYERAAL-HREIDARSSON SYNDROME	0.0030644440000000004	0.1413116253067872
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.0030644440000000004	0.1413116253067872
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.0030644440000000004	0.1413116253067872
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.0030644440000000004	0.1413116253067872
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.0030644440000000004	0.1413116253067872
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.0030644440000000004	0.1413116253067872
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.0030644440000000004	0.1413116253067872
MACDERMOT-WINTER SYNDROME	0.0030644440000000004	0.1413116253067872
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.0030644440000000004	0.1413116253067872
KOOLEN-DE VRIES SYNDROME	0.0030644440000000004	0.1413116253067872
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.0030644440000000004	0.1413116253067872
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.0030644440000000004	0.1413116253067872
JOUBERT SYNDROME 31; JBTS31	0.0030644440000000004	0.1413116253067872
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.0030644440000000004	0.1413116253067872
SECKEL SYNDROME 9; SCKL9	0.0030644440000000004	0.1413116253067872
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.0030644440000000004	0.1413116253067872
ROIFMAN-CHITAYAT SYNDROME	0.0030644440000000004	0.1413116253067872
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.0030644440000000004	0.1413116253067872
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.0030644440000000004	0.1413116253067872
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.0030644440000000004	0.1413116253067872
LISSENCEPHALY 1; LIS1	0.0030644440000000004	0.1413116253067872
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.0030644440000000004	0.1413116253067872
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.0030644440000000004	0.1413116253067872
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.0030644440000000004	0.1413116253067872
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.0030644440000000004	0.1413116253067872
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.0030644440000000004	0.1413116253067872
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.0030644440000000004	0.1413116253067872
PYRUVATE DEHYDROGENASE DEFICIENCY	0.0030644440000000004	0.1413116253067872
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.0030644440000000004	0.1413116253067872
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.0030644440000000004	0.1413116253067872
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.0030644440000000004	0.1413116253067872
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.0030644440000000004	0.1413116253067872
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.0030644440000000004	0.1413116253067872
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.0030644440000000004	0.1413116253067872
OROFACIODIGITAL SYNDROME XVI; OFD16	0.0030644440000000004	0.1413116253067872
PYRIDOXINE-DEPENDENT EPILEPSY	0.0030644440000000004	0.1413116253067872
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.0030644440000000004	0.1413116253067872
COWCHOCK SYNDROME; COWCK	0.00302121	0.13931796289738643
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5	0.00302121	0.13931796289738643
DEAFNESS, AUTOSOMAL RECESSIVE 29	0.00302121	0.13931796289738643
DEAFNESS, AUTOSOMAL RECESSIVE 20; DFNB20	0.00302121	0.13931796289738643
AYME-GRIPP SYNDROME; AYGRP	0.00302121	0.13931796289738643
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.00302121	0.13931796289738643
DYSSEGMENTAL DYSPLASIA, ROLLAND-DESBUQUOIS TYPE	0.00275482	0.12703384092763434
DANDY-WALKER MALFORMATION WITH MENTAL RETARDATION, MACROCEPHALY, MYOPIA, AND BRACHYTELEPHALANGY	0.00275482	0.12703384092763434
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.00275482	0.12703384092763434
ATYPICAL TERATOID RHABDOID TUMOR	0.00275482	0.12703384092763434
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.00275482	0.12703384092763434
MECKEL SYNDROME, TYPE 4; MKS4	0.00275482	0.12703384092763434
BIEMOND SYNDROME TYPE 2	0.00275482	0.12703384092763434
NEPHRONOPHTHISIS 18; NPHP18	0.00275482	0.12703384092763434
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.00275482	0.12703384092763434
FANCONI ANEMIA, COMPLEMENTATION GROUP R	0.00275482	0.12703384092763434
EDINBURGH MALFORMATION SYNDROME	0.00275482	0.12703384092763434
OMPHALOCELE-CLEFT PALATE SYNDROME, LETHAL	0.00275482	0.12703384092763434
258040 OEIS COMPLEX;;OMPHALOCELE-EXSTROPHY-IMPERFORATE ANUS-SPINAL DEFECTS	0.00275482	0.12703384092763434
DANDY-WALKER SYNDROME	0.00275482	0.12703384092763434
DIENCEPHALIC SYNDROME	0.00275482	0.12703384092763434
X-LINKED DOMINANT CHONDRODYSPLASIA, CHASSAING-LACOMBE TYPE	0.00275482	0.12703384092763434
PORT-WINE NEVI-MEGA CISTERNA MAGNA-HYDROCEPHALUS SYNDROME	0.00275482	0.12703384092763434
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.00275482	0.12703384092763434
HYDROCEPHALUS-COSTOVERTEBRAL DYSPLASIA-SPRENGEL ANOMALY SYNDROME	0.00275482	0.12703384092763434
CRYPTOCOCCOSIS	0.00275482	0.12703384092763434
STROMME SYNDROME; STROMS	0.00275482	0.12703384092763434
GÓMEZ-LÓPEZ-HERNÁNDEZ SYNDROME	0.00275482	0.12703384092763434
243440 ISOTRETINOIN EMBRYOPATHY-LIKE SYNDROME;;MICROTIA-AORTIC ARCH SYNDROME	0.00275482	0.12703384092763434
GENITOPALATOCARDIAC SYNDROME	0.00275482	0.12703384092763434
HEMANGIOBLASTOMA	0.00275482	0.12703384092763434
HYDROCEPHALY-TALL STATURE-JOINT LAXITY SYNDROME	0.00275482	0.12703384092763434
BIEMOND SYNDROME II	0.00275482	0.12703384092763434
HYDROCEPHALUS, TALL STATURE, JOINT LAXITY, AND KYPHOSCOLIOSIS	0.00275482	0.12703384092763434
HB BART'S HYDROPS FETALIS	0.00275482	0.12703384092763434
FUNCTIONING GONADOTROPIC ADENOMA	0.00275482	0.12703384092763434
PITUITARY DEFICIENCY DUE TO RATHKE CLEFT CYSTS	0.00275482	0.12703384092763434
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.00275482	0.12703384092763434
HYDROCEPHALUS-OBESITY-HYPOGONADISM SYNDROME	0.00275482	0.12703384092763434
MECKEL SYNDROME, TYPE 6; MKS6	0.00275482	0.12703384092763434
CHIARI MALFORMATION TYPE II	0.00275482	0.12703384092763434
LETHAL OMPHALOCELE-CLEFT PALATE SYNDROME	0.00275482	0.12703384092763434
EDINBURGH MALFORMATION SYNDROME	0.00275482	0.12703384092763434
KNOBLOCH SYNDROME	0.00275482	0.12703384092763434
AASE-SMITH SYNDROME I	0.00275482	0.12703384092763434
GAUCHER DISEASE, TYPE IIIC	0.00275482	0.12703384092763434
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5; MDDGA5	0.00275482	0.12703384092763434
COLOBOMA-OBESITY-HYPOGENITALISM-MENTAL RETARDATION SYNDROME	0.00275482	0.12703384092763434
HOLOPROSENCEPHALY-POSTAXIAL POLYDACTYLY SYNDROME	0.00275482	0.12703384092763434
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.00275482	0.12703384092763434
NEURAL TUBE DEFECTS, SUSCEPTIBILITY TO; NTD	0.00275482	0.12703384092763434
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.00275482	0.12703384092763434
THORACOABDOMINAL SYNDROME	0.00275482	0.12703384092763434
CRANIOFACIAL CONODYSPLASIA	0.00275482	0.12703384092763434
LYMPHANGIOLEIOMYOMATOSIS	0.00275482	0.12703384092763434
RADIAL APLASIA, X-LINKED	0.00275482	0.12703384092763434
HYDROCEPHALUS, CONGENITAL, 3, WITH BRAIN ANOMALIES; HYC3	0.00275482	0.12703384092763434
HYPOPLASMINOGENEMIA	0.00275482	0.12703384092763434
MYOPATHY, CENTRONUCLEAR, X-LINKED; CNMX	0.00275482	0.12703384092763434
ALEXANDER DISEASE	0.00275482	0.12703384092763434
MEGALENCEPHALY-POLYMICROGYRIA-POSTAXIAL POLYDACTYLY-HYDROCEPHALUS SYNDROME	0.00275482	0.12703384092763434
BASAL CELL NEVUS SYNDROME	0.00275482	0.12703384092763434
FRONTAL ENCEPHALOCELE	0.00275482	0.12703384092763434
307010 HYDROCEPHALUS WITH CEREBELLAR AGENESIS	0.00275482	0.12703384092763434
NEUROFIBROMATOSIS, TYPE I	0.00275482	0.12703384092763434
HYDROCEPHALUS DUE TO CONGENITAL STENOSIS OF AQUEDUCT OF SYLVIUS	0.00275482	0.12703384092763434
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.00275482	0.12703384092763434
MEGALENCEPHALY	0.00275482	0.12703384092763434
ABSENT RADIUS-ANOGENITAL ANOMALIES SYNDROME	0.00275482	0.12703384092763434
B4GALT1-CDG	0.00275482	0.12703384092763434
GORLIN SYNDROME	0.00275482	0.12703384092763434
FAMILIAL LAMBDOID SYNOSTOSIS	0.00275482	0.12703384092763434
CENTRAL PRECOCIOUS PUBERTY	0.00275482	0.12703384092763434
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.00275482	0.12703384092763434
PAPILLOMA OF CHOROID PLEXUS	0.00275482	0.12703384092763434
POSTERIOR MENINGOCELE	0.00275482	0.12703384092763434
CHONDRODYSPLASIA WITH PLATYSPONDYLY, DISTINCTIVE BRACHYDACTYLY, HYDROCEPHALY, AND MICROPHTHALMIA	0.00275482	0.12703384092763434
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.00275482	0.12703384092763434
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.00275482	0.12703384092763434
TETRAAMELIA-MULTIPLE MALFORMATIONS SYNDROME	0.00275482	0.12703384092763434
PENTALOGY OF CANTRELL	0.00275482	0.12703384092763434
MUSCLE-EYE-BRAIN DISEASE	0.00275482	0.12703384092763434
SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY	0.00275482	0.12703384092763434
OSTEOCHONDRODYSPLASIA, RHIZOMELIC, WITH CALLOSAL AGENESIS, THROMBOCYTOPENIA,HYDROCEPHALUS, AND HYPERTENSION	0.00275482	0.12703384092763434
ALEXANDER DISEASE	0.00275482	0.12703384092763434
PAPILLOMA OF CHOROID PLEXUS	0.00275482	0.12703384092763434
NEONATAL LUPUS ERYTHEMATOSUS	0.00275482	0.12703384092763434
LHERMITTE-DUCLOS DISEASE	0.00275482	0.12703384092763434
HISTIOCYTOID CARDIOMYOPATHY	0.00275482	0.12703384092763434
LARGE CONGENITAL MELANOCYTIC NEVUS	0.00275482	0.12703384092763434
MECKEL SYNDROME	0.00275482	0.12703384092763434
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7	0.00275482	0.12703384092763434
9P13 MICRODELETION SYNDROME	0.0027248000000000003	0.12564951966357804
ACROFACIAL DYSOSTOSIS, WEYERS TYPE	0.0027248000000000003	0.12564951966357804
PENOSCROTAL TRANSPOSITION	0.0027248000000000003	0.12564951966357804
MESOMELIC DYSPLASIA, KANTAPUTRA TYPE	0.0027248000000000003	0.12564951966357804
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME; NPLCS	0.0027248000000000003	0.12564951966357804
ROIFMAN SYNDROME	0.0027248000000000003	0.12564951966357804
3M SYNDROME	0.0027248000000000003	0.12564951966357804
FETAL MINOXIDIL SYNDROME	0.0027248000000000003	0.12564951966357804
X-LINKED INTELLECTUAL DISABILITY, STOLL TYPE	0.0027248000000000003	0.12564951966357804
SECKEL SYNDROME 5; SCKL5	0.0027248000000000003	0.12564951966357804
HAND-FOOT-GENITAL SYNDROME	0.0027248000000000003	0.12564951966357804
DENTAL ANKYLOSIS	0.0027248000000000003	0.12564951966357804
ANONYCHIA-MICROCEPHALY SYNDROME	0.0027248000000000003	0.12564951966357804
ALAGILLE SYNDROME	0.0027248000000000003	0.12564951966357804
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.0027248000000000003	0.12564951966357804
CLEFT LIP/PALATE-INTESTINAL MALROTATION-CARDIOPATHY SYNDROME	0.0027248000000000003	0.12564951966357804
PELVIS-SHOULDER DYSPLASIA	0.0027248000000000003	0.12564951966357804
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME	0.0027248000000000003	0.12564951966357804
MICROCEPHALY 24, PRIMARY, AUTOSOMAL RECESSIVE; MCPH24	0.0027248000000000003	0.12564951966357804
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.0027248000000000003	0.12564951966357804
BOWEN-CONRADI SYNDROME	0.0027248000000000003	0.12564951966357804
BRACHYDACTYLY TYPE A1	0.0027248000000000003	0.12564951966357804
PATENT DUCTUS ARTERIOSUS-BICUSPID AORTIC VALVE-HAND ANOMALIES SYNDROME	0.0027248000000000003	0.12564951966357804
BRACHYDACTYLY TYPE C	0.0027248000000000003	0.12564951966357804
311895 PIERRE ROBIN SEQUENCE WITH FACIAL AND DIGITAL ANOMALIES	0.0027248000000000003	0.12564951966357804
SECKEL SYNDROME 2; SCKL2	0.0027248000000000003	0.12564951966357804
SHORT STATURE-VALVULAR HEART DISEASE-CHARACTERISTIC FACIES SYNDROME	0.0027248000000000003	0.12564951966357804
WEYERS ACROFACIAL DYSOSTOSIS	0.0027248000000000003	0.12564951966357804
SECKEL SYNDROME 1; SCKL1	0.0027248000000000003	0.12564951966357804
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 4	0.0027248000000000003	0.12564951966357804
PTOSIS-UPPER OCULAR MOVEMENT LIMITATION-ABSENCE OF LACRIMAL PUNCTUM SYNDROME	0.0027248000000000003	0.12564951966357804
604381 PATENT DUCTUS ARTERIOSUS AND BICUSPID AORTIC VALVE WITH HAND ANOMALIES	0.0027248000000000003	0.12564951966357804
PERIPHERAL DYSOSTOSIS	0.0027248000000000003	0.12564951966357804
BRACHYDACTYLY TYPE A2	0.0027248000000000003	0.12564951966357804
TRICHORHINOPHALANGEAL SYNDROME TYPE 1 AND 3	0.0027248000000000003	0.12564951966357804
MOLAR I REINCLUSION	0.0027248000000000003	0.12564951966357804
APLASIA CUTIS CONGENITA-INTESTINAL LYMPHANGIECTASIA SYNDROME	0.0027248000000000003	0.12564951966357804
CLEIDORHIZOMELIC SYNDROME	0.0027248000000000003	0.12564951966357804
MICROCEPHALY-CARDIOMYOPATHY	0.0027248000000000003	0.12564951966357804
ROBIN SEQUENCE-OLIGODACTYLY SYNDROME	0.0027248000000000003	0.12564951966357804
HYPOSPADIAS-INTELLECTUAL DISABILITY, GOLDBLATT TYPE SYNDROME	0.0027248000000000003	0.12564951966357804
BRACHYDACTYLY-ELBOW WRIST DYSPLASIA SYNDROME	0.0027248000000000003	0.12564951966357804
RETT SYNDROME	0.0027248000000000003	0.12564951966357804
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.0027248000000000003	0.12564951966357804
269870 SHORT STATURE-OBESITY SYNDROME; SSOS	0.0027248000000000003	0.12564951966357804
OSLAM SYNDROME	0.0027248000000000003	0.12564951966357804
HALLUX VARUS-PREAXIAL POLYSYNDACTYLY SYNDROME	0.0027248000000000003	0.12564951966357804
INTELLECTUAL DISABILITY-SHORT STATURE-HYPERTELORISM SYNDROME	0.0027248000000000003	0.12564951966357804
EPIPHYSEAL DYSPLASIA, BAUMANN TYPE	0.0027248000000000003	0.12564951966357804
SKELETAL DYSPLASIA WITH DELAYED EPIPHYSEAL AND CARPAL BONE OSSIFICATION	0.0027248000000000003	0.12564951966357804
INTELLECTUAL DISABILITY, BUENOS-AIRES TYPE	0.0027248000000000003	0.12564951966357804
KERATOSIS PALMARIS ET PLANTARIS-CLINODACTYLY SYNDROME	0.0027248000000000003	0.12564951966357804
RING CHROMOSOME 1 SYNDROME	0.0027248000000000003	0.12564951966357804
FRYNS SYNDROME	0.0027248000000000003	0.12564951966357804
FRANK-TER HAAR SYNDROME	0.0027248000000000003	0.12564951966357804
CLEIDORHIZOMELIC SYNDROME	0.0027248000000000003	0.12564951966357804
TALONAVICULAR COALITION	0.0027248000000000003	0.12564951966357804
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.0027248000000000003	0.12564951966357804
NIGHT BLINDNESS-SKELETAL ANOMALIES-DYSMORPHISM SYNDROME	0.0027248000000000003	0.12564951966357804
INTELLECTUAL DISABILITY, WOLFF TYPE	0.0027248000000000003	0.12564951966357804
BANKI SYNDROME	0.0027248000000000003	0.12564951966357804
HAND-FOOT-GENITAL SYNDROME; HFG	0.0027248000000000003	0.12564951966357804
NON-DISTAL MONOSOMY 10Q	0.0027248000000000003	0.12564951966357804
BRACHYDACTYLY, TYPE A3	0.0027248000000000003	0.12564951966357804
KERATOSIS PALMARIS ET PLANTARIS WITH CLINODACTYLY	0.0027248000000000003	0.12564951966357804
CEREBELLAR ATAXIA-HYPOGONADISM SYNDROME	0.0027248000000000003	0.12564951966357804
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.00251889	0.11615433007391004
LUNG AGENESIS-HEART DEFECT-THUMB ANOMALIES SYNDROME	0.00251889	0.11615433007391004
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.00251889	0.11615433007391004
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.00251889	0.11615433007391004
ENAMEL HYPOPLASIA, CATARACTS, AND AQUEDUCTAL STENOSIS	0.00251889	0.11615433007391004
COLOBOMA, OCULAR	0.00251889	0.11615433007391004
LISSENCEPHALY 3; LIS3	0.00251889	0.11615433007391004
FANCONI ANEMIA, COMPLEMENTATION GROUP B; FANCB	0.00251889	0.11615433007391004
CAREY-FINEMAN-ZITER SYNDROME	0.00251889	0.11615433007391004
AMISH LETHAL MICROCEPHALY	0.00251889	0.11615433007391004
FANCONI ANEMIA, COMPLEMENTATION GROUP W; FANCW	0.00251889	0.11615433007391004
3-HYDROXYISOBUTYRIC ACIDURIA	0.00251889	0.11615433007391004
MACROCEPHALY, BENIGN FAMILIAL	0.00251889	0.11615433007391004
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.00251889	0.11615433007391004
TRISOMY 5P	0.00251889	0.11615433007391004
SANJAD-SAKATI SYNDROME	0.00251889	0.11615433007391004
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6; MC1DN6	0.00251889	0.11615433007391004
OROFACIODIGITAL SYNDROME XV; OFD15	0.00251889	0.11615433007391004
GLUTAMINE DEFICIENCY, CONGENITAL	0.00251889	0.11615433007391004
ISOLATED SEDOHEPTULOKINASE DEFICIENCY	0.00251889	0.11615433007391004
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.00251889	0.11615433007391004
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.00251889	0.11615433007391004
NORMAL PRESSURE HYDROCEPHALUS	0.00251889	0.11615433007391004
CEREBROFACIOTHORACIC DYSPLASIA	0.00251889	0.11615433007391004
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.00251889	0.11615433007391004
COG8-CDG	0.00251889	0.11615433007391004
AICARDI SYNDROME	0.00251889	0.11615433007391004
CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 1	0.00251889	0.11615433007391004
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.00251889	0.11615433007391004
CONGENITAL MUSCULAR DYSTROPHY WITHOUT INTELLECTUAL DISABILITY	0.00251889	0.11615433007391004
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.00251889	0.11615433007391004
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT; SMALED2B	0.00251889	0.11615433007391004
CONGENITAL OSTEOGENESIS IMPERFECTA-MICROCEPHALY-CATARACTS SYNDROME	0.00251889	0.11615433007391004
MUSCULAR DYSTROPHY, CONGENITAL, WITH SEVERE CENTRAL NERVOUS SYSTEM ATROPHY AND ABSENCE OF LARGE MYELINATED FIBERS	0.00251889	0.11615433007391004
X-LINKED INTELLECTUAL DISABILITY-DANDY-WALKER MALFORMATION-BASAL GANGLIA DISEASE-SEIZURES SYNDROME	0.00251889	0.11615433007391004
KNOBLOCH SYNDROME 1; KNO1	0.00251889	0.11615433007391004
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.00251889	0.11615433007391004
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.00251889	0.11615433007391004
MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00251889	0.11615433007391004
PSEUDO-TORCH SYNDROME 2	0.00251889	0.11615433007391004
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.00251889	0.11615433007391004
JUVENILE HUNTINGTON DISEASE	0.00251889	0.11615433007391004
BONNEMANN-MEINECKE-REICH SYNDROME	0.00251889	0.11615433007391004
SPASTIC PARAPLEGIA-INTELLECTUAL DISABILITY-NYSTAGMUS-OBESITY SYNDROME	0.00251889	0.11615433007391004
MOYAMOYA DISEASE	0.00251889	0.11615433007391004
MÜLLERIAN DERIVATIVES-LYMPHANGIECTASIA-POLYDACTYLY SYNDROME	0.00251889	0.11615433007391004
LOWE OCULOCEREBRORENAL SYNDROME	0.00251889	0.11615433007391004
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.00251889	0.11615433007391004
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.00251889	0.11615433007391004
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.00251889	0.11615433007391004
LISSENCEPHALY, X-LINKED, 2	0.00251889	0.11615433007391004
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.00251889	0.11615433007391004
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.00251889	0.11615433007391004
GAPO SYNDROME; GAPOS	0.00251889	0.11615433007391004
MICROCEPHALY-GLOMERULONEPHRITIS-MARFANOID HABITUS SYNDROME	0.00251889	0.11615433007391004
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.00251889	0.11615433007391004
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.00251889	0.11615433007391004
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.00251889	0.11615433007391004
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.00251889	0.11615433007391004
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.00251889	0.11615433007391004
MICROCEPHALY-POLYMICROGYRIA-CORPUS CALLOSUM AGENESIS SYNDROME	0.00251889	0.11615433007391004
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.00251889	0.11615433007391004
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO ZNF335 DEFICIENCY	0.00251889	0.11615433007391004
WHITE MATTER HYPOPLASIA-CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY SYNDROME	0.00251889	0.11615433007391004
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.00251889	0.11615433007391004
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.00251889	0.11615433007391004
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.00251889	0.11615433007391004
OCULOCEREBRORENAL SYNDROME OF LOWE	0.00251889	0.11615433007391004
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.00251889	0.11615433007391004
CARIBBEAN PARKINSONISM	0.00251889	0.11615433007391004
ADENYLOSUCCINASE DEFICIENCY	0.002450314	0.11299206441755011
SPINOCEREBELLAR ATAXIA TYPE 29	0.002450314	0.11299206441755011
15Q14 MICRODELETION SYNDROME	0.002450314	0.11299206441755011
CK SYNDROME	0.002450314	0.11299206441755011
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.002450314	0.11299206441755011
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.002450314	0.11299206441755011
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.002450314	0.11299206441755011
WIEACKER-WOLFF SYNDROME	0.002450314	0.11299206441755011
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.002450314	0.11299206441755011
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.002450314	0.11299206441755011
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.002450314	0.11299206441755011
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.002450314	0.11299206441755011
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.002450314	0.11299206441755011
SALLA DISEASE	0.002450314	0.11299206441755011
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.002450314	0.11299206441755011
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.002450314	0.11299206441755011
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.002450314	0.11299206441755011
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.002450314	0.11299206441755011
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.002450314	0.11299206441755011
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.002450314	0.11299206441755011
LIG4 SYNDROME	0.002450314	0.11299206441755011
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.002450314	0.11299206441755011
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.002450314	0.11299206441755011
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.002450314	0.11299206441755011
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.002450314	0.11299206441755011
MENTAL RETARDATION, X-LINKED 9	0.002450314	0.11299206441755011
SHUKLA-VERNON SYNDROME; SHUVER	0.002450314	0.11299206441755011
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.002450314	0.11299206441755011
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.002450314	0.11299206441755011
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.002450314	0.11299206441755011
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.002450314	0.11299206441755011
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.002450314	0.11299206441755011
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.002450314	0.11299206441755011
7P22.1 MICRODUPLICATION SYNDROME	0.002450314	0.11299206441755011
COHEN-GIBSON SYNDROME; COGIS	0.002450314	0.11299206441755011
XQ25 DUPLICATION SYNDROME	0.002450314	0.11299206441755011
TONNE-KALSCHEUER SYNDROME; TOKAS	0.002450314	0.11299206441755011
JOUBERT SYNDROME 30; JBTS30	0.002450314	0.11299206441755011
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.002450314	0.11299206441755011
CHROMOSOME 9P DELETION SYNDROME	0.002450314	0.11299206441755011
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.002450314	0.11299206441755011
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.002450314	0.11299206441755011
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.002450314	0.11299206441755011
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.002450314	0.11299206441755011
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.002450314	0.11299206441755011
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.002450314	0.11299206441755011
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.002450314	0.11299206441755011
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.002450314	0.11299206441755011
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.002450314	0.11299206441755011
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.002450314	0.11299206441755011
FORSYTHE-WAKELING SYNDROME; FWS	0.002450314	0.11299206441755011
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.002450314	0.11299206441755011
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.002450314	0.11299206441755011
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.002450314	0.11299206441755011
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.002450314	0.11299206441755011
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.002450314	0.11299206441755011
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.002450314	0.11299206441755011
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.002450314	0.11299206441755011
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.002450314	0.11299206441755011
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.002450314	0.11299206441755011
GLASS SYNDROME	0.002450314	0.11299206441755011
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.002450314	0.11299206441755011
CHROMOSOME 5Q12 DELETION SYNDROME	0.002450314	0.11299206441755011
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.002450314	0.11299206441755011
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.002450314	0.11299206441755011
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.002450314	0.11299206441755011
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.002450314	0.11299206441755011
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.002450314	0.11299206441755011
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.002450314	0.11299206441755011
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.002450314	0.11299206441755011
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.002450314	0.11299206441755011
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.002450314	0.11299206441755011
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.002450314	0.11299206441755011
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.002450314	0.11299206441755011
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.002450314	0.11299206441755011
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.002450314	0.11299206441755011
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.002450314	0.11299206441755011
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.002450314	0.11299206441755011
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.002450314	0.11299206441755011
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.002450314	0.11299206441755011
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.002450314	0.11299206441755011
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.002450314	0.11299206441755011
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.002450314	0.11299206441755011
DUCHENNE MUSCULAR DYSTROPHY	0.002450314	0.11299206441755011
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.002450314	0.11299206441755011
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.002450314	0.11299206441755011
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.002450314	0.11299206441755011
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.002450314	0.11299206441755011
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.002450314	0.11299206441755011
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.002450314	0.11299206441755011
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.002450314	0.11299206441755011
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.002450314	0.11299206441755011
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.002450314	0.11299206441755011
17Q11.2 MICRODUPLICATION SYNDROME	0.002450314	0.11299206441755011
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.002450314	0.11299206441755011
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.002450314	0.11299206441755011
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.002450314	0.11299206441755011
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.002450314	0.11299206441755011
48,XYYY SYNDROME	0.002450314	0.11299206441755011
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.002450314	0.11299206441755011
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.002450314	0.11299206441755011
WRINKLY SKIN SYNDROME	0.002450314	0.11299206441755011
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.002450314	0.11299206441755011
HYPERPROLINEMIA, TYPE I	0.002450314	0.11299206441755011
DIGEORGE SYNDROME; DGS	0.002450314	0.11299206441755011
LANDAU-KLEFFNER SYNDROME	0.002450314	0.11299206441755011
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.002450314	0.11299206441755011
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.002450314	0.11299206441755011
EPILEPSY, PYRIDOXINE-DEPENDENT	0.002450314	0.11299206441755011
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.002450314	0.11299206441755011
11P15.4 MICRODUPLICATION SYNDROME	0.002450314	0.11299206441755011
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.002450314	0.11299206441755011
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.002450314	0.11299206441755011
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.002450314	0.11299206441755011
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.002450314	0.11299206441755011
PMM2-CDG	0.002450314	0.11299206441755011
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.002450314	0.11299206441755011
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.002450314	0.11299206441755011
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.002450314	0.11299206441755011
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.002450314	0.11299206441755011
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.002450314	0.11299206441755011
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.002450314	0.11299206441755011
1P21.3 MICRODELETION SYNDROME	0.002450314	0.11299206441755011
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.002450314	0.11299206441755011
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.002450314	0.11299206441755011
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.002450314	0.11299206441755011
KLEEFSTRA SYNDROME 2; KLEFS2	0.002450314	0.11299206441755011
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.002450314	0.11299206441755011
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.002450314	0.11299206441755011
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.002450314	0.11299206441755011
MENTAL RETARDATION, X-LINKED 90	0.002450314	0.11299206441755011
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.002450314	0.11299206441755011
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.0020630040000000002	0.09513192221962719
HYDROXYKYNURENINURIA	0.0020630040000000002	0.09513192221962719
KEUTEL SYNDROME	0.0020630040000000002	0.09513192221962719
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.0020630040000000002	0.09513192221962719
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.0020630040000000002	0.09513192221962719
KABUKI SYNDROME 1	0.0020630040000000002	0.09513192221962719
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.0020630040000000002	0.09513192221962719
17Q12 MICRODELETION SYNDROME	0.0020630040000000002	0.09513192221962719
CONGENITAL HYPOTHYROIDISM	0.0020630040000000002	0.09513192221962719
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.0020630040000000002	0.09513192221962719
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.0020630040000000002	0.09513192221962719
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.0020630040000000002	0.09513192221962719
BIOTINIDASE DEFICIENCY	0.0020630040000000002	0.09513192221962719
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.0020630040000000002	0.09513192221962719
TAY-SACHS DISEASE	0.0020630040000000002	0.09513192221962719
ALPHA-MANNOSIDOSIS	0.0020630040000000002	0.09513192221962719
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.0020630040000000002	0.09513192221962719
RFT1-CDG	0.0020630040000000002	0.09513192221962719
LEBER CONGENITAL AMAUROSIS	0.0020630040000000002	0.09513192221962719
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.0020630040000000002	0.09513192221962719
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.0020630040000000002	0.09513192221962719
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.0020630040000000002	0.09513192221962719
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.0020630040000000002	0.09513192221962719
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.0020630040000000002	0.09513192221962719
TRANSIENT NEONATAL DIABETES MELLITUS	0.0020630040000000002	0.09513192221962719
GENITOPATELLAR SYNDROME; GTPTS	0.0020630040000000002	0.09513192221962719
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.0020630040000000002	0.09513192221962719
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.0020630040000000002	0.09513192221962719
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.0020630040000000002	0.09513192221962719
DYSKERATOSIS CONGENITA	0.0020630040000000002	0.09513192221962719
SEVERE CANAVAN DISEASE	0.0020630040000000002	0.09513192221962719
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.0020630040000000002	0.09513192221962719
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.0020630040000000002	0.09513192221962719
LYMPHEDEMA, HEREDITARY, III	0.0020630040000000002	0.09513192221962719
SPINOCEREBELLAR ATAXIA TYPE 13	0.0020630040000000002	0.09513192221962719
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.0020630040000000002	0.09513192221962719
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.0020630040000000002	0.09513192221962719
PERMANENT NEONATAL DIABETES MELLITUS	0.0020630040000000002	0.09513192221962719
ISOLATED PLAGIOCEPHALY	0.0020630040000000002	0.09513192221962719
FUCOSIDOSIS	0.0020630040000000002	0.09513192221962719
OCULOSKELETODENTAL SYNDROME; OCSKD	0.0020630040000000002	0.09513192221962719
BARDET-BIEDL SYNDROME 16; BBS16	0.0020630040000000002	0.09513192221962719
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.0020630040000000002	0.09513192221962719
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.0020630040000000002	0.09513192221962719
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.0020630040000000002	0.09513192221962719
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.0020630040000000002	0.09513192221962719
COWDEN SYNDROME	0.0020630040000000002	0.09513192221962719
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.0020630040000000002	0.09513192221962719
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.0020630040000000002	0.09513192221962719
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.0020630040000000002	0.09513192221962719
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.0020630040000000002	0.09513192221962719
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.0020630040000000002	0.09513192221962719
AURICULOCONDYLAR SYNDROME	0.0020630040000000002	0.09513192221962719
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.0020630040000000002	0.09513192221962719
DUPLICATION OF THE PITUITARY GLAND	0.0020630040000000002	0.09513192221962719
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.0020630040000000002	0.09513192221962719
MULTIPLE CARBOXYLASE DEFICIENCY	0.0020630040000000002	0.09513192221962719
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.0020630040000000002	0.09513192221962719
CANAVAN DISEASE	0.0020630040000000002	0.09513192221962719
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.0020630040000000002	0.09513192221962719
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.0020630040000000002	0.09513192221962719
ALG11-CDG	0.0020630040000000002	0.09513192221962719
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.0020630040000000002	0.09513192221962719
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.0020630040000000002	0.09513192221962719
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.0020630040000000002	0.09513192221962719
INFANTILE REFSUM DISEASE	0.002049314	0.09450063114351356
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.002049314	0.09450063114351356
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.002049314	0.09450063114351356
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.002049314	0.09450063114351356
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.002049314	0.09450063114351356
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.002049314	0.09450063114351356
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.002049314	0.09450063114351356
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.002049314	0.09450063114351356
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.002049314	0.09450063114351356
WAARDENBURG-SHAH SYNDROME	0.002049314	0.09450063114351356
THAUVIN-ROBINET-FAIVRE SYNDROME	0.002049314	0.09450063114351356
EAST SYNDROME	0.002049314	0.09450063114351356
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.002049314	0.09450063114351356
OPITZ G/BBB SYNDROME	0.002049314	0.09450063114351356
MICROPHTHALMIA, SYNDROMIC 3	0.002049314	0.09450063114351356
VICI SYNDROME	0.002049314	0.09450063114351356
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.002049314	0.09450063114351356
CODAS SYNDROME	0.002049314	0.09450063114351356
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.002049314	0.09450063114351356
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.002049314	0.09450063114351356
VICI SYNDROME; VICIS	0.002049314	0.09450063114351356
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.002049314	0.09450063114351356
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.002049314	0.09450063114351356
NOONAN SYNDROME 11; NS11	0.002049314	0.09450063114351356
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.002049314	0.09450063114351356
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.002049314	0.09450063114351356
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.002049314	0.09450063114351356
LEIGH SYNDROME; LS	0.002049314	0.09450063114351356
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.002049314	0.09450063114351356
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.002049314	0.09450063114351356
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.002049314	0.09450063114351356
PEROXISOME BIOGENESIS DISORDER 3B	0.002049314	0.09450063114351356
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.002049314	0.09450063114351356
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.002049314	0.09450063114351356
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.002049314	0.09450063114351356
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.002049314	0.09450063114351356
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.002049314	0.09450063114351356
PEROXISOME BIOGENESIS DISORDER 6B	0.002049314	0.09450063114351356
JOUBERT SYNDROME 21	0.002049314	0.09450063114351356
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.002049314	0.09450063114351356
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.002049314	0.09450063114351356
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.002049314	0.09450063114351356
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.002049314	0.09450063114351356
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.002049314	0.09450063114351356
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.002049314	0.09450063114351356
BRAIN-LUNG-THYROID SYNDROME	0.002049314	0.09450063114351356
8Q12 MICRODUPLICATION SYNDROME	0.002049314	0.09450063114351356
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.002049314	0.09450063114351356
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.002049314	0.09450063114351356
USHER SYNDROME TYPE 1	0.002049314	0.09450063114351356
STEEL SYNDROME; STLS	0.002049314	0.09450063114351356
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.002049314	0.09450063114351356
INFANTILE LIVER FAILURE SYNDROME 1	0.002049314	0.09450063114351356
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.002049314	0.09450063114351356
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.002049314	0.09450063114351356
PEROXISOME BIOGENESIS DISORDER 5B	0.002049314	0.09450063114351356
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.002049314	0.09450063114351356
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.002049314	0.09450063114351356
CHROMOSOME 2Q37 DELETION SYNDROME	0.002049314	0.09450063114351356
ISOLATED COMPLEX I DEFICIENCY	0.002049314	0.09450063114351356
CEDNIK SYNDROME	0.002049314	0.09450063114351356
HYPERTRYPTOPHANEMIA; HYPTRP	0.002049314	0.09450063114351356
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.002049314	0.09450063114351356
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.002049314	0.09450063114351356
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.002049314	0.09450063114351356
ASPARTYLGLUCOSAMINURIA	0.00190476	0.08783476918467295
EPISODIC ATAXIA TYPE 1	0.00190476	0.08783476918467295
POSTORGASMIC ILLNESS SYNDROME	0.00190476	0.08783476918467295
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.00190476	0.08783476918467295
SMITH-FINEMAN-MYERS SYNDROME	0.00190476	0.08783476918467295
PARTINGTON SYNDROME	0.00190476	0.08783476918467295
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.00190476	0.08783476918467295
3Q27.3 MICRODELETION SYNDROME	0.00190476	0.08783476918467295
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.00190476	0.08783476918467295
INTELLECTUAL DISABILITY-MUSCLE WEAKNESS-SHORT STATURE-FACIAL DYSMORPHISM SYNDROME	0.00190476	0.08783476918467295
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.00190476	0.08783476918467295
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.00190476	0.08783476918467295
MILD CANAVAN DISEASE	0.00190476	0.08783476918467295
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO WWOX DEFICIENCY	0.00190476	0.08783476918467295
MICROTIA	0.00190476	0.08783476918467295
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.00190476	0.08783476918467295
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.00190476	0.08783476918467295
PROGRESSIVE SUPRANUCLEAR PALSY	0.00190476	0.08783476918467295
ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.00190476	0.08783476918467295
DELAYED SPEECH-FACIAL ASYMMETRY-STRABISMUS-EAR LOBE CREASES SYNDROME	0.00190476	0.08783476918467295
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.00190476	0.08783476918467295
SEVERE EARLY-ONSET OBESITY-INSULIN RESISTANCE SYNDROME DUE TO SH2B1 DEFICIENCY	0.00190476	0.08783476918467295
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.00190476	0.08783476918467295
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00190476	0.08783476918467295
HYPOHIDROSIS-ENAMEL HYPOPLASIA-PALMOPLANTAR KERATODERMA-INTELLECTUAL DISABILITY SYNDROME	0.00190476	0.08783476918467295
9Q33.3Q34.11 MICRODELETION SYNDROME	0.00190476	0.08783476918467295
ACERULOPLASMINEMIA	0.00190476	0.08783476918467295
X-LINKED INTELLECTUAL DISABILITY-PLAGIOCEPHALY SYNDROME	0.00190476	0.08783476918467295
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.00190476	0.08783476918467295
CONGENITAL MUSCULAR DYSTROPHY-RESPIRATORY FAILURE-SKIN ABNORMALITIES-JOINT HYPERLAXITY SYNDROME	0.00190476	0.08783476918467295
POMT1-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R11	0.00190476	0.08783476918467295
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.00190476	0.08783476918467295
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.00190476	0.08783476918467295
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.00190476	0.08783476918467295
22Q11 DELETION SYNDROME (VELOCARDIOFACIAL / DIGEORGE SYNDROME)	0.00190476	0.08783476918467295
SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4	0.00190476	0.08783476918467295
AUTOSOMAL RECESSIVE DOPA-RESPONSIVE DYSTONIA	0.00190476	0.08783476918467295
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.00190476	0.08783476918467295
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.00190476	0.08783476918467295
SPEECH-LANGUAGE DISORDER 1	0.00190476	0.08783476918467295
BETA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R4	0.00190476	0.08783476918467295
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.00190476	0.08783476918467295
MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	0.00190476	0.08783476918467295
SPECIFIC LANGUAGE IMPAIRMENT 1; SLI1	0.00190476	0.08783476918467295
LARYNGOTRACHEAL ANGIOMA	0.00190476	0.08783476918467295
%606772 MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKINANOMALIES;;MOMES SYNDROME	0.00190476	0.08783476918467295
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.00190476	0.08783476918467295
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.00190476	0.08783476918467295
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.00190476	0.08783476918467295
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.00190476	0.08783476918467295
MENTAL RETARDATION, TRUNCAL OBESITY, RETINAL DYSTROPHY, AND MICROPENIS SYNDROME; MORMS	0.00190476	0.08783476918467295
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.00190476	0.08783476918467295
VERVERI-BRADY SYNDROME; VERBRAS	0.00190476	0.08783476918467295
DYSTONIA 16; DYT16	0.00190476	0.08783476918467295
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.00190476	0.08783476918467295
FG SYNDROME 2; FGS2	0.00190476	0.08783476918467295
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.00190476	0.08783476918467295
AUTOSOMAL RECESSIVE CENTRONUCLEAR MYOPATHY	0.00190476	0.08783476918467295
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.00190476	0.08783476918467295
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.00190476	0.08783476918467295
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.00190476	0.08783476918467295
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.00190476	0.08783476918467295
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.00190476	0.08783476918467295
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.00190476	0.08783476918467295
MENTAL RETARDATION, X-LINKED 93	0.00190476	0.08783476918467295
MENTAL RETARDATION, X-LINKED 95	0.00190476	0.08783476918467295
MENTAL RETARDATION, X-LINKED 97; MRX97	0.00190476	0.08783476918467295
MENTAL RETARDATION, X-LINKED 19	0.00190476	0.08783476918467295
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.00190476	0.08783476918467295
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.00190476	0.08783476918467295
HYPOGLOSSIA WITH SITUS INVERSUS	0.00190476	0.08783476918467295
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.00190476	0.08783476918467295
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	0.00190476	0.08783476918467295
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 54	0.00190476	0.08783476918467295
HYPERPARATHYROIDISM, TRANSIENT NEONATAL; HRPTTN	0.00190476	0.08783476918467295
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.00190476	0.08783476918467295
STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET	0.00190476	0.08783476918467295
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.00190476	0.08783476918467295
BARDET-BIEDL SYNDROME 21; BBS21	0.00190476	0.08783476918467295
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 8; MDDGC8	0.00190476	0.08783476918467295
OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17	0.00190476	0.08783476918467295
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.00190476	0.08783476918467295
SPINOCEREBELLAR ATAXIA 44; SCA44	0.00190476	0.08783476918467295
HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS	0.00190476	0.08783476918467295
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7; NBIA7	0.00190476	0.08783476918467295
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8; NBIA8	0.00190476	0.08783476918467295
OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18	0.00190476	0.08783476918467295
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.00190476	0.08783476918467295
RETINITIS PIGMENTOSA 71; RP71	0.00190476	0.08783476918467295
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.00190476	0.08783476918467295
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24	0.00190476	0.08783476918467295
MEIER-GORLIN SYNDROME 3; MGORS3	0.00190476	0.08783476918467295
CHROMOSOME 13Q14 DELETION SYNDROME	0.00190476	0.08783476918467295
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.00190476	0.08783476918467295
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 14	0.00190476	0.08783476918467295
COFFIN-SIRIS SYNDROME 8; CSS8	0.00190476	0.08783476918467295
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.00190476	0.08783476918467295
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 25	0.00190476	0.08783476918467295
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.00190476	0.08783476918467295
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 28	0.00190476	0.08783476918467295
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.00190476	0.08783476918467295
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.00190476	0.08783476918467295
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.00190476	0.08783476918467295
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.00190476	0.08783476918467295
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.00190476	0.08783476918467295
SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD	0.00190476	0.08783476918467295
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.00190476	0.08783476918467295
THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT	0.00190476	0.08783476918467295
FAMILIAL INFANTILE BILATERAL STRIATAL NECROSIS	0.00190476	0.08783476918467295
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.00190476	0.08783476918467295
ASPARTYLGLUCOSAMINURIA; AGU	0.00190476	0.08783476918467295
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.00190476	0.08783476918467295
MAXILLOFACIAL DYSOSTOSIS	0.00190476	0.08783476918467295
224550 DYSTONIA WITH RINGBINDEN	0.00190476	0.08783476918467295
GERODERMA OSTEODYSPLASTICUM; GO	0.00190476	0.08783476918467295
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.00190476	0.08783476918467295
HYPERLYSINEMIA, TYPE I	0.00190476	0.08783476918467295
AUTISM	0.00190476	0.08783476918467295
SPEECH DEVELOPMENT, DELAYED, WITH FACIAL ASYMMETRY, STRABISMUS, ANDTRANSVERSE EARLOBE CREASE	0.00190476	0.08783476918467295
ATAXIA-TELANGIECTASIA-LIKE DISORDER	0.00190476	0.08783476918467295
22Q13 DELETION SYNDROME (PHELAN-MCDERMID SYNDROME)	0.00190476	0.08783476918467295
RECURRENT 16P12.1 MICRODELETION (NEURODEVELOPMENTAL SUSCEPTIBILITY LOCUS)	0.00190476	0.08783476918467295
CENTRAL CONGENITAL HYPOTHYROIDISM	0.00190476	0.08783476918467295
7Q11.23 DUPLICATION SYNDROME	0.00190476	0.08783476918467295
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.00151745	0.06997462698675003
TIETZ SYNDROME	0.00151745	0.06997462698675003
FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	0.00151745	0.06997462698675003
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.00151745	0.06997462698675003
CARNEY-STRATAKIS SYNDROME	0.00151745	0.06997462698675003
KNUCKLE PADS, LEUKONYCHIA, AND SENSORINEURAL DEAFNESS	0.00151745	0.06997462698675003
BRITTLE CORNEA SYNDROME 2; BCS2	0.00151745	0.06997462698675003
MENIERE DISEASE	0.00151745	0.06997462698675003
%614187 HYPERTELORISM, PREAURICULAR SINUS, PUNCTAL PITS, AND DEAFNESS; HPPD	0.00151745	0.06997462698675003
GYRATE ATROPHY OF CHOROID AND RETINA	0.00151745	0.06997462698675003
WOLFRAM-LIKE SYNDROME, AUTOSOMAL DOMINANT; WFSL	0.00151745	0.06997462698675003
KERATODERMA, PALMOPLANTAR, WITH DEAFNESS	0.00151745	0.06997462698675003
IVIC SYNDROME	0.00151745	0.06997462698675003
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	0.00151745	0.06997462698675003
%613916 DEAFNESS, AUTOSOMAL RECESSIVE 89; DFNB89	0.00151745	0.06997462698675003
156620 MICROCEPHALY-DEAFNESS SYNDROME	0.00151745	0.06997462698675003
DEAFNESS, AUTOSOMAL RECESSIVE 47	0.00151745	0.06997462698675003
MYOCLONUS, CEREBELLAR ATAXIA, AND DEAFNESS	0.00151745	0.06997462698675003
DEAFNESS, AUTOSOMAL RECESSIVE 55	0.00151745	0.06997462698675003
PIEBALD TRAIT WITH NEUROLOGIC DEFECTS	0.00151745	0.06997462698675003
PAGET DISEASE OF BONE 3; PDB3	0.00151745	0.06997462698675003
DEAFNESS, AUTOSOMAL RECESSIVE 65; DFNB65	0.00151745	0.06997462698675003
KEARNS-SAYRE SYNDROME	0.00151745	0.06997462698675003
USHER SYNDROME, TYPE IID; USH2D	0.00151745	0.06997462698675003
OSTEOGENESIS IMPERFECTA, TYPE IV	0.00151745	0.06997462698675003
OTOSCLEROSIS 8; OTSC8	0.00151745	0.06997462698675003
DIAMOND-BLACKFAN ANEMIA 7; DBA7	0.00151745	0.06997462698675003
HARDIKAR SYNDROME	0.00151745	0.06997462698675003
OPTIC ATROPHY 3, AUTOSOMAL DOMINANT	0.00151745	0.06997462698675003
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2A	0.00151745	0.06997462698675003
%614414 DEAFNESS, AUTOSOMAL RECESSIVE 96; DFNB96	0.00151745	0.06997462698675003
DEAFNESS, AUTOSOMAL RECESSIVE 84; DFNB84	0.00151745	0.06997462698675003
PSEUDOHYPOPARATHYROIDISM WITH ALBRIGHT HEREDITARY OSTEODYSTROPHY	0.00151745	0.06997462698675003
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.00151745	0.06997462698675003
EHLERS-DANLOS SYNDROME, BEASLEY-COHEN TYPE	0.00151745	0.06997462698675003
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5; PEOA5	0.00151745	0.06997462698675003
BONE MARROW FAILURE SYNDROME 1; BMFS1	0.00151745	0.06997462698675003
HYPERLIPOPROTEINEMIA, TYPE II, AND DEAFNESS	0.00151745	0.06997462698675003
ADULT-ONSET CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL MYOPATHY	0.00151745	0.06997462698675003
121450 CORNEAL DEGENERATION, RIBBONLIKE, WITH DEAFNESS;;BAND KERATOPATHY WITH DEAFNESS	0.00151745	0.06997462698675003
BRANCHIOOTIC SYNDROME 2	0.00151745	0.06997462698675003
CLEIDOCRANIAL DYSPLASIA; CCD	0.00151745	0.06997462698675003
CHIARI MALFORMATION TYPE I	0.00151745	0.06997462698675003
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 46	0.00151745	0.06997462698675003
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2A2B; CMT2A2B	0.00151745	0.06997462698675003
HOLOPROSENCEPHALY-RADIAL HEART RENAL ANOMALIES SYNDROME	0.00151745	0.06997462698675003
NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET	0.00151745	0.06997462698675003
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1A	0.00151745	0.06997462698675003
DEMENTIA, FAMILIAL DANISH	0.00151745	0.06997462698675003
DEAFNESS, AUTOSOMAL RECESSIVE 106; DFNB106	0.00151745	0.06997462698675003
DEAFNESS, AUTOSOMAL RECESSIVE 107; DFNB107	0.00151745	0.06997462698675003
TURCOT SYNDROME WITH POLYPOSIS	0.00151745	0.06997462698675003
LASSA FEVER	0.00151745	0.06997462698675003
DEAFNESS, AUTOSOMAL DOMINANT 73; DFNA73	0.00151745	0.06997462698675003
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.00151745	0.06997462698675003
NEUROFIBROMATOSIS, TYPE II	0.00151745	0.06997462698675003
AUDITORY NEUROPATHY AND OPTIC ATROPHY; ANOA	0.00151745	0.06997462698675003
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.00151745	0.06997462698675003
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 5	0.00151745	0.06997462698675003
COXOAURICULAR SYNDROME	0.00151745	0.06997462698675003
EAR EXOSTOSES	0.00151745	0.06997462698675003
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.00151745	0.06997462698675003
%614617 DEAFNESS, AUTOSOMAL RECESSIVE 86; DFNB86	0.00151745	0.06997462698675003
PULMONIC STENOSIS AND DEAFNESS	0.00151745	0.06997462698675003
DEAFNESS-CRANIOFACIAL SYNDROME	0.00151745	0.06997462698675003
DEAFNESS, AUTOSOMAL RECESSIVE 18B; DFNB18B	0.00151745	0.06997462698675003
HYPOGONADOTROPIC HYPOGONADISM 17 WITH OR WITHOUT ANOSMIA; HH17	0.00151745	0.06997462698675003
HYPOGONADOTROPIC HYPOGONADISM 18 WITH OR WITHOUT ANOSMIA; HH18	0.00151745	0.06997462698675003
HYPOGONADOTROPIC HYPOGONADISM 19 WITH OR WITHOUT ANOSMIA; HH19	0.00151745	0.06997462698675003
HYPOGONADOTROPIC HYPOGONADISM 21 WITH OR WITHOUT ANOSMIA; HH21	0.00151745	0.06997462698675003
SEVERE MOTOR AND INTELLECTUAL DISABILITIES-SENSORINEURAL DEAFNESS-DYSTONIA SYNDROME	0.00151745	0.06997462698675003
SPINOCEREBELLAR ATAXIA TYPE 18	0.00151745	0.06997462698675003
%615649 DEAFNESS, AUTOSOMAL DOMINANT 54; DFNA54	0.00151745	0.06997462698675003
%615654 DEAFNESS, AUTOSOMAL DOMINANT 58; DFNA58	0.00151745	0.06997462698675003
GALACTOSIALIDOSIS	0.00151745	0.06997462698675003
AUTOSOMAL DOMINANT DOPA-RESPONSIVE DYSTONIA	0.00151745	0.06997462698675003
CHIME SYNDROME	0.00151745	0.06997462698675003
DEAFNESS, CONGENITAL, WITH KERATOPACHYDERMIA AND CONSTRICTIONS OFFINGERS AND TOES	0.00151745	0.06997462698675003
MYASTHENIC SYNDROME, CONGENITAL, 7, PRESYNAPTIC; CMS7	0.00151745	0.06997462698675003
VIRAL HEMORRHAGIC FEVER	0.00151745	0.06997462698675003
RETICULAR DYSGENESIS	0.00151745	0.06997462698675003
DEAFNESS, AUTOSOMAL RECESSIVE 32, WITH OR WITHOUT IMMOTILE SPERM; DFNB32	0.00151745	0.06997462698675003
CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC 1	0.00151745	0.06997462698675003
OTOSCLEROSIS 3; OTSC3	0.00151745	0.06997462698675003
OTOPALATODIGITAL SYNDROME TYPE 1	0.00151745	0.06997462698675003
SANDHOFF DISEASE	0.00151745	0.06997462698675003
BROOKE-SPIEGLER SYNDROME	0.00151745	0.06997462698675003
HIRSCHSPRUNG DISEASE WITH POLYDACTYLY, RENAL AGENESIS, AND DEAFNESS	0.00151745	0.06997462698675003
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA INVERSA	0.00151745	0.06997462698675003
BRITTLE CORNEA SYNDROME	0.00151745	0.06997462698675003
CONGENITAL NON-BULLOUS ICHTHYOSIFORM ERYTHRODERMA	0.00151745	0.06997462698675003
FETAL IODINE DEFICIENCY DISORDER	0.00151745	0.06997462698675003
EPIPHYSEAL DYSPLASIA OF FEMORAL HEAD, MYOPIA, AND DEAFNESS	0.00151745	0.06997462698675003
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 2	0.00151745	0.06997462698675003
DYSOSTEOSCLEROSIS	0.00151745	0.06997462698675003
DWARFISM, LOW-BIRTH-WEIGHT TYPE, WITH UNRESPONSIVENESS TO GROWTH HORMONE	0.00151745	0.06997462698675003
DEAFNESS, CONGENITAL, WITH VITILIGO AND ACHALASIA	0.00151745	0.06997462698675003
DEAFNESS, X-LINKED 5; DFNX5	0.00151745	0.06997462698675003
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.00151745	0.06997462698675003
PELVISCAPULAR DYSPLASIA	0.00151745	0.06997462698675003
DEAFNESS, CONGENITAL, WITH TOTAL ALBINISM	0.00151745	0.06997462698675003
%300719 DEAFNESS, CATARACT, RETINITIS PIGMENTOSA, AND SPERM ABNORMALITIES	0.00151745	0.06997462698675003
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.00151745	0.06997462698675003
CARDIOAUDITORY SYNDROME OF SANCHEZ CASCOS	0.00151745	0.06997462698675003
ADRENOLEUKODYSTROPHY	0.00151745	0.06997462698675003
CANAVAN DISEASE	0.00151745	0.06997462698675003
RETINAL VENOUS BEADING	0.00151745	0.06997462698675003
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 3	0.00151745	0.06997462698675003
KEUTEL SYNDROME; KTLS	0.00151745	0.06997462698675003
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.00151745	0.06997462698675003
WAARDENBURG-SHAH SYNDROME	0.00151745	0.06997462698675003
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.00151745	0.06997462698675003
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.00151745	0.06997462698675003
MORQUIO SYNDROME A	0.00151745	0.06997462698675003
NATHALIE SYNDROME	0.00151745	0.06997462698675003
NEPHROSIS WITH DEAFNESS AND URINARY TRACT AND DIGITAL MALFORMATIONS	0.00151745	0.06997462698675003
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.00151745	0.06997462698675003
ALPORT SYNDROME-INTELLECTUAL DISABILITY-MIDFACE HYPOPLASIA-ELLIPTOCYTOSIS SYNDROME	0.00151745	0.06997462698675003
AGEL AMYLOIDOSIS	0.00151745	0.06997462698675003
PRIMROSE SYNDROME; PRIMS	0.00151745	0.06997462698675003
X-LINKED INTELLECTUAL DISABILITY, ABIDI TYPE	0.00151745	0.06997462698675003
RAMON SYNDROME	0.00151745	0.06997462698675003
RAPADILINO SYNDROME	0.00151745	0.06997462698675003
RENAL, GENITAL, AND MIDDLE EAR ANOMALIES	0.00151745	0.06997462698675003
CAMPTODACTYLY-TALL STATURE-SCOLIOSIS-HEARING LOSS SYNDROME	0.00151745	0.06997462698675003
SPASTIC QUADRIPLEGIA, RETINITIS PIGMENTOSA, AND MENTAL RETARDATION	0.00151745	0.06997462698675003
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.00151745	0.06997462698675003
ACQUIRED PARTIAL LIPODYSTROPHY	0.00151745	0.06997462698675003
BARBER-SAY SYNDROME; BBRSAY	0.00151745	0.06997462698675003
DEAFNESS, X-LINKED 7; DFNX7	0.00151745	0.06997462698675003
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.00151745	0.06997462698675003
AUTOSOMAL RECESSIVE SPINOCEREBELLAR ATAXIA-BLINDNESS-DEAFNESS SYNDROME	0.00151745	0.06997462698675003
MARSHALL-SMITH SYNDROME; MRSHSS	0.00151745	0.06997462698675003
BOSMA ARHINIA MICROPHTHALMIA SYNDROME	0.00151745	0.06997462698675003
MYASTHENIA GRAVIS	0.00151745	0.06997462698675003
MUCOPOLYSACCHARIDOSIS TYPE 6	0.00151745	0.06997462698675003
MUCOPOLYSACCHARIDOSIS TYPE 4	0.00151745	0.06997462698675003
MUCOPOLYSACCHARIDOSIS TYPE 3	0.00151745	0.06997462698675003
FACIAL PARESIS, HEREDITARY CONGENITAL, 2; HCFP2	0.00151745	0.06997462698675003
ALPORT SYNDROME, AUTOSOMAL RECESSIVE	0.00151745	0.06997462698675003
SPINOCEREBELLAR ATAXIA 13	0.00151745	0.06997462698675003
ISOLATED ANORECTAL MALFORMATION	0.00151745	0.06997462698675003
GRACILE SYNDROME	0.00151745	0.06997462698675003
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.00151745	0.06997462698675003
PAGET DISEASE OF BONE 4; PDB4	0.00151745	0.06997462698675003
DEAFNESS, AUTOSOMAL DOMINANT 24	0.00151745	0.06997462698675003
TUNE DEAFNESS	0.00151745	0.06997462698675003
DEAFNESS, AUTOSOMAL RECESSIVE 33	0.00151745	0.06997462698675003
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.00151745	0.06997462698675003
%607683 DEAFNESS, AUTOSOMAL DOMINANT 52; DFNA52;;DEAFNESS, AUTOSOMAL DOMINANT 42; DFNA42	0.00151745	0.06997462698675003
DIASTROPHIC DWARFISM	0.00151745	0.06997462698675003
ANUS, IMPERFORATE	0.00151745	0.06997462698675003
ACRODYSOSTOSIS	0.00151745	0.06997462698675003
CYCLIC VOMITING SYNDROME	0.00151745	0.06997462698675003
CEREBRAL SCLEROSIS, DIFFUSE, SCHOLZ TYPE	0.00151745	0.06997462698675003
CHARGE-LIKE SYNDROME, X-LINKED	0.00151745	0.06997462698675003
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.00151745	0.06997462698675003
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.00151745	0.06997462698675003
N SYNDROME	0.00151745	0.06997462698675003
SCHIMKE X-LINKED MENTAL RETARDATION SYNDROME	0.00151745	0.06997462698675003
SPASTIC PARAPARESIS AND DEAFNESS	0.00151745	0.06997462698675003
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.00151745	0.06997462698675003
PLAGUE	0.00151745	0.06997462698675003
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C; CMT4C	0.00151745	0.06997462698675003
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.00151745	0.06997462698675003
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 2	0.00151745	0.06997462698675003
FRIEDREICH ATAXIA	0.00151745	0.06997462698675003
ABCD SYNDROME	0.00151745	0.06997462698675003
CONE-ROD DYSTROPHY 1; CORD1	0.00151745	0.06997462698675003
OSTEOGENESIS IMPERFECTA	0.00151745	0.06997462698675003
USHER SYNDROME, TYPE ID	0.00151745	0.06997462698675003
BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS	0.00151745	0.06997462698675003
WILDERVANCK SYNDROME	0.00151745	0.06997462698675003
CILIARY DYSKINESIA, PRIMARY, 37; CILD37	0.00151745	0.06997462698675003
45,X/46,XY MIXED GONADAL DYSGENESIS	0.00151745	0.06997462698675003
BETA-THALASSEMIA MAJOR	0.00151745	0.06997462698675003
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 13	0.00151745	0.06997462698675003
HIDROTIC ECTODERMAL DYSPLASIA, HALAL TYPE	0.00151745	0.06997462698675003
ECTODERMAL DYSPLASIA-BLINDNESS SYNDROME	0.00151745	0.06997462698675003
DYSOSTEOSCLEROSIS	0.00151745	0.06997462698675003
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 10	0.00151745	0.06997462698675003
NAIL-PATELLA SYNDROME	0.00151745	0.06997462698675003
HYPERTRICHOSIS LANUGINOSA CONGENITA	0.00151745	0.06997462698675003
PRIMARY HYPERGONADOTROPIC HYPOGONADISM-PARTIAL ALOPECIA SYNDROME	0.00151745	0.06997462698675003
DISTAL TRISOMY 14Q	0.00151745	0.06997462698675003
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00151745	0.06997462698675003
CONGENITAL VELOPHARYNGEAL INCOMPETENCE	0.00151745	0.06997462698675003
IVIC SYNDROME	0.00151745	0.06997462698675003
BARBER-SAY SYNDROME	0.00151745	0.06997462698675003
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.00151745	0.06997462698675003
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.00151745	0.06997462698675003
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26; MC1DN26	0.00151745	0.06997462698675003
SENSORINEURAL DEAFNESS WITH DILATED CARDIOMYOPATHY	0.00151745	0.06997462698675003
SPINOCEREBELLAR ATAXIA TYPE 31	0.00151745	0.06997462698675003
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 3	0.00151745	0.06997462698675003
CLEFT LIP WITH OR WITHOUT CLEFT PALATE	0.00151745	0.06997462698675003
FETAL METHYLMERCURY SYNDROME	0.00151745	0.06997462698675003
CRIGLER-NAJJAR SYNDROME	0.00151745	0.06997462698675003
CHARCOT-MARIE-TOOTH DISEASE TYPE 1B	0.00151745	0.06997462698675003
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 4	0.00151745	0.06997462698675003
FREEMAN-SHELDON SYNDROME	0.00151745	0.06997462698675003
GAPO SYNDROME	0.00151745	0.06997462698675003
GROWTH HORMONE INSENSITIVITY SYNDROME	0.00151745	0.06997462698675003
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 1	0.00151745	0.06997462698675003
JUVENILE PAGET DISEASE	0.00151745	0.06997462698675003
BETA-MANNOSIDOSIS	0.00151745	0.06997462698675003
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.00151745	0.06997462698675003
INFANTILE ONSET SPINOCEREBELLAR ATAXIA	0.00151745	0.06997462698675003
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.00151745	0.06997462698675003
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.00151745	0.06997462698675003
BOR SYNDROME	0.00151745	0.06997462698675003
ISOLATED KLIPPEL-FEIL SYNDROME	0.00151745	0.06997462698675003
MAYER-ROKITANSKY-KÜSTER-HAUSER SYNDROME TYPE 2	0.00151745	0.06997462698675003
OVERGROWTH-MACROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.00151745	0.06997462698675003
46,XX GONADAL DYSGENESIS	0.00151745	0.06997462698675003
DYSCHROMATOSIS UNIVERSALIS HEREDITARIA	0.00151745	0.06997462698675003
RHYNS SYNDROME	0.00151745	0.06997462698675003
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.00151745	0.06997462698675003
PILI TORTI	0.00151745	0.06997462698675003
LOCKED-IN SYNDROME	0.00151745	0.06997462698675003
RICHARDS-RUNDLE SYNDROME	0.00151745	0.06997462698675003
SPINOCEREBELLAR ATAXIA TYPE 36	0.00151745	0.06997462698675003
RENAL COLOBOMA SYNDROME	0.00151745	0.06997462698675003
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.00151745	0.06997462698675003
PITUITARY CARCINOMA	0.00151745	0.06997462698675003
COXOAURICULAR SYNDROME	0.00151745	0.06997462698675003
DEAFNESS, AUTOSOMAL DOMINANT 74; DFNA74	0.00151745	0.06997462698675003
EPIDERMOLYSIS BULLOSA SIMPLEX WITH ANODONTIA/HYPODONTIA	0.00151745	0.06997462698675003
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.00151745	0.06997462698675003
CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT; ADCADN	0.00150376	0.06934333591063642
NEUROENDOCRINE CARCINOMA OF SALIVARY GLANDS, SENSORINEURAL HEARING LOSS, AND ENAMEL HYPOPLASIA	0.00150376	0.06934333591063642
DEAFNESS, AUTOSOMAL RECESSIVE 14	0.00150376	0.06934333591063642
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.00150376	0.06934333591063642
WAARDENBURG SYNDROME, TYPE IIB	0.00150376	0.06934333591063642
DEAFNESS, AUTOSOMAL RECESSIVE 16; DFNB16	0.00150376	0.06934333591063642
GROWTH RETARDATION, DEAFNESS, FEMORAL EPIPHYSEAL DYSPLASIA, AND LACRIMAL DUCT OBSTRUCTION	0.00150376	0.06934333591063642
CATARACT-DEAFNESS-HYPOGONADISM SYNDROME	0.00150376	0.06934333591063642
MADRAS MOTOR NEURON DISEASE	0.00150376	0.06934333591063642
FAMILIAL OR SPORADIC HEMIPLEGIC MIGRAINE	0.00150376	0.06934333591063642
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 2	0.00150376	0.06934333591063642
ARTHROGRYPOSIS-LIKE HAND ANOMALY-SENSORINEURAL DEAFNESS SYNDROME	0.00150376	0.06934333591063642
CADASIL	0.00150376	0.06934333591063642
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B2; CMT4B2	0.00150376	0.06934333591063642
STICKLER SYNDROME, TYPE II	0.00150376	0.06934333591063642
WOLFRAM SYNDROME 2; WFS2	0.00150376	0.06934333591063642
CARDIOMYOPATHY, DILATED, 1J; CMD1J	0.00150376	0.06934333591063642
DEAFNESS, AUTOSOMAL RECESSIVE 26	0.00150376	0.06934333591063642
SENSORINEURAL HEARING LOSS-EARLY GRAYING-ESSENTIAL TREMOR SYNDROME	0.00150376	0.06934333591063642
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 7	0.00150376	0.06934333591063642
ENLARGED VESTIBULAR AQUEDUCT	0.00150376	0.06934333591063642
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.00150376	0.06934333591063642
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 12	0.00150376	0.06934333591063642
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 3	0.00150376	0.06934333591063642
NORRIE DISEASE	0.00150376	0.06934333591063642
NEUROFIBROMATOSIS TYPE 2	0.00150376	0.06934333591063642
ENDOSTEAL HYPEROSTOSIS, WORTH TYPE	0.00150376	0.06934333591063642
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 13	0.00150376	0.06934333591063642
MERRF	0.00150376	0.06934333591063642
DEAFNESS, CHILDHOOD-ONSET NEUROSENSORY, AUTOSOMAL RECESSIVE 8	0.00150376	0.06934333591063642
BJÖRNSTAD SYNDROME	0.00150376	0.06934333591063642
DEAFNESS, AUTOSOMAL RECESSIVE 9	0.00150376	0.06934333591063642
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.00150376	0.06934333591063642
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 5	0.00150376	0.06934333591063642
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.00150376	0.06934333591063642
ALPORT SYNDROME	0.00150376	0.06934333591063642
AUTOSOMAL DOMINANT OPTIC ATROPHY PLUS SYNDROME	0.00150376	0.06934333591063642
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.00150376	0.06934333591063642
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 18	0.00150376	0.06934333591063642
DEAFNESS, AUTOSOMAL RECESSIVE 17; DFNB17	0.00150376	0.06934333591063642
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.00150376	0.06934333591063642
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 10	0.00150376	0.06934333591063642
DEAFNESS, AUTOSOMAL RECESSIVE 13	0.00150376	0.06934333591063642
CONGENITAL MYASTHENIC SYNDROME	0.00150376	0.06934333591063642
DEAFNESS, AUTOSOMAL RECESSIVE 57; DFNB57	0.00150376	0.06934333591063642
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.00150376	0.06934333591063642
DEAFNESS, AUTOSOMAL DOMINANT 25	0.00150376	0.06934333591063642
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.00150376	0.06934333591063642
DEAFNESS, AUTOSOMAL RECESSIVE 68	0.00150376	0.06934333591063642
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.00150376	0.06934333591063642
KID SYNDROME	0.00150376	0.06934333591063642
FAMILIAL COLD URTICARIA	0.00150376	0.06934333591063642
X-LINKED AGAMMAGLOBULINEMIA	0.00150376	0.06934333591063642
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2; FCAS2	0.00150376	0.06934333591063642
HYPOGONADOTROPIC HYPOGONADISM 5 WITH OR WITHOUT ANOSMIA	0.00150376	0.06934333591063642
DEAFNESS, AUTOSOMAL DOMINANT 27	0.00150376	0.06934333591063642
DEAFNESS, AUTOSOMAL DOMINANT 59	0.00150376	0.06934333591063642
DEAFNESS, AUTOSOMAL RECESSIVE 99	0.00150376	0.06934333591063642
DEAFNESS, AUTOSOMAL RECESSIVE 115; DFNB115	0.00150376	0.06934333591063642
OPTIC ATROPHY 7 WITH OR WITHOUT AUDITORY NEUROPATHY; OPA7	0.00150376	0.06934333591063642
DEAFNESS, AUTOSOMAL RECESSIVE 114; DFNB114	0.00150376	0.06934333591063642
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.00150376	0.06934333591063642
WAARDENBURG SYNDROME, TYPE 4B; WS4B	0.00150376	0.06934333591063642
%605818 DEAFNESS, AUTOSOMAL RECESSIVE 27; DFNB27	0.00150376	0.06934333591063642
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2N	0.00150376	0.06934333591063642
DEAFNESS, AUTOSOMAL RECESSIVE 100; DFNB100	0.00150376	0.06934333591063642
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.00150376	0.06934333591063642
MICROCEPHALY-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00150376	0.06934333591063642
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.00150376	0.06934333591063642
PIEBALD TRAIT-NEUROLOGIC DEFECTS SYNDROME	0.00150376	0.06934333591063642
RETINITIS PIGMENTOSA 59; RP59	0.00150376	0.06934333591063642
DEAFNESS, AUTOSOMAL RECESSIVE 113	0.00150376	0.06934333591063642
NEONATAL ADRENOLEUKODYSTROPHY	0.00150376	0.06934333591063642
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.00150376	0.06934333591063642
NEUROPATHY, HEREDITARY SENSORY, TYPE IE; HSN1E	0.00150376	0.06934333591063642
CONE-ROD DYSTROPHY AND HEARING LOSS 2; CRDHL2	0.00150376	0.06934333591063642
DEAFNESS, AUTOSOMAL DOMINANT 64; DFNA64	0.00150376	0.06934333591063642
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.00150376	0.06934333591063642
OCULAR ALBINISM WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.00150376	0.06934333591063642
DEAFNESS, AUTOSOMAL RECESSIVE 66; DFNB66	0.00150376	0.06934333591063642
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 5A	0.00150376	0.06934333591063642
DEAFNESS, AUTOSOMAL DOMINANT 53	0.00150376	0.06934333591063642
SPONDYLOOCULAR SYNDROME; SOS	0.00150376	0.06934333591063642
HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	0.00150376	0.06934333591063642
SPASTIC PARAPARESIS-DEAFNESS SYNDROME	0.00150376	0.06934333591063642
DEAFNESS, AUTOSOMAL DOMINANT 30	0.00150376	0.06934333591063642
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.00150376	0.06934333591063642
ACUTE BILIRUBIN ENCEPHALOPATHY	0.00150376	0.06934333591063642
USHER SYNDROME, TYPE IG	0.00150376	0.06934333591063642
%607017 DEAFNESS, AUTOSOMAL DOMINANT 21; DFNA21	0.00150376	0.06934333591063642
STIFF SKIN SYNDROME	0.00150376	0.06934333591063642
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.00150376	0.06934333591063642
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.00150376	0.06934333591063642
CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY-COLOBOMA-MICROGNATHIA SYNDROME	0.00150376	0.06934333591063642
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE I, WITH COUGH AND GASTROESOPHAGEAL REFLUX	0.00150376	0.06934333591063642
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.00150376	0.06934333591063642
RENAL CALICEAL DIVERTICULI-DEAFNESS SYNDROME	0.00150376	0.06934333591063642
DEAFNESS, AUTOSOMAL DOMINANT 43	0.00150376	0.06934333591063642
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 28	0.00150376	0.06934333591063642
DEAFNESS, AUTOSOMAL DOMINANT 47	0.00150376	0.06934333591063642
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 27	0.00150376	0.06934333591063642
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 24	0.00150376	0.06934333591063642
AUDITORY NEUROPATHY, AUTOSOMAL DOMINANT, 1	0.00150376	0.06934333591063642
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 2; PEOA2	0.00150376	0.06934333591063642
THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME	0.00150376	0.06934333591063642
DEAFNESS, AUTOSOMAL RECESSIVE 23	0.00150376	0.06934333591063642
SPONDYLOMEGAEPIPHYSEAL DYSPLASIA WITH UPPER LIMB MESOMELIA, PUNCTATECALCIFICATIONS, AND DEAFNESS	0.00150376	0.06934333591063642
KERATODERMA HEREDITARIUM MUTILANS	0.00150376	0.06934333591063642
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 42	0.00150376	0.06934333591063642
SPASTIC PARAPLEGIA 29, AUTOSOMAL DOMINANT	0.00150376	0.06934333591063642
DEAFNESS, AUTOSOMAL RECESSIVE 51	0.00150376	0.06934333591063642
PENDRED SYNDROME	0.00150376	0.06934333591063642
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 6; CMTX6	0.00150376	0.06934333591063642
KEARNS-SAYRE SYNDROME; KSS	0.00150376	0.06934333591063642
STICKLER SYNDROME, TYPE III	0.00150376	0.06934333591063642
ADENOHYPOPHYSITIS	0.00150376	0.06934333591063642
LEBER CONGENITAL AMAUROSIS, TYPE I	0.00150376	0.06934333591063642
MATERNALLY-INHERITED DIABETES AND DEAFNESS	0.00150376	0.06934333591063642
ATAXIA, DEAFNESS, AND CARDIOMYOPATHY	0.00150376	0.06934333591063642
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.00150376	0.06934333591063642
DEAFNESS-INFERTILITY SYNDROME	0.00150376	0.06934333591063642
RENIER-GABREELS-JASPER SYNDROME	0.00150376	0.06934333591063642
JUBERG-MARSIDI SYNDROME	0.00150376	0.06934333591063642
PALMOPLANTAR KERATODERMA-DEAFNESS SYNDROME	0.00150376	0.06934333591063642
BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	0.00150376	0.06934333591063642
HURLER-SCHEIE SYNDROME	0.00150376	0.06934333591063642
SCHEIE SYNDROME	0.00150376	0.06934333591063642
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.00150376	0.06934333591063642
CEREBELLAR ATAXIA AND NEUROSENSORY DEAFNESS	0.00150376	0.06934333591063642
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.00150376	0.06934333591063642
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, WITH DEAFNESS, MENTAL RETARDATION,AND ABSENT SENSORY LARGE MYELINATED FIBERS	0.00150376	0.06934333591063642
CORNEAL DYSTROPHY AND PERCEPTIVE DEAFNESS	0.00150376	0.06934333591063642
DEAFNESS, NERVE TYPE, WITH MESENTERIC DIVERTICULA OF SMALL BOWEL ANDPROGRESSIVE SENSORY NEUROPATHY	0.00150376	0.06934333591063642
DEAFNESS, NEURAL, CONGENITAL MODERATE	0.00150376	0.06934333591063642
DEAFNESS, NEURAL, WITH ATYPICAL ATOPIC DERMATITIS	0.00150376	0.06934333591063642
DEAFNESS, SENSORINEURAL, WITH PITUITARY DWARFISM	0.00150376	0.06934333591063642
%223200 DISORGANIZATION, MOUSE, HOMOLOG OF;;DS	0.00150376	0.06934333591063642
HIRSCHSPRUNG DISEASE-DEAFNESS-POLYDACTYLY SYNDROME	0.00150376	0.06934333591063642
ECTODERMAL DYSPLASIA AND NEUROSENSORY DEAFNESS	0.00150376	0.06934333591063642
ERMINE PHENOTYPE	0.00150376	0.06934333591063642
FOUNTAIN SYNDROME	0.00150376	0.06934333591063642
GEMIGNANI SYNDROME	0.00150376	0.06934333591063642
SHEEHAN SYNDROME	0.00150376	0.06934333591063642
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.00150376	0.06934333591063642
PANHYPOPHYSITIS	0.00150376	0.06934333591063642
OTODENTAL DYSPLASIA	0.00150376	0.06934333591063642
DEAFNESS, Y-LINKED 2; DFNY2	0.00150376	0.06934333591063642
USHER SYNDROME TYPE 2	0.00150376	0.06934333591063642
ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	0.00150376	0.06934333591063642
ARTHROGRYPOSIS-LIKE HAND ANOMALY AND SENSORINEURAL DEAFNESS	0.00150376	0.06934333591063642
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.00150376	0.06934333591063642
HADDAD SYNDROME	0.00150376	0.06934333591063642
ALBINISM-DEAFNESS SYNDROME	0.00150376	0.06934333591063642
115250 COLLAGENOMA, FAMILIAL CUTANEOUS	0.00150376	0.06934333591063642
SPINOCEREBELLAR ATAXIA 31	0.00150376	0.06934333591063642
MULTIPLE EPIPHYSEAL DYSPLASIA	0.00150376	0.06934333591063642
AUTOSOMAL RECESSIVE STICKLER SYNDROME	0.00150376	0.06934333591063642
PAPILLORENAL SYNDROME	0.00150376	0.06934333591063642
MOYNAHAN SYNDROME	0.00150376	0.06934333591063642
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.00150376	0.06934333591063642
NEUTRAL LIPID STORAGE MYOPATHY	0.00150376	0.06934333591063642
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.00150376	0.06934333591063642
CRANIOFACIAL-DEAFNESS-HAND SYNDROME; CDHS	0.00150376	0.06934333591063642
MYOPATHY AND DIABETES MELLITUS	0.00150376	0.06934333591063642
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.00150376	0.06934333591063642
FRIEDREICH ATAXIA, SO-CALLED, WITH OPTIC ATROPHY AND SENSORINEURALDEAFNESS	0.00150376	0.06934333591063642
LOWE-KOHN-COHEN SYNDROME	0.00150376	0.06934333591063642
ENDOSTEAL HYPEROSTOSIS, AUTOSOMAL DOMINANT	0.00150376	0.06934333591063642
HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DISEASE	0.00150376	0.06934333591063642
KALLMANN SYNDROME-HEART DISEASE SYNDROME	0.00150376	0.06934333591063642
NON-ACQUIRED COMBINED PITUITARY HORMONE DEFICIENCY-SENSORINEURAL HEARING LOSS-SPINE ABNORMALITIES SYNDROME	0.00150376	0.06934333591063642
MACROTHROMBOCYTOPENIA AND GRANULOCYTE INCLUSIONS WITH OR WITHOUT NEPHRITIS OR SENSORINEURAL HEARING LOSS; MATINS	0.00150376	0.06934333591063642
JOHANSON-BLIZZARD SYNDROME	0.00150376	0.06934333591063642
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.00150376	0.06934333591063642
USHER SYNDROME TYPE 3	0.00150376	0.06934333591063642
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IA; HSAN1A	0.00150376	0.06934333591063642
OCULOPHARYNGODISTAL MYOPATHY; OPDM	0.00150376	0.06934333591063642
OSTEOPENIA-MYOPIA-HEARING LOSS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.00150376	0.06934333591063642
XERODERMA PIGMENTOSUM	0.00150376	0.06934333591063642
HYPERLEUCINE-ISOLEUCINEMIA	0.00150376	0.06934333591063642
PAGET DISEASE OF BONE 5, JUVENILE-ONSET	0.00150376	0.06934333591063642
SIALIDOSIS TYPE 1	0.00150376	0.06934333591063642
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.00150376	0.06934333591063642
DE SANCTIS-CACCHIONE SYNDROME	0.00150376	0.06934333591063642
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.00150376	0.06934333591063642
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.00150376	0.06934333591063642
KERATODERMA HEREDITARIUM MUTILANS WITH ICHTHYOSIS	0.00150376	0.06934333591063642
AUTOSOMAL DOMINANT OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	0.00150376	0.06934333591063642
MENTAL RETARDATION, X-LINKED 46	0.00150376	0.06934333591063642
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.00150376	0.06934333591063642
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.00150376	0.06934333591063642
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.00150376	0.06934333591063642
RETINAL CILIOPATHY DUE TO MUTATION IN USHER GENE	0.00150376	0.06934333591063642
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.00150376	0.06934333591063642
FAMILIAL ISOLATED DILATED CARDIOMYOPATHY	0.00150376	0.06934333591063642
CRANIOFACIAL-DEAFNESS-HAND SYNDROME	0.00150376	0.06934333591063642
CORNEAL DYSTROPHY-PERCEPTIVE DEAFNESS SYNDROME	0.00150376	0.06934333591063642
REFSUM DISEASE	0.00150376	0.06934333591063642
STICKLER SYNDROME, TYPE V; STL5	0.00150376	0.06934333591063642
FAMILIAL LONG QT SYNDROME	0.00150376	0.06934333591063642
IMMUNODEFICIENCY 47	0.00150376	0.06934333591063642
ALPORT SYNDROME, X-LINKED; ATS	0.00150376	0.06934333591063642
UVEAL COLOBOMA-CLEFT LIP AND PALATE-INTELLECTUAL DISABILITY	0.00150376	0.06934333591063642
COGAN SYNDROME	0.00150376	0.06934333591063642
COFS SYNDROME	0.00150376	0.06934333591063642
DEAFNESS, X-LINKED 1	0.00150376	0.06934333591063642
FRONTOMETAPHYSEAL DYSPLASIA	0.00150376	0.06934333591063642
OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	0.00150376	0.06934333591063642
DEAFNESS, Y-LINKED 1	0.00150376	0.06934333591063642
DENTINOGENESIS IMPERFECTA-SHORT STATURE-HEARING LOSS-INTELLECTUAL DISABILITY SYNDROME	0.00150376	0.06934333591063642
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.00150376	0.06934333591063642
USHER SYNDROME, TYPE IIIA	0.00150376	0.06934333591063642
CHANARIN-DORFMAN SYNDROME	0.00150376	0.06934333591063642
NEURAMINIDASE DEFICIENCY	0.00150376	0.06934333591063642
STICKLER SYNDROME TYPE 2	0.00150376	0.06934333591063642
WOODHOUSE-SAKATI SYNDROME	0.00150376	0.06934333591063642
ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS	0.00150376	0.06934333591063642
GINGIVAL FIBROMATOSIS-PROGRESSIVE DEAFNESS SYNDROME	0.00150376	0.06934333591063642
CRANDALL SYNDROME	0.00150376	0.06934333591063642
DEAFNESS WITH LABYRINTHINE APLASIA, MICROTIA, AND MICRODONTIA	0.00150376	0.06934333591063642
WAARDENBURG SYNDROME TYPE 2	0.00150376	0.06934333591063642
NATHALIE SYNDROME	0.00150376	0.06934333591063642
NEPHROPATHY-DEAFNESS-HYPERPARATHYROIDISM SYNDROME	0.00150376	0.06934333591063642
NASODIGITOACOUSTIC SYNDROME	0.00150376	0.06934333591063642
USHER SYNDROME	0.00150376	0.06934333591063642
256120 NEPHROPATHY, DEAFNESS, AND HYPERPARATHYROIDISM	0.00150376	0.06934333591063642
TRIPLE A SYNDROME	0.00150376	0.06934333591063642
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.00150376	0.06934333591063642
THYROCEREBRORETINAL SYNDROME	0.00150376	0.06934333591063642
PRUNE BELLY SYNDROME WITH PULMONIC STENOSIS, MENTAL RETARDATION, ANDDEAFNESS	0.00150376	0.06934333591063642
FETAL IODINE SYNDROME	0.00150376	0.06934333591063642
ECTODERMAL DYSPLASIA-SENSORINEURAL DEAFNESS SYNDROME	0.00150376	0.06934333591063642
REFSUM DISEASE	0.00150376	0.06934333591063642
RENAL TUBULAR ACIDOSIS, DISTAL, WITH PROGRESSIVE NERVE DEAFNESS	0.00150376	0.06934333591063642
NEUTROPENIA-MONOCYTOPENIA-DEAFNESS SYNDROME	0.00150376	0.06934333591063642
RETINITIS PIGMENTOSA INVERSA WITH DEAFNESS	0.00150376	0.06934333591063642
SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A	0.00150376	0.06934333591063642
KNUCKLE PADS-LEUKONYCHIA-SENSORINEURAL DEAFNESS-PALMOPLANTAR HYPERKERATOSIS SYNDROME	0.00150376	0.06934333591063642
SEVERE COMBINED IMMUNODEFICIENCY	0.00150376	0.06934333591063642
MYH9-RELATED DISEASE	0.00150376	0.06934333591063642
SPONDYLOPERIPHERAL DYSPLASIA	0.00150376	0.06934333591063642
SUSAC SYNDROME	0.00150376	0.06934333591063642
%614211 DEAFNESS, AUTOSOMAL DOMINANT 33; DFNA33	0.00150376	0.06934333591063642
DYSTONIA, JUVENILE-ONSET	0.00150376	0.06934333591063642
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA 2	0.00150376	0.06934333591063642
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4	0.00150376	0.06934333591063642
OPTIC ATROPHY 8	0.00150376	0.06934333591063642
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.00150376	0.06934333591063642
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.00150376	0.06934333591063642
DEAFNESS, AUTOSOMAL RECESSIVE 103; DFNB103	0.00150376	0.06934333591063642
VOGT-KOYANAGI-HARADA DISEASE	0.00150376	0.06934333591063642
ACROCALLOSAL SYNDROME	0.00150376	0.06934333591063642
HYPEROSTOSIS CORTICALIS GENERALISATA	0.00150376	0.06934333591063642
APHONIA-DEAFNESS-RETINAL DYSTROPHY-BIFID HALLUCES-INTELLECTUAL DISABILITY SYNDROME	0.00150376	0.06934333591063642
DEAFNESS, AUTOSOMAL DOMINANT 72; DFNA72	0.00150376	0.06934333591063642
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO FKBP22 DEFICIENCY	0.00150376	0.06934333591063642
DEAFNESS-CRANIOFACIAL SYNDROME	0.00150376	0.06934333591063642
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.00150376	0.06934333591063642
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 5; PEOB5	0.00150376	0.06934333591063642
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.00150376	0.06934333591063642
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.00150376	0.06934333591063642
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K	0.00150376	0.06934333591063642
DEAFNESS-VITILIGO-ACHALASIA SYNDROME	0.00150376	0.06934333591063642
HIRSCHSPRUNG DISEASE	0.00150376	0.06934333591063642
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA WITH LATE-ONSET SPASTICITY	0.00150376	0.06934333591063642
PEROXISOME BIOGENESIS DISORDER 9B; PBD9B	0.00150376	0.06934333591063642
PERRAULT SYNDROME 2; PRLTS2	0.00150376	0.06934333591063642
CONE-ROD DYSTROPHY AND HEARING LOSS; CRDHL	0.00150376	0.06934333591063642
SHORT SYNDROME	0.00150376	0.06934333591063642
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2; FTDALS2	0.00150376	0.06934333591063642
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 6	0.00150376	0.06934333591063642
WOLFRAM SYNDROME	0.00150376	0.06934333591063642
DEAFNESS, AUTOSOMAL DOMINANT 68	0.00150376	0.06934333591063642
DEAFNESS, AUTOSOMAL RECESSIVE 97	0.00150376	0.06934333591063642
DEAFNESS, AUTOSOMAL DOMINANT 69	0.00150376	0.06934333591063642
FETAL CYTOMEGALOVIRUS SYNDROME	0.00150376	0.06934333591063642
WORSTER-DROUGHT SYNDROME	0.00150376	0.06934333591063642
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.00150376	0.06934333591063642
RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY-DEAFNESS-HYPOGONADISM SYNDROME	0.00150376	0.06934333591063642
DEAFNESS, AUTOSOMAL DOMINANT 71; DFNA71	0.00150376	0.06934333591063642
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.00150376	0.06934333591063642
DEAFNESS-LYMPHEDEMA-LEUKEMIA SYNDROME	0.00150376	0.06934333591063642
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.00150376	0.06934333591063642
DEAFNESS, AUTOSOMAL RECESSIVE 110; DFNB110	0.00150376	0.06934333591063642
THYROCEREBRORENAL SYNDROME	0.00150376	0.06934333591063642
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.00150376	0.06934333591063642
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.00150376	0.06934333591063642
HEARING LOSS-FAMILIAL SALIVARY GLAND INSENSITIVITY TO ALDOSTERONE SYNDROME	0.00150376	0.06934333591063642
DEAFNESS-OLIGODONTIA SYNDROME	0.00150376	0.06934333591063642
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE G; CMTDIG	0.00150376	0.06934333591063642
DEAFNESS, AUTOSOMAL DOMINANT 66	0.00150376	0.06934333591063642
DEAFNESS-SMALL BOWEL DIVERTICULOSIS-NEUROPATHY SYNDROME	0.00150376	0.06934333591063642
DEAF BLIND HYPOPIGMENTATION SYNDROME, YEMENITE TYPE	0.00150376	0.06934333591063642
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 50; MRT50	0.00150376	0.06934333591063642
ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS; ACPHD	0.00150376	0.06934333591063642
DEAFNESS-ENAMEL HYPOPLASIA-NAIL DEFECTS SYNDROME	0.00150376	0.06934333591063642
SPINOCEREBELLAR ATAXIA TYPE 37	0.00150376	0.06934333591063642
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.000545554	0.025157295232877144
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.000545554	0.025157295232877144
ADULT-ONSET DYSTONIA-PARKINSONISM	0.000545554	0.025157295232877144
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.000545554	0.025157295232877144
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000545554	0.025157295232877144
NIEMANN-PICK DISEASE, TYPE A	0.000545554	0.025157295232877144
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.000545554	0.025157295232877144
LISSENCEPHALY 2; LIS2	0.000545554	0.025157295232877144
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.000545554	0.025157295232877144
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.000545554	0.025157295232877144
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.000545554	0.025157295232877144
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.000545554	0.025157295232877144
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.000545554	0.025157295232877144
OROTIC ACIDURIA	0.000545554	0.025157295232877144
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.000545554	0.025157295232877144
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.000545554	0.025157295232877144
FETAL ALCOHOL SYNDROME	0.000545554	0.025157295232877144
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.000545554	0.025157295232877144
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.000545554	0.025157295232877144
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.000545554	0.025157295232877144
NAVAJO NEUROHEPATOPATHY	0.000545554	0.025157295232877144
JOUBERT SYNDROME 25	0.000545554	0.025157295232877144
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000545554	0.025157295232877144
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.000545554	0.025157295232877144
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.000545554	0.025157295232877144
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.000545554	0.025157295232877144
METHYLMALONIC ACIDURIA, CBLA TYPE	0.000545554	0.025157295232877144
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.000545554	0.025157295232877144
METHYLMALONIC ACIDURIA, CBLB TYPE	0.000545554	0.025157295232877144
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.000545554	0.025157295232877144
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.000545554	0.025157295232877144
MYOCLONIC-ASTASTIC EPILEPSY	0.000545554	0.025157295232877144
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.000545554	0.025157295232877144
ARGININEMIA	0.000545554	0.025157295232877144
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000545554	0.025157295232877144
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.000545554	0.025157295232877144
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.000545554	0.025157295232877144
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.000545554	0.025157295232877144
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.000545554	0.025157295232877144
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.000545554	0.025157295232877144
EVEN-PLUS SYNDROME	0.000545554	0.025157295232877144
EARLY MYOCLONIC ENCEPHALOPATHY	0.000545554	0.025157295232877144
HEREDITARY FOLATE MALABSORPTION	0.000545554	0.025157295232877144
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.000545554	0.025157295232877144
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.000545554	0.025157295232877144
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.000545554	0.025157295232877144
NETHERTON SYNDROME; NETH	0.000545554	0.025157295232877144
MARINESCO-SJOGREN SYNDROME; MSS	0.000545554	0.025157295232877144
TOLUENE EMBRYOPATHY	0.000545554	0.025157295232877144
MYOCLONIC EPILEPSY OF INFANCY	0.000545554	0.025157295232877144
JOUBERT SYNDROME 26	0.000545554	0.025157295232877144
PHENOBARBITAL EMBRYOPATHY	0.000545554	0.025157295232877144
ELEJALDE DISEASE	0.000545554	0.025157295232877144
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.000545554	0.025157295232877144
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.000545554	0.025157295232877144
PEHO SYNDROME; PEHO	0.000545554	0.025157295232877144
JOUBERT SYNDROME 23; JBTS23	0.000545554	0.025157295232877144
ALG1-CDG	0.000545554	0.025157295232877144
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.000545554	0.025157295232877144
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.000545554	0.025157295232877144
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.000545554	0.025157295232877144
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.000545554	0.025157295232877144
CHÉDIAK-HIGASHI SYNDROME	0.000545554	0.025157295232877144
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.000545554	0.025157295232877144
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000545554	0.025157295232877144
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.000545554	0.025157295232877144
GRISCELLI SYNDROME TYPE 1	0.000545554	0.025157295232877144
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.000545554	0.025157295232877144
MENTAL RETARDATION, X-LINKED 72	0.000545554	0.025157295232877144
300270 ADRENOMYODYSTROPHY	0.000545554	0.025157295232877144
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.000545554	0.025157295232877144
OCULO-PALATO-CEREBRAL SYNDROME	0.000545554	0.025157295232877144
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.000545554	0.025157295232877144
ALG3-CDG	0.000545554	0.025157295232877144
ALG6-CDG	0.000545554	0.025157295232877144
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.000545554	0.025157295232877144
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.000545554	0.025157295232877144
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.000545554	0.025157295232877144
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.000545554	0.025157295232877144
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.000545554	0.025157295232877144
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.000545554	0.025157295232877144
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.000545554	0.025157295232877144
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.000545554	0.025157295232877144
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000545554	0.025157295232877144
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.025157295232877144
2P21 MICRODELETION SYNDROME	0.000545554	0.025157295232877144
CLASSIC PHENYLKETONURIA	0.000545554	0.025157295232877144
FARBER DISEASE	0.000545554	0.025157295232877144
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.000545554	0.025157295232877144
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.000545554	0.025157295232877144
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.000545554	0.025157295232877144
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.000545554	0.025157295232877144
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.000545554	0.025157295232877144
ISOVALERIC ACIDEMIA	0.000545554	0.025157295232877144
PELLAGRA-LIKE SYNDROME	0.000545554	0.025157295232877144
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.000545554	0.025157295232877144
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.000545554	0.025157295232877144
REVESZ SYNDROME	0.000545554	0.025157295232877144
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.000545554	0.025157295232877144
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.000545554	0.025157295232877144
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.000545554	0.025157295232877144
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.000545554	0.025157295232877144
FETAL TRIMETHADIONE SYNDROME	0.000545554	0.025157295232877144
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.000545554	0.025157295232877144
SHWACHMAN-DIAMOND SYNDROME	0.000545554	0.025157295232877144
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000545554	0.025157295232877144
PYRUVATE CARBOXYLASE DEFICIENCY	0.000545554	0.025157295232877144
ABETAL34V AMYLOIDOSIS	0.000545554	0.025157295232877144
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000545554	0.025157295232877144
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.000545554	0.025157295232877144
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.000545554	0.025157295232877144
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.000545554	0.025157295232877144
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.000545554	0.025157295232877144
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.000545554	0.025157295232877144
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.000545554	0.025157295232877144
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.000545554	0.025157295232877144
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.000545554	0.025157295232877144
NOONAN SYNDROME 9; NS9	0.000545554	0.025157295232877144
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.000545554	0.025157295232877144
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.000545554	0.025157295232877144
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.000545554	0.025157295232877144
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.000545554	0.025157295232877144
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.000545554	0.025157295232877144
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.000545554	0.025157295232877144
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.000545554	0.025157295232877144
RING CHROMOSOME 14 SYNDROME	0.000545554	0.025157295232877144
GM2-GANGLIOSIDOSIS, AB VARIANT	0.000545554	0.025157295232877144
SULFOCYSTEINURIA	0.000545554	0.025157295232877144
SENIOR-LOKEN SYNDROME 9	0.000545554	0.025157295232877144
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.000545554	0.025157295232877144
SYNDROMIC DIARRHEA	0.000545554	0.025157295232877144
KETOADIPICACIDURIA	0.000545554	0.025157295232877144
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.000545554	0.025157295232877144
ARIMA SYNDROME	0.000545554	0.025157295232877144
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.000545554	0.025157295232877144
MONOSOMY 13Q34	0.000545554	0.025157295232877144
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.000545554	0.025157295232877144
RAHMAN SYNDROME	0.000545554	0.025157295232877144
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000545554	0.025157295232877144
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.000545554	0.025157295232877144
MECKEL SYNDROME 13; MKS13	0.000545554	0.025157295232877144
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.000545554	0.025157295232877144
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000545554	0.025157295232877144
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.000545554	0.025157295232877144
HOLOPROSENCEPHALY 2; HPE2	0.000545554	0.025157295232877144
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.000545554	0.025157295232877144
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.000545554	0.025157295232877144
ZEBRA BODY MYOPATHY	0.000545554	0.025157295232877144
RIGID SPINE SYNDROME	0.000545554	0.025157295232877144
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.000545554	0.025157295232877144
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.000545554	0.025157295232877144
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.000545554	0.025157295232877144
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.000545554	0.025157295232877144
THYROID ECTOPIA	0.000545554	0.025157295232877144
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.000545554	0.025157295232877144
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.000545554	0.025157295232877144
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.000545554	0.025157295232877144
FAMILIAL THYROID DYSHORMONOGENESIS	0.000545554	0.025157295232877144
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.000545554	0.025157295232877144
THYROID HEMIAGENESIS	0.000545554	0.025157295232877144
THYROID HYPOPLASIA	0.000545554	0.025157295232877144
PRIMARY CONGENITAL HYPOTHYROIDISM	0.000545554	0.025157295232877144
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000545554	0.025157295232877144
PELGER-HUET ANOMALY; PHA	0.000545554	0.025157295232877144
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.000545554	0.025157295232877144
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.000545554	0.025157295232877144
PERIPHERAL HYPOTHYROIDISM	0.000545554	0.025157295232877144
SEPTOOPTIC DYSPLASIA	0.000545554	0.025157295232877144
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.000545554	0.025157295232877144
MICROVILLUS INCLUSION DISEASE	0.000545554	0.025157295232877144
HEREDITARY OROTIC ACIDURIA	0.000545554	0.025157295232877144
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.000545554	0.025157295232877144
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.000545554	0.025157295232877144
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.000545554	0.025157295232877144
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.000545554	0.025157295232877144
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.000545554	0.025157295232877144
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.000545554	0.025157295232877144
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.000545554	0.025157295232877144
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.000545554	0.025157295232877144
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.000545554	0.025157295232877144
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.000545554	0.025157295232877144
HYPEREKPLEXIA 4; HKPX4	0.000545554	0.025157295232877144
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.000545554	0.025157295232877144
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.000545554	0.025157295232877144
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.000545554	0.025157295232877144
8P23.1 MICRODELETION SYNDROME	0.000545554	0.025157295232877144
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.000545554	0.025157295232877144
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.000545554	0.025157295232877144
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.000545554	0.025157295232877144
POTOCKI-SHAFFER SYNDROME	0.000545554	0.025157295232877144
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.000545554	0.025157295232877144
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.000545554	0.025157295232877144
8P11.2 DELETION SYNDROME	0.000545554	0.025157295232877144
MICRO SYNDROME	0.000545554	0.025157295232877144
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.000545554	0.025157295232877144
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.000545554	0.025157295232877144
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.000545554	0.025157295232877144
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.000545554	0.025157295232877144
JOUBERT SYNDROME 32; JBTS32	0.000545554	0.025157295232877144
CENTRAL BILATERAL MACROGYRIA	0.000545554	0.025157295232877144
JOUBERT SYNDROME 33; JBTS33	0.000545554	0.025157295232877144
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.025157295232877144
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.000545554	0.025157295232877144
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.000545554	0.025157295232877144
RETINITIS PIGMENTOSA 80; RP80	0.000545554	0.025157295232877144
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.000545554	0.025157295232877144
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.000545554	0.025157295232877144
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.000545554	0.025157295232877144
CITRULLINEMIA TYPE II	0.000545554	0.025157295232877144
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.000545554	0.025157295232877144
ATHYREOSIS	0.000545554	0.025157295232877144
PERMANENT CONGENITAL HYPOTHYROIDISM	0.000545554	0.025157295232877144
CHROMOSOME 15Q14 DELETION SYNDROME	0.000545554	0.025157295232877144
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.000545554	0.025157295232877144
HARTNUP DISEASE	0.000545554	0.025157295232877144
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.000545554	0.025157295232877144
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.000545554	0.025157295232877144
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.000545554	0.025157295232877144
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.000545554	0.025157295232877144
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.000545554	0.025157295232877144
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.000545554	0.025157295232877144
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.000545554	0.025157295232877144
HYPERMANGANESEMIA WITH DYSTONIA 2	0.000545554	0.025157295232877144
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.000545554	0.025157295232877144
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.000545554	0.025157295232877144
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.000545554	0.025157295232877144
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.000545554	0.025157295232877144
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.000545554	0.025157295232877144
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.000545554	0.025157295232877144
JOUBERT SYNDROME 35; JBTS35	0.000545554	0.025157295232877144
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.000545554	0.025157295232877144
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.000545554	0.025157295232877144
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.000545554	0.025157295232877144
HOLOPROSENCEPHALY 1; HPE1	0.000545554	0.025157295232877144
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.000545554	0.025157295232877144
HEART AND BRAIN MALFORMATION SYNDROME	0.000545554	0.025157295232877144
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.000545554	0.025157295232877144
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000545554	0.025157295232877144
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.000545554	0.025157295232877144
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.000545554	0.025157295232877144
LYSOSOMAL ACID LIPASE DEFICIENCY	0.000545554	0.025157295232877144
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.000545554	0.025157295232877144
FOLATE MALABSORPTION, HEREDITARY	0.000545554	0.025157295232877144
HARTNUP DISORDER	0.000545554	0.025157295232877144
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.000545554	0.025157295232877144
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.000545554	0.025157295232877144
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000545554	0.025157295232877144
GAUCHER DISEASE, TYPE II	0.000545554	0.025157295232877144
GERODERMA OSTEODYSPLASTICA	0.000545554	0.025157295232877144
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.000545554	0.025157295232877144
CITRULLINEMIA, CLASSIC	0.000545554	0.025157295232877144
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.000545554	0.025157295232877144
GRISCELLI SYNDROME, TYPE 1	0.000545554	0.025157295232877144
NEPHROGENIC DIABETES INSIPIDUS	0.000545554	0.025157295232877144
SENIOR-LOKEN SYNDROME	0.000545554	0.025157295232877144
CEREBELLAR ATAXIA, CAYMAN TYPE	0.000545554	0.025157295232877144
SPINOCEREBELLAR ATAXIA TYPE 7	0.000545554	0.025157295232877144
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.000545554	0.025157295232877144
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.000545554	0.025157295232877144
ARGININOSUCCINIC ACIDURIA	0.000545554	0.025157295232877144
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.000545554	0.025157295232877144
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.025157295232877144
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.000545554	0.025157295232877144
DYSTONIA 28, CHILDHOOD-ONSET	0.000545554	0.025157295232877144
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.000545554	0.025157295232877144
PITUITARY STALK INTERRUPTION SYNDROME	0.000545554	0.025157295232877144
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.000545554	0.025157295232877144
PEROXISOME BIOGENESIS DISORDER 10B	0.000545554	0.025157295232877144
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.000545554	0.025157295232877144
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.000545554	0.025157295232877144
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.000545554	0.025157295232877144
HYPERTRICHOSIS CUBITI	0.000545554	0.025157295232877144
AUSTRALIA ANTIGEN	0.000545554	0.025157295232877144
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.000545554	0.025157295232877144
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.000545554	0.025157295232877144
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.000545554	0.025157295232877144
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.000545554	0.025157295232877144
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.000545554	0.025157295232877144
JOUBERT SYNDROME 27	0.000545554	0.025157295232877144
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.000545554	0.025157295232877144
JOUBERT SYNDROME 28	0.000545554	0.025157295232877144
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.000545554	0.025157295232877144
ALAZAMI-YUAN SYNDROME	0.000545554	0.025157295232877144
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.000545554	0.025157295232877144
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.000545554	0.025157295232877144
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.000545554	0.025157295232877144
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.000545554	0.025157295232877144
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.000545554	0.025157295232877144
XQ27.3Q28 DUPLICATION SYNDROME	0.000545554	0.025157295232877144
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.000545554	0.025157295232877144
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.000545554	0.025157295232877144
JOUBERT SYNDROME 10	0.000545554	0.025157295232877144
TRANSALDOLASE DEFICIENCY	0.000545554	0.025157295232877144
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.000545554	0.025157295232877144
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.000545554	0.025157295232877144
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.000545554	0.025157295232877144
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.000545554	0.025157295232877144
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.000545554	0.025157295232877144
JOUBERT SYNDROME 6	0.000545554	0.025157295232877144
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.000545554	0.025157295232877144
MEVALONIC ACIDURIA; MEVA	0.000545554	0.025157295232877144
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.025157295232877144
PERLMAN SYNDROME	0.000545554	0.025157295232877144
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.000545554	0.025157295232877144
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.000545554	0.025157295232877144
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.000545554	0.025157295232877144
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.000545554	0.025157295232877144
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.000545554	0.025157295232877144
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.000545554	0.025157295232877144
AICARDI-GOUTIERES SYNDROME 6	0.000545554	0.025157295232877144
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.000545554	0.025157295232877144
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000545554	0.025157295232877144
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.000545554	0.025157295232877144
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.000545554	0.025157295232877144
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.000545554	0.025157295232877144
JOUBERT SYNDROME 8	0.000545554	0.025157295232877144
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.000545554	0.025157295232877144
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.000545554	0.025157295232877144
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.000545554	0.025157295232877144
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.000545554	0.025157295232877144
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.000545554	0.025157295232877144
611961 STEVENSON-CAREY SYNDROME	0.000545554	0.025157295232877144
NOONAN SYNDROME 5; NS5	0.000545554	0.025157295232877144
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.000545554	0.025157295232877144
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.000545554	0.025157295232877144
TEMPLE-BARAITSER SYNDROME; TMBTS	0.000545554	0.025157295232877144
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000545554	0.025157295232877144
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.000545554	0.025157295232877144
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.000545554	0.025157295232877144
JOUBERT SYNDROME 7	0.000545554	0.025157295232877144
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.000545554	0.025157295232877144
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.000545554	0.025157295232877144
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.000545554	0.025157295232877144
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.000545554	0.025157295232877144
SSR4-CDG	0.000545554	0.025157295232877144
STT3B-CDG	0.000545554	0.025157295232877144
STT3A-CDG	0.000545554	0.025157295232877144
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.000545554	0.025157295232877144
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.000545554	0.025157295232877144
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.000545554	0.025157295232877144
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.000545554	0.025157295232877144
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000545554	0.025157295232877144
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.000545554	0.025157295232877144
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.000545554	0.025157295232877144
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.000545554	0.025157295232877144
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.000545554	0.025157295232877144
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.000545554	0.025157295232877144
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.000545554	0.025157295232877144
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.000545554	0.025157295232877144
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.000545554	0.025157295232877144
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.000545554	0.025157295232877144
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.000545554	0.025157295232877144
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.000545554	0.025157295232877144
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000545554	0.025157295232877144
ALAZAMI SYNDROME; ALAZS	0.000545554	0.025157295232877144
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.000545554	0.025157295232877144
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.000545554	0.025157295232877144
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.000545554	0.025157295232877144
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.000545554	0.025157295232877144
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.000545554	0.025157295232877144
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.025157295232877144
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.000545554	0.025157295232877144
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.000545554	0.025157295232877144
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.000545554	0.025157295232877144
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000545554	0.025157295232877144
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.000545554	0.025157295232877144
SCHINDLER DISEASE, TYPE I	0.000545554	0.025157295232877144
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.000545554	0.025157295232877144
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.000545554	0.025157295232877144
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.000545554	0.025157295232877144
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.000545554	0.025157295232877144
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.000545554	0.025157295232877144
DIAMOND-BLACKFAN ANEMIA 5	0.000545554	0.025157295232877144
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.025157295232877144
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.000545554	0.025157295232877144
COG2-CDG	0.000545554	0.025157295232877144
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.000545554	0.025157295232877144
N-ACETYLASPARTATE DEFICIENCY; NACED	0.000545554	0.025157295232877144
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000545554	0.025157295232877144
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.000545554	0.025157295232877144
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.000545554	0.025157295232877144
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.000545554	0.025157295232877144
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.000545554	0.025157295232877144
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.000545554	0.025157295232877144
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.000545554	0.025157295232877144
LISSENCEPHALY 4	0.000545554	0.025157295232877144
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.000545554	0.025157295232877144
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.000545554	0.025157295232877144
JOUBERT SYNDROME 15	0.000545554	0.025157295232877144
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.000545554	0.025157295232877144
OROFACIODIGITAL SYNDROME TYPE 14	0.000545554	0.025157295232877144
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.000545554	0.025157295232877144
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.000545554	0.025157295232877144
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000545554	0.025157295232877144
ISOLATED GLYCEROL KINASE DEFICIENCY	0.000545554	0.025157295232877144
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.000545554	0.025157295232877144
CHROMOSOME 15Q25 DELETION SYNDROME	0.000545554	0.025157295232877144
MEVALONIC ACIDURIA	0.000545554	0.025157295232877144
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.000545554	0.025157295232877144
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000545554	0.025157295232877144
DYSTONIA-APHONIA SYNDROME	0.000545554	0.025157295232877144
ADAMS-OLIVER SYNDROME 2; AOS2	0.000545554	0.025157295232877144
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.000545554	0.025157295232877144
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.000545554	0.025157295232877144
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.000545554	0.025157295232877144
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.000545554	0.025157295232877144
RIDDLE SYNDROME	0.000545554	0.025157295232877144
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.000545554	0.025157295232877144
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.000545554	0.025157295232877144
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.000545554	0.025157295232877144
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.000545554	0.025157295232877144
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.000545554	0.025157295232877144
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.000545554	0.025157295232877144
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.000545554	0.025157295232877144
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.000545554	0.025157295232877144
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.000545554	0.025157295232877144
PRADER-WILLI-LIKE SYNDROME	0.000545554	0.025157295232877144
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.000545554	0.025157295232877144
GABA-TRANSAMINASE DEFICIENCY	0.000545554	0.025157295232877144
BETA-UREIDOPROPIONASE DEFICIENCY	0.000545554	0.025157295232877144
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.000545554	0.025157295232877144
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.000545554	0.025157295232877144
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.000545554	0.025157295232877144
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.000545554	0.025157295232877144
AICARDI-GOUTIERES SYNDROME 5	0.000545554	0.025157295232877144
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.000545554	0.025157295232877144
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.000545554	0.025157295232877144
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.000545554	0.025157295232877144
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.000545554	0.025157295232877144
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.000545554	0.025157295232877144
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.000545554	0.025157295232877144
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.000545554	0.025157295232877144
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.000545554	0.025157295232877144
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.000545554	0.025157295232877144
CONGENITAL VARICELLA SYNDROME	0.000545554	0.025157295232877144
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.000545554	0.025157295232877144
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.000545554	0.025157295232877144
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.000545554	0.025157295232877144
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.000545554	0.025157295232877144
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.000545554	0.025157295232877144
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.000545554	0.025157295232877144
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.000545554	0.025157295232877144
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.000545554	0.025157295232877144
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.000545554	0.025157295232877144
CHROMOSOME 16Q22 DELETION SYNDROME	0.000545554	0.025157295232877144
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000545554	0.025157295232877144
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.000545554	0.025157295232877144
NEPHRONOPHTHISIS 11; NPHP11	0.000545554	0.025157295232877144
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.000545554	0.025157295232877144
CHROMOSOME 4Q21 DELETION SYNDROME	0.000545554	0.025157295232877144
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.000545554	0.025157295232877144
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.000545554	0.025157295232877144
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.000545554	0.025157295232877144
DIAPHANOSPONDYLODYSOSTOSIS	0.000545554	0.025157295232877144
SPINOCEREBELLAR ATAXIA 5; SCA5	0.000545554	0.025157295232877144
BARDET-BIEDL SYNDROME 8; BBS8	0.000545554	0.025157295232877144
BARDET-BIEDL SYNDROME 3; BBS3	0.000545554	0.025157295232877144
BARDET-BIEDL SYNDROME 13; BBS13	0.000545554	0.025157295232877144
BARDET-BIEDL SYNDROME 14; BBS14	0.000545554	0.025157295232877144
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.000545554	0.025157295232877144
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.000545554	0.025157295232877144
BARDET-BIEDL SYNDROME 17; BBS17	0.000545554	0.025157295232877144
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.000545554	0.025157295232877144
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.000545554	0.025157295232877144
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.000545554	0.025157295232877144
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000545554	0.025157295232877144
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000545554	0.025157295232877144
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.000545554	0.025157295232877144
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.000545554	0.025157295232877144
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.000545554	0.025157295232877144
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.000545554	0.025157295232877144
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000545554	0.025157295232877144
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.000545554	0.025157295232877144
CONGENITAL DISORDER OF GLYCOSYLATION	0.000545554	0.025157295232877144
PROPIONIC ACIDEMIA	0.000545554	0.025157295232877144
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.000545554	0.025157295232877144
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.000545554	0.025157295232877144
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.000545554	0.025157295232877144
NIEMANN-PICK DISEASE TYPE C	0.000545554	0.025157295232877144
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.000545554	0.025157295232877144
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.000545554	0.025157295232877144
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.000545554	0.025157295232877144
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.000545554	0.025157295232877144
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.000545554	0.025157295232877144
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.000545554	0.025157295232877144
WEBB-DATTANI SYNDROME; WEDAS	0.000545554	0.025157295232877144
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.000545554	0.025157295232877144
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.000545554	0.025157295232877144
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.000545554	0.025157295232877144
WILSON-TURNER SYNDROME	0.000545554	0.025157295232877144
BARDET-BIEDL SYNDROME 2	0.000545554	0.025157295232877144
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.000545554	0.025157295232877144
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.000545554	0.025157295232877144
WAISMAN SYNDROME; WSMN	0.000545554	0.025157295232877144
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.000545554	0.025157295232877144
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.000545554	0.025157295232877144
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.000545554	0.025157295232877144
RABSON-MENDENHALL SYNDROME	0.000545554	0.025157295232877144
MENTAL RETARDATION, X-LINKED 99	0.000545554	0.025157295232877144
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.000545554	0.025157295232877144
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.000545554	0.025157295232877144
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.000545554	0.025157295232877144
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.000545554	0.025157295232877144
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000545554	0.025157295232877144
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.000545554	0.025157295232877144
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.000545554	0.025157295232877144
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.000545554	0.025157295232877144
MENTAL RETARDATION, X-LINKED 88	0.000545554	0.025157295232877144
MENTAL RETARDATION, X-LINKED 41	0.000545554	0.025157295232877144
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.000545554	0.025157295232877144
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.000545554	0.025157295232877144
MENTAL RETARDATION, X-LINKED 106; MRX106	0.000545554	0.025157295232877144
CEREBELLOFACIODENTAL SYNDROME	0.000545554	0.025157295232877144
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.000545554	0.025157295232877144
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.000545554	0.025157295232877144
ALPERS-HUTTENLOCHER SYNDROME	0.000545554	0.025157295232877144
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.000545554	0.025157295232877144
10Q22.3Q23.3 MICRODELETION SYNDROME	0.000545554	0.025157295232877144
GLYCEROL KINASE DEFICIENCY; GKD	0.000545554	0.025157295232877144
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.000545554	0.025157295232877144
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.000545554	0.025157295232877144
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.000545554	0.025157295232877144
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.000545554	0.025157295232877144
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.000545554	0.025157295232877144
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.000545554	0.025157295232877144
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000545554	0.025157295232877144
WOLMAN DISEASE	0.000545554	0.025157295232877144
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.000545554	0.025157295232877144
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.000545554	0.025157295232877144
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.000545554	0.025157295232877144
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.000545554	0.025157295232877144
GALACTOSEMIA	0.000545554	0.025157295232877144
HELSMOORTEL-VAN DER AA SYNDROME	0.000545554	0.025157295232877144
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.000545554	0.025157295232877144
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.000545554	0.025157295232877144
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.000545554	0.025157295232877144
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.000545554	0.025157295232877144
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.000545554	0.025157295232877144
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.000545554	0.025157295232877144
HYPOTONIA-CYSTINURIA SYNDROME	0.000545554	0.025157295232877144
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.000545554	0.025157295232877144
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.000545554	0.025157295232877144
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.000545554	0.025157295232877144
FUMARASE DEFICIENCY; FMRD	0.000545554	0.025157295232877144
DISTAL MONOSOMY 1Q	0.000545554	0.025157295232877144
PROPIONIC ACIDEMIA	0.000545554	0.025157295232877144
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.000545554	0.025157295232877144
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.000545554	0.025157295232877144
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.000545554	0.025157295232877144
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.000545554	0.025157295232877144
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000545554	0.025157295232877144
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.000545554	0.025157295232877144
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.000545554	0.025157295232877144
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.000545554	0.025157295232877144
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.000545554	0.025157295232877144
MAPLE SYRUP URINE DISEASE	0.000545554	0.025157295232877144
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.000545554	0.025157295232877144
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.000545554	0.025157295232877144
NIEMANN-PICK DISEASE, TYPE C2	0.000545554	0.025157295232877144
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.000545554	0.025157295232877144
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.000545554	0.025157295232877144
XQ25 MICRODUPLICATION SYNDROME	0.000545554	0.025157295232877144
OBESITY DUE TO SIM1 DEFICIENCY	0.000545554	0.025157295232877144
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.000545554	0.025157295232877144
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.000545554	0.025157295232877144
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.000545554	0.025157295232877144
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.000545554	0.025157295232877144
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.000545554	0.025157295232877144
JABERI-ELAHI SYNDROME; JABELS	0.000545554	0.025157295232877144
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.000545554	0.025157295232877144
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000545554	0.025157295232877144
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.000545554	0.025157295232877144
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.000545554	0.025157295232877144
NETHERTON SYNDROME	0.000545554	0.025157295232877144
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.000545554	0.025157295232877144
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.000545554	0.025157295232877144
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.000545554	0.025157295232877144
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.000545554	0.025157295232877144
ALDH18A1-RELATED DE BARSY SYNDROME	0.000545554	0.025157295232877144
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.000545554	0.025157295232877144
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.000545554	0.025157295232877144
XIA-GIBBS SYNDROME	0.000545554	0.025157295232877144
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.000545554	0.025157295232877144
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.000545554	0.025157295232877144
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.000545554	0.025157295232877144
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.000545554	0.025157295232877144
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.000545554	0.025157295232877144
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.000545554	0.025157295232877144
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.000545554	0.025157295232877144
CULLER-JONES SYNDROME; CJS	0.000545554	0.025157295232877144
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.000545554	0.025157295232877144
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000545554	0.025157295232877144
SECKEL SYNDROME 8; SCKL8	0.000545554	0.025157295232877144
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.000545554	0.025157295232877144
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.000545554	0.025157295232877144
MACROCEPHALY/AUTISM SYNDROME	0.000545554	0.025157295232877144
NOONAN SYNDROME 2; NS2	0.000545554	0.025157295232877144
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.025157295232877144
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.000545554	0.025157295232877144
ATELOSTEOGENESIS TYPE III	0.000545554	0.025157295232877144
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.000545554	0.025157295232877144
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.000545554	0.025157295232877144
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.000545554	0.025157295232877144
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.000545554	0.025157295232877144
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.000545554	0.025157295232877144
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.000545554	0.025157295232877144
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.000545554	0.025157295232877144
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.000545554	0.025157295232877144
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000545554	0.025157295232877144
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.000545554	0.025157295232877144
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000545554	0.025157295232877144
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.000545554	0.025157295232877144
